Infection Flashcards

1
Q

COVID-19?

A

infectious disease caused by the novel coronavirus SARS-CoV-2, first identified in Wuhan, China, in late 2019. It has led to a global pandemic with significant morbidity and mortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

COVID-19 presents with?

A

wide spectrum of clinical manifestations, from asymptomatic to severe respiratory failure and multi-organ dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cause of COVID-19?

A

Causative Agent: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Transmission of COVID-19?

A

Primarily via respiratory droplets

Contact with contaminated surfaces

Aerosol transmission in certain settings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology of COVID-19?

A

Virus binds to the ACE2 receptor on host cells, facilitating entry and replication

Causes a range of immune responses from mild inflammation to cytokine storm

Predominantly affects the respiratory system but can involve multiple organ systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical features of COVID-19?

A

Common: Fever, cough, fatigue, loss of taste or smell, myalgia

Severe: Shortness of breath, chest pain, confusion, bluish lips or face

Other: Gastrointestinal symptoms (nausea, diarrhoea), dermatological manifestations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

COVID-19 disease course?

A

Incubation period: 2-14 days, median 5 days

Mild to moderate illness: Majority of cases

Severe illness: Occurs in approximately 14% of cases, characterised by hypoxia and pneumonia

Critical illness: Approximately 5% of cases, involving respiratory failure, shock, and multi-organ dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COVID-19 incubation period?

A

2-14d, median 5d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnosis of COVID-19?

A

Testing=
Reverse transcription polymerase chain reaction (RT-PCR): GOLD STANDARD for diagnosis, detects viral RNA

Antigen Tests: Useful for rapid diagnosis but less sensitive than RT-PCR

Serological Tests: Detect antibodies, used for assessing past infection and immune response

  • CXR: May show bilateral infiltrates
  • CT: More sensitive, can reveal ground-glass opacities and consolidation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

COVID-19= what does CXR and CT show?

A
  • CXR: May show bilateral infiltrates
  • CT: More sensitive, can reveal ground-glass opacities and consolidation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

COVID-19 gold standard for diagnosis?

A

Reverse transcription polymerase chain reaction (RT-PCR): detects viral RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mx of COVID-19?

A
  • general measures= isolation to prevent transmission; supportive- hydration, antipyretics, O2 therapy
  • pharmacological Tx
  • supportive care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mx of COVID-19= supportive care?

A

Oxygen Therapy: Nasal cannula, high-flow nasal oxygen, non-invasive ventilation

Mechanical Ventilation: For patients with refractory hypoxia

Extracorporeal Membrane Oxygenation (ECMO): In cases of severe ARDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mx of COVID-19= pharmacological Tx?

A

Antivirals= Remdesivir for hospitalised patients requiring oxygen

Corticosteroids= Dexamethasone for hospitalised patients requiring oxygen

Immunomodulators= Baricitinib or tocilizumab in selected cases with systemic inflammation / requiring higher levels of oxygen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

COVID-19= prevention and vaccination?

A

Vaccination is the cornerstone of prevention, with several vaccines approved for use in the UK (e.g., Pfizer-BioNTech, Moderna, AstraZeneca)

Booster doses recommended to maintain immunity, especially in vulnerable populations

Non-pharmacological interventions: Mask-wearing, hand hygiene, social distancing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Prognosis of COVID-19?

A

Prognostic Factors:
- Age, comorbidities (e.g., cardiovascular disease, diabetes, obesity), and severity of respiratory involvement
- Early intervention and supportive care improve outcomes

Outcomes:
- Recovery in mild to moderate cases usually within 2-6 weeks
- Long-term sequelae (Long COVID) in some patients, including fatigue, dyspnoea, cognitive impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Coronavirus disease (COVID-19) definition?

A

infectious disease caused by a novel betacoronavirus known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

‘Acute COVID-19’?

A

signs and symptoms of infection consistent with COVID-19 for up to 4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

‘Ongoing symptomatic COVID-19’?

A

signs and symptoms of COVID-19 infection from 4–12 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

‘Post-COVID-19 syndrome’?

A

signs and symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks, and are not explained by an alternative diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

‘Longer term effects of COVID-19’ or ‘long COVID’ ?

A

signs and symptoms that develop during or after an infection consistent with COVID-19, continue for more than 4 weeks, and are not explained by an alternative diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Risk factors for severe infection of COVID-19?

A

increasing age, male sex, co-morbidities, health and social care workers, and Black and Asian ethnic groups.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cx of COVID-19?

A

acute respiratory distress syndrome; venous thromboembolism; acute myocardial or kidney injury; and sepsis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When to suspect COVID-19?

A

Fever or chills.
A new, continuous cough; breathlessness.
A loss or change to sense of smell or taste.
Fatigue; muscle aches and pains; headache.
Sore throat; blocked or runny nose.
Loss of appetite; diarrhoea; nausea and/or vomiting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
If a person has suspected or confirmed COVID-19, assessment for severe illness includes identifying:
Severe breathlessness; haemoptysis; hypoxia. Cyanosis; feeling cold and clammy; pale or mottled skin. Collapse or syncope. New confusion; drowsiness. Reduced urine output.
26
If a person has suspected COVID-19 and hospital admission is not needed, management includes advice to:
Take a lateral flow test if a person is at highest risk of becoming seriously ill. Try to stay at home and avoid contact with other people, for all other people. Self-manage symptoms and consider self-monitoring at home.
27
If a person has suspected or confirmed COVID-19, hospital admission should be arranged if the person:
Is moderately or severely unwell. Has a suspected acute or life-threatening complication.
28
If a person has confirmed COVID-19 and hospital admission is not needed, management includes advice:
About antibody and antiviral treatments for people at highest risk of becoming seriously ill. To try to stay at home and avoid contact with other people, for all other people. To self-manage symptoms and consider self-monitoring at home. To notify any confirmed case to the local health protection team.
29
Advice for all people to live safely with COVID-19 includes
Getting vaccinated, ensuring adequate ventilation, good hygiene, and when to consider wearing a face covering or mask. Accessing mental health support, if needed. Entry requirements and travel warnings when travelling abroad. Support at work, self-employment and benefits.
30
Hypoxia (reduced oxygen saturation levels measured by pulse oximetry) levels in COVID-19?
92% or less in room air in adults (suggests severe hypoxia). >4% lower than usual levels (suggests severe hypoxia). 93–94% in room air in adults (suggests moderate hypoxia). below 91% in room air at rest in children and young people aged 17 years and under (suggests severe hypoxia). Consider using 'exertion oximetry' tests (such as the 40-step walk and one-minute sit-to-stand tests) if oxygen saturation is at least 93% and the person is aged 65 years or more and/or at highest risk of serious illness, to assess for oxygen desaturation on exercise — a 3% or greater reduction in oxygen saturation level is considered significant.
31
If the person has been in close contact with a person with COVID-19: If they are a household or overnight contact of a person who has had a positive COVID-19 test result, advise that it can take up to how long for infection to develop?
10d
32
Advise on common new or ongoing symptoms after COVID-19, and expected recovery times. Reassure that for most people symptoms resolve by
12w
33
People with the following clinical conditions are at highest risk of getting seriously ill from COVID-19 infection
Down's syndrome or other chromosomal disorders known to affect immune competence. Certain types of solid cancer, and/or received or receiving treatment for certain types of cancer. Haematological diseases (such as some forms of leukaemia, lymphoma, myeloma, myelodysplastic syndrome, myelofibrosis, sickle cell disease) and recipients of haematological stem cell transplant. Renal disease (including renal transplant recipients, non-transplant renal patients who are immunosuppressed, chronic kidney disease [CKD] stage 4 or 5). Liver disease (some forms of cirrhosis especially decompensated liver disease, liver transplant recipients, liver disease on immunosuppressive therapy). Other solid organ transplant recipients. Immune-mediated inflammatory disorders (including people taking some forms of immunotherapy, biologics, JAK-inhibitors, corticosteroids, uncontrolled or clinically active disease, major organ involvement). Immune deficiencies (including common variable immune deficiency, severe combined immunodeficiency). HIV or AIDS (if immunosuppressed, have uncontrolled or untreated HIV, or acute presentation of AIDS-defining diagnosis). Rare neurological and neurodisability conditions (multiple sclerosis, motor neurone disease, myasthenia gravis, or Huntington's disease)
34
COVID-19= In the UK, the following vaccines targeting the S protein have been authorized for supply....
Two vaccines use an mRNA platform (Pfizer BioNTech BNT162b2 vaccine, Comirnaty®) and Moderna mRNA-1273 COVID-19 vaccine (Spikevax®). These vaccines have no whole or live virus involved, and the vaccines cannot cause disease. The mRNA naturally degrades after a few days. - Comirnaty 3 micrograms/dose mRNA COVID-19 vaccine is licensed for use in infants and children aged 6 months to 4 years. Two vaccines use an adenovirus vector (AstraZeneca COVID-19 ChAdOx1-S vaccine/Vaxzevria®) and COVID-19 Janssen Ad26.COV2-S (recombinant, less widely used). The adenovirus is modified so it cannot replicate in human cells, and cannot cause disease.
35
The recommended vaccines for the autumn 2024 campaign are monovalent products containing mRNA for the spike protein of the JN.1 sub-lineage of the Omicron variant strain of the SARS-CoV-2 virus. What are they?
18 years and over: - Moderna mRNA (Spikevax) vaccine 50 micrograms , or - Pfizer-BioNTech mRNA (Comirnaty) vaccine 30 micrograms 12 to 17 years: - Pfizer-BioNTech mRNA (Comirnaty) vaccine 30 micrograms 5 to 11 years: - Pfizer-BioNTech mRNA (Comirnaty) vaccine 10 micrograms 6 months to 4 years. - Pfizer-BioNTech mRNA (Comirnaty) vaccine 3 micrograms
36
Prolonged symptoms of COVID-19 is or is not a contraindication to COVID-19 vaccine.
NOT but active illness is
37
Common or very common adverse effects of COVID-19 vaccines?
Local injection site reactions, such as pain, swelling, redness, tenderness; fatigue; headache; chills; myalgia; arthralgia; fever. Lymphadenopathy (in the axillary, supraclavicular, or cervical areas on the ipsilateral side to injection).
38
COVID-19 vaccines are what?
black triangle drugs, and any adverse reactions should be reported to the Medicines and Healthcare products Regulatory Agency (MHRA) using the Coronavirus Yellow Card reporting site.
39
Rare or uncommon potential adverse effects of COVID-19 vaccines?
Myocarditis and pericarditis Vaccine-induced immune thrombocytopenia and thrombosis (VITT) Acute disseminated encephalomyelitis (ADEM) — extremely rare cases have been reported following vaccination with the AstraZeneca vaccine, although a causal relationship has not been established. Cases with fatal outcome have been reported. Guillain-Barré syndrome Capillary leak syndrome Transverse myelitis Dizziness Paraesthesia and hypoaesthesia
40
Recommended COVID-19 vaccines for pregnant women?
If she is over the age of 18 years, the Pfizer BioNTech or Moderna vaccines should be offered. If she is under the age of 18 years, the Pfizer BioNTech vaccine should be offered. If she has already received a dose of the AstraZeneca vaccine, she can complete the course with the same vaccine or an mRNA vaccine. If a woman finds out she is pregnant after she has started a course of vaccine: She may complete vaccination during pregnancy, and should complete vaccination at the recommended interval. If a woman is breastfeeding: Advise there is no known risk associated with a non-live COVID-19 vaccine while breastfeeding.
41
There is no evidence for any safety concerns with the co-administration of COVID-19 vaccine with other vaccines, and interference between inactivated vaccines with different antigenic content is likely to be limited. Be aware that co-administration may make the attribution of adverse effects more difficult. Be aware that administration of Novavax COVID-19 vaccine should be separated from administration of .....
influenza vaccine by at least 7 days.
42
Viral warts?
common and do not require treatment unless painful, unsightly or a patient is requesting treatment for a persistent wart.
43
Prognosis of viral warts?
Most of them will resolve spontaneously within months or at most within 2 years. In adults it can take up to 10 years.
44
Gangrene?
death of body tissue due to a lack of blood supply, infection, or both
45
Where does gangrene commonly affect?
anywhere but commonly in the extremities, such as the toes, fingers, feet, and hands
46
Why is gangrene a medical emergency that requires prompt diagnosis and Tx?
to prevent further tissue loss, systemic infection, and potentially life-threatening complications
47
Pathophysiology of gangrene?
involves the interruption of blood supply, leading to tissue ischaemia and necrosis
48
The pathophysiology of gangrene involves the interruption of blood supply, leading to tissue ischaemia and necrosis. This can occur due to what?
Arterial occlusion: Atherosclerosis, thrombosis, or embolism can obstruct blood flow. Infection: Bacteria, especially in wet and gas gangrene, can exacerbate tissue necrosis through toxin production. Trauma: Severe injuries can compromise blood supply and introduce pathogens. Chronic conditions: Diabetes mellitus and other chronic diseases can predispose individuals to gangrene by impairing vascular function and immune response.
49
Types of gangrene?
1) Dry gangrene 2) Wet gangrene 3) Gas gangrene (Clostridial myonecrosis) 4) Necrotising fasciitis
50
Types of gangrene= dry gangrene- cause?
chronic ischaemia, usually due to peripheral arterial disease (PAD).
51
Types of gangrene= dry gangrene- appearance?
Characterised by dry, shrivelled, and blackened tissue ('mummified'). Clear demarcation between healthy and necrotic tissue. Typically painless due to nerve damage.
52
Types of gangrene= dry gangrene- prognosis?
Often develops slowly and is usually not associated with infection.
53
Types of gangrene= wet gangrene- cause?
Results from a sudden lack of blood supply combined with bacterial infection.
54
Types of gangrene= wet gangrene- appearance?
Swollen, moist, and blistered tissue with a foul odour. Rapid spread and marked systemic symptoms such as fever and malaise. Severe pain and erythema around the affected area.
55
Types of gangrene= wet gangrene- prognosis?
Progresses rapidly and can lead to systemic sepsis.
56
Types of gangrene= gas gangrene (Clostridial myonecrosis)- cause?
Caused by infection with Clostridium bacteria, which produce gas and toxins.
57
Types of gangrene= gas gangrene (Clostridial myonecrosis)- appearance?
Severe pain and swelling at the site of infection. Crepitus due to gas production by Clostridium bacteria. Rapid onset of systemic symptoms, including tachycardia, hypotension, and shock.
58
Types of gangrene= gas gangrene (Clostridial myonecrosis)- prognosis?
Requires urgent medical intervention due to rapid progression and high mortality.
59
Types of gangrene= necrotising fasciitis?
A severe form of gangrene involving the fascia and subcutaneous tissues.
60
Types of gangrene= necrotising fasciitis- cause?
Caused by mixed bacterial infections, often including Streptococcus pyogenes and Staphylococcus aureus.
61
Types of gangrene= necrotising fasciitis- appearance?
Intense pain disproportionate to the visible signs. Rapid progression of erythema, swelling, and tissue necrosis. Systemic signs of sepsis, such as fever, tachycardia, and hypotension
62
Mx of gangrene requires what?
urgent intervention to control infection, restore blood supply, and remove necrotic tissue
63
Key Mx strategies of gangrene?
- surgical intervention - antibiotic therapy - supportive care - hyperbaric oxygen therapy
64
Mx of gangrene= surgical intervention?
Debridement: Surgical removal of necrotic tissue to prevent the spread of infection. Amputation: In severe cases, partial or complete amputation of the affected limb may be necessary. Revascularisation: Procedures such as angioplasty or bypass surgery to restore blood flow in cases of arterial occlusion.
65
Mx of gangrene= antibiotic therapy?
Empirical broad-spectrum antibiotics initially, followed by targeted therapy based on culture results. For gas gangrene, high-dose penicillin and clindamycin are often recommended.
66
Mx of gangrene= antibiotic therapy recommended for gas gangrene?
high-dose penicillin and clindamycin
67
Mx of gangrene= supportive care?
Management of systemic symptoms, including fluid resuscitation, pain control, and nutritional support. Monitoring and treatment of comorbid conditions such as diabetes and cardiovascular disease.
68
Mx of gangrene= hyperbaric oxygen therapy?
Used in some cases of gas gangrene to enhance oxygen delivery to ischaemic tissues and inhibit anaerobic bacterial growth.
69
Why is diarrhoea common in pts with HIV?
may be due to the effects of the virus itself (HIV enteritis) or opportunistic infections
70
Possible causes of diarrhoea in pts with HIV?
Cryptosporidium + other protozoa (most common) Cytomegalovirus Mycobacterium avium intracellulare Giardia
71
Most common cause of diarrhoea in pts with HIV?
Cryptosporidium
72
Cryptosporidium causing diarrhoea in pts with HIV?
an intracellular protozoa and has an incubation period of 7 days Presentation is very variable, ranging from mild to severe diarrhoea
73
Cryptosporidium causing diarrhoea in pts with HIV= staining?
A modified Ziehl-Neelsen stain (acid-fast stain) of the stool may reveal the characteristic red cysts of Cryptosporidium.
74
Cryptosporidium causing diarrhoea in pts with HIV= Tx?
difficult, with the mainstay of management being supportive therapy (nitazoxanide is licensed in the US for immunocompetent patients)
75
Mycobacterium avium intracellulare causing diarrhoea in pts with HIV?
an atypical mycobacteria seen with the CD4 count is below 50. Typical features include fever, sweats, abdominal pain and diarrhoea. There may be hepatomegaly and deranged LFTs. Diagnosis is made by blood cultures and bone marrow examination.
76
Mycobacterium avium intracellulare causing diarrhoea in pts with HIV= Mx?
rifabutin, ethambutol and clarithromycin
77
Mycobacterium avium intracellulare causing diarrhoea in pts with HIV= diagnosis?
may be hepatomegaly and deranged LFTs Diagnosis is made by blood cultures and bone marrow examination
78
Kaposi's sarcoma= caused by what?
HHV-8 (human herpes virus 8)
79
Kaposi's sarcoma= presentation?
purple papules or plaques on the skin or mucosa (e.g. gastrointestinal and respiratory tract) skin lesions may later ulcerate respiratory involvement may cause massive haemoptysis and pleural effusion
80
Pt with HIV: - purple papules or plaques on the skin or mucosa (e.g. gastrointestinal and respiratory tract) - skin lesions may later ulcerate - respiratory involvement may cause massive haemoptysis and pleural effusion
Kaposi's sarcoma
81
Kaposi's sarcoma= Mx?
radiotherapy + resection
82
Kaposi's sarcoma more common in who?
pt with HIV
83
HIV= Antiretroviral therapy (ART) involves a combination of what?
at least three drugs, typically two nucleoside reverse transcriptase inhibitors (NRTI) and either a protease inhibitor (PI) or a non-nucleoside reverse transcriptase inhibitor (NNRTI)
84
HIV= Antiretroviral therapy (ART)- the combination of drugs decreases what?
viral replication but also reduces the risk of viral resistance emerging
85
HIV= it is now recommended that patients start ART when?
as soon as they have been diagnosed with HIV, rather than waiting until a particular CD4 count, as was previously advocated.
86
HIV Mx= entry inhibitors?
maraviroc (binds to CCR5, preventing an interaction with gp41), enfuvirtide (binds to gp41, also known as a 'fusion inhibitor') prevent HIV-1 from entering and infecting immune cells
87
HIV Mx= Nucleoside analogue reverse transcriptase inhibitors (NRTI)?
examples: zidovudine (AZT), abacavir, emtricitabine, didanosine, lamivudine, stavudine, zalcitabine, tenofovir general NRTI side-effects: peripheral neuropathy tenofovir: used in BHIVAs two recommended regime NRTI. Adverse effects include renal impairment and ostesoporosis zidovudine: anaemia, myopathy, black nails didanosine: pancreatitis
88
HIV Mx= Nucleoside analogue reverse transcriptase inhibitors (NRTI) general side effects?
peripheral neuropathy
89
HIV Mx= Nucleoside analogue reverse transcriptase inhibitors (NRTI)- tenofovir?
used in BHIVAs two recommended regime NRTI. Adverse effects include renal impairment and ostesoporosis
90
HIV Mx= Nucleoside analogue reverse transcriptase inhibitors (NRTI)- zidovudine?
anaemia, myopathy, black nails
91
HIV Mx= Nucleoside analogue reverse transcriptase inhibitors (NRTI)- didanosine?
pancreatitis
92
HIV Mx= Non-nucleoside reverse transcriptase inhibitors (NNRTI)?
examples: nevirapine, efavirenz side-effects: P450 enzyme interaction (nevirapine induces), rashes
93
HIV Mx= Protease inhibitors (PI)?
examples: indinavir, nelfinavir, ritonavir, saquinavir side-effects: diabetes, hyperlipidaemia, buffalo hump, central obesity, P450 enzyme inhibition indinavir: renal stones, asymptomatic hyperbilirubinaemia ritonavir: a potent inhibitor of the P450 system
94
HIV Mx= Protease inhibitors (PI)- side effects?
diabetes, hyperlipidaemia, buffalo hump, central obesity, P450 enzyme inhibition
95
HIV Mx= Protease inhibitors (PI)- indinavir?
renal stones, asymptomatic hyperbilirubinaemia
96
HIV Mx= Protease inhibitors (PI)- ritonavir?
a potent inhibitor of the P450 system
97
HIV Mx= Integrase inhibitors?
block the action of integrase, a viral enzyme that inserts the viral genome into the DNA of the host cell examples: raltegravir, elvitegravir, dolutegravir
98
HIV Mx= Integrase inhibitors examples?
raltegravir, elvitegravir, dolutegravir
99
HIV focal neurological lesions= Toxoplasmosis?
accounts for around 50% of cerebral lesions in patients with HIV constitutional symptoms, headache, confusion, drowsiness
100
HIV focal neurological lesions= Toxoplasmosis- CT findings?
single or multiple ring enhancing lesions, mass effect may be seen
101
HIV focal neurological lesions= Toxoplasmosis- Mx?
sulfadiazine and pyrimethamine
102
HIV focal neurological lesions= Primary CNS lymphoma?
accounts for around 30% of cerebral lesions associated with the Epstein-Barr virus
103
HIV focal neurological lesions= Primary CNS lymphoma- CT findings?
single or multiple homogenous enhancing lesions
104
HIV focal neurological lesions= Primary CNS lymphoma- Tx?
involves steroids (may significantly reduce tumour size), chemotherapy (e.g. methotrexate) + with or without whole brain irradiation. Surgical may be considered for lower grade tumours
105
HIV focal neurological lesions= Differentiating between toxoplasmosis and lymphoma is a common clinical scenario in HIV patients. It is clearly important given the vastly
different treatment strategies.
106
HIV focal neurological lesions= Toxoplasmosis vs Primary CNS lymphoma?
Lymphoma= Single lesion; Solid (homogenous) enhancement; Thallium SPECT positive Toxoplasmosis= Multiple lesions, Ring or nodular enhancement, Thallium SPECT negative TB= single enhancing lesion
107
HIV focal neurological lesions= Tuberculosis?
much less common than toxoplasmosis or primary CNS lymphoma
108
HIV focal neurological lesions= Tuberculosis- CT findings?
single enhancing lesion
109
HIV general neurological disease= encephalitis?
may be due to CMV or HIV itself HSV encephalitis but is relatively rare in the context of HIV
110
HIV general neurological disease= encephalitis- CT findings?
oedematous brain
111
HIV general neurological disease= Cryptococcus?
most common fungal infection of CNS headache, fever, malaise, nausea/vomiting, seizures, focal neurological deficit
112
HIV general neurological disease= Cryptococcus- CSF findings?
high opening pressure elevated protein reduced glucose normally a lymphocyte predominance but in HIV white cell count many be normal India ink test positive
113
HIV general neurological disease= Cryptococcus- CT findings?
meningeal enhancement, cerebral oedema
114
HIV general neurological disease= Cryptococcus- what is a typical presentation?
meningitis is typical presentation but may occasionally cause a space-occupying lesion
115
HIV general neurological disease= most common fungal infection of CNS?
Cryptococcus
116
HIV general neurological disease= Progressive multifocal leukoencephalopathy (PML)?
widespread demyelination due to infection of oligodendrocytes by JC virus (a polyoma DNA virus)
117
HIV general neurological disease= Progressive multifocal leukoencephalopathy (PML)- symptoms?
subacute onset : behavioural changes, speech, motor, visual impairment
118
HIV general neurological disease= Progressive multifocal leukoencephalopathy (PML)- CT findings?
single or multiple lesions, no mass effect, don't usually enhance. MRI is better - high-signal demyelinating white matter lesions are seen
119
HIV general neurological disease= AIDS dementia complex?
caused by HIV virus itself symptoms: behavioural changes, motor impairment
120
HIV general neurological disease= AIDS dementia complex- CT findings?
cortical and subcortical atrophy
121
most common cause of oesophagitis in patients with HIV?
Oesophageal candidiasis
122
HIV= Oesophageal candidiasis generally seen in who?
generally seen in patients with a CD4 count of less than 100
123
HIV= Oesophageal candidiasis?
most common cause of oesophagitis in patients with HIV
124
HIV= Oesophageal candidiasis symptoms?
dysphagia and odynophagia
125
HIV= Oesophageal candidiasis Tx?
1st line treatments= Fluconazole and itraconazole
126
HIV= some infections and other disorders may be encountered by pts with HIV according to what?
CD4 count
127
HIV= List 4 infections/disorders may be likely if CD4 count 200 - 500 cells/mm³?
Oral thrush Shingles Hairy leukoplakia Kaposi sarcoma
128
HIV= infections/disorders may be likely if CD4 count 200 - 500: oral thrush secondary to?
Candida albicans
129
HIV= infections/disorders may be likely if CD4 count 200 - 500: shingles secondary to?
herpes zoster
130
HIV= infections/disorders may be likely if CD4 count 200 - 500: hairy leukoplakia secondary to?
EBV
131
HIV= infections/disorders may be likely if CD4 count 200 - 500: Kaposi sarcoma secondary to?
HHV-8
132
HIV= List 5 infections/disorders may be likely if CD4 count 100-200 cells/mm³?
Cryptosporidiosis Cerebral toxoplasmosis Progressive multifocal leukoencephalopathy Pneumocystis jirovecii pneumonia HIV dementia
133
HIV= infections/disorders may be likely if CD4 count 100-200: Cryptosporidiosis?
Whilst patients with a CD4 count of 200-500 may develop cryptosporidiosis the disease is usually self-limiting and similar to that in immunocompetent hosts
134
HIV= infections/disorders may be likely if CD4 count 100-200: Progressive multifocal leukoencephalopathy secondary to what?
JC virus
135
HIV= List 4 infections/disorders may be likely if CD4 count 50-100 cells/mm³?
Aspergillosis Oesophageal candidiasis Cryptococcal meningitis Primary CNS lymphoma
136
HIV= infections/disorders may be likely if CD4 count 50-100: aspergillosis secondary to what?
Aspergillus fumigatus
137
HIV= infections/disorders may be likely if CD4 count 50-100: oesophageal candidiasis secondary to what?
Candida albicans
138
HIV= infections/disorders may be likely if CD4 count 50-100: primary CNS lyphoma secondary to what?
EBV
139
HIV= List 2 infections/disorders may be likely if CD4 count <50 cells/mm³?
Cytomegalovirus retinitis Mycobacterium avium-intracellulare infection
140
HIV= infections/disorders may be likely if CD4 count <50: Cytomegalovirus retinitis?
Affects around 30-40% of patients with CD4 < 50 cells/mm³
141
HIV= What affects around 30-40% of patients with CD4 < 50 cells/mm³?
Cytomegalovirus retinitis
142
Pneumocystis carinii is now referred to as...
Pneumocystis jiroveci, the term Pneumocystis carinii pneumonia (PCP) is still in common use
143
HIV= Pneumocystis jiroveci pneumonia?
an unicellular eukaryote, generally classified as a fungus but some authorities consider it a protozoa most common opportunistic infection in AIDS
144
most common opportunistic infection in AIDS?
Pneumocystis jiroveci
145
HIV= all pts with CD4 count <200 should have what?
PCP prophylaxis (Pneumocystis jiroveci)
146
HIV= Pneumocystis jiroveci pneumonia features?
dyspnoea dry cough fever very few chest signs
147
HIV= Pneumocystis jiroveci pneumonia (PCP) common Cx?
Pneumothorax
148
HIV= Pneumocystis jiroveci pneumonia (PCP) extrapulmonary manifestations?
rare (1-2%) hepatosplenomegaly lymphadenopathy choroid lesions
149
HIV= Pneumocystis jiroveci pneumonia (PCP) Ix?
CXR: typically shows bilateral interstitial pulmonary infiltrates but can present with other x-ray findings e.g. lobar consolidation. May be normal exercise-induced desaturation sputum often fails to show PCP, bronchoalveolar lavage (BAL) often needed to demonstrate PCP (silver stain shows characteristic cysts)
150
HIV= Pneumocystis jiroveci pneumonia (PCP) Ix- CXR shows what?
typically shows bilateral interstitial pulmonary infiltrates but can present with other x-ray findings e.g. lobar consolidation. May be normal
151
HIV= Pneumocystis jiroveci pneumonia (PCP) Ix- sputum often fails to show PCP, bronchoalveolar lavage (BAL) often needed to demonstrate PCP. Results?
silver stain shows characteristic cysts
152
HIV= Pneumocystis jiroveci pneumonia (PCP) Mx?
co-trimoxazole IV pentamidine in severe cases steroids if hypoxic (if pO2 < 9.3kPa then steroids reduce risk of respiratory failure by 50% and death by a third) aerosolized pentamidine is an alternative treatment for Pneumocystis jiroveci pneumonia but is less effective with a risk of pneumothorax
153
Renal involvement in HIV patients may occur as a consequence of what?
Tx or the virus itself
154
Renal involvement in HIV= Protease inhibitors such as indinavir can precipitate what?
intratubular crystal obstruction
155
HIV-associated nephropathy (HIVAN)= Tx?
Antiretroviral therapy If a patient is already taking antiretroviral therapy (which should be all HIV-diagnosed patients) adherence should be checked.
156
HIV-associated nephropathy (HIVAN)= 5 key features?
massive proteinuria resulting in nephrotic syndrome normal or large kidneys focal segmental glomerulosclerosis with focal or global capillary collapse on renal biopsy elevated urea and creatinine normotension
157
Pt with HIV massive proteinuria resulting in nephrotic syndrome normal or large kidneys focal segmental glomerulosclerosis with focal or global capillary collapse on renal biopsy elevated urea and creatinine normotension
HIV-associated nephropathy (HIVAN)
158
HIVAN stands for what?
HIV-associated nephropathy
159
HIV-associated nephropathy (HIVAN)= there is massive proteinuria resulting in what?
nephrotic syndrome
160
HIV-associated nephropathy (HIVAN)= what is shown on renal biopsy?
focal segmental glomerulosclerosis with focal or global capillary collapse
161
HIV seroconversion is symptomatic in 60-80% of patients and typically presents as what?
glandular fever-type illness
162
glandular fever-type illness in HIV pt?
HIV seroconversion
163
HIV seroconversion= Increased symptomatic severity is associated with what?
poorer long-term prognosi
164
HIV seroconversion= typically occurs when?
3-12w after infection
165
HIV seroconversion= features?
sore throat lymphadenopathy malaise, myalgia, arthralgia diarrhoea maculopapular rash mouth ulcers rarely meningoencephalitis
166
HIV replication stages?
1) Fusion of HIV to host cell surface 2) HIV RNA, reverse transcriptase, integrase and other viral proteins enter the host cell 3) Viral DNA is formed by reverse transcription 4) Viral DNA is transported across the nucleus and integrates into the host DNA 5) New viral RNA is used as genomic RNA and to make viral proteins 6) New viral RNA and proteins move to cell surface and a new immature HIV forms 7) The virus matures by protease releasing individual HIV proteins
167
HIV seroconversion?
period when the body produces antibodies to fight the HIV virus Seroconversion can be mild (not notice it), mistaken for the flu, or severe enough to require hospitalization period when someone with HIV is most infectious After seroconversion, most people feel well and don't have symptoms for several years However, the virus is still active and damaging the immune system
168
Diagnosis and screening for HIV?
combination tests (HIV p24 antigen and HIV antibody) are now standard if the combined test is positive it should be repeated to confirm the diagnosis some centres may also test the viral load (HIV RNA levels) if HIV is suspected at the same time
169
Diagnosis of HIV= HIV antibodies?
may not be present in early infection, but most people develop antibodies to HIV at 4-6 weeks but 99% do by 3 months usually consists of both a screening ELISA (Enzyme Linked Immuno-Sorbent Assay) test and a confirmatory Western Blot Assay
170
Diagnosis of HIV= p24 antigen?
a viral core protein that appears early in the blood as the viral RNA levels rise usually positive from about 1 week to 3 - 4 weeks after infection with HIV
171
Diagnosis of HIV= what is the standard test?
combination tests (HIV p24 antigen and HIV antibody) if the combined test is positive it should be repeated to confirm the diagnosis some centres may also test the viral load (HIV RNA levels) if HIV is suspected at the same time
172
Diagnosis of HIV= testing for HIV in asymptomatic patients should be done at?
4 weeks after possible exposure
173
Diagnosis of HIV= after an initial negative result when testing for HIV in an asymptomatic patient, offer what?
repeat test at 12w
174
Main tests available to test for HIV?
- HIV antibody - HIV antibody and antigen - HIV RNA (qualitative or quantitative)
175
Main tests available to test for HIV= HIV antibody?
enzyme-linked immunosorbent assays (ELISAs) are often used for screening Western blot was previously used as a confirmation test but HIV-1/HIV-2 differentiation assays are now more commonly used most people develop antibodies to HIV at 4-6 weeks but 99% do by 3 months
176
Main tests available to test for HIV= HIV antibody and HIV antigen?
often referred to as 'fourth-generation' tests p24 antigen can be detected as early as 2-3 weeks after exposure the sensitivity of these fourth-generation tests approaches 100% for patients with chronic HIV infection now the first-line test for HIV screening of asymptomatic individuals or patients with signs and symptoms of chronic infection
177
Main tests available to test for HIV= first-line test for HIV screening of asymptomatic individuals or patients with signs and symptoms of chronic infection?
HIV antibody and HIV antigen
178
Main tests available to test for HIV= HIV RNA (qualitative or quantitative)?
not routinely used for screening/testing however, may be useful for diagnosis of neonatal HIV infection and screening blood donors
179
Human immunodeficiency virus (HIV) is what?
retrovirus that preferentially infects and destroys cells of the immune system, in particular the CD4 cells (a class of T lymphocyte).
180
How is HIV transmitted?
from infected body fluids: Through sexual activity. Vertically from mother to child — during pregnancy, childbirth, or through breastfeeding. By inoculation — via a contaminated needle, instrument, blood, or blood product; through direct exposure of mucous membranes or an open wound to infected bodily fluids; or by a human bite that breaks the skin.
181
Primary HIV infection (PHI) or HIV seroconversion illness often presents with?
a flu-like illness in the first few weeks following infection and can be mild or severe. - The person is highly infectious during PHI.
182
Progression of HIV infection involves?
An asymptomatic stage once symptoms of PHI resolve — some people progress rapidly to advanced HIV infection or AIDS (acquired immunodeficiency syndrome) within 1–2 years, while others may remain immunocompetent more than 10 years later. Advanced HIV infection occurs when the number of CD4 cells is very low (less than 200 cells per microlitre) and certain opportunistic infections (such as pneumocystis pneumonia) or malignancies (such as Kaposi’s sarcoma) develop.
183
The possibility of HIV infection should be considered whenever a person presents with one or more alerting features:
Common symptoms or infections that are unusually severe, prolonged, recurrent, or unexplained. Persistent enlarged lymph nodes other than in the inguinal area. Conditions related to immunosuppression. Glandular fever-like illness. Lifestyle and social risk factors for contracting HIV, such as living in, working in, or coming from a high prevalence area; men who have sex with men; and injecting drug users.
184
HIV testing should be offered in primary care when?
- As part of routine antenatal care. - If the person requests a test, has a risk factor for HIV, or has another sexually transmitted infection. - To people newly registering at a practice or having a blood test if they have not had an HIV test in the past 12 months, in areas where the prevalence of diagnosed HIV is greater than 2 in 1000. - To people presenting with symptoms of PHI or longstanding HIV infection. - Some HIV-related conditions such as pneumocystis pneumonia or cryptococcal meningitis can be life threatening and require urgent admission or referral to secondary care.
185
Management of HIV is complex and is carried out by specialist HIV services in secondary care. It involves what?
Antiretroviral therapy (ART) is initiated and monitored in secondary care — ART can be associated with serious or life-threatening adverse effects that may present in primary care.
186
What must be done before ART is prescribed for HRT?
ART can also have serious or life-threatening interactions with many drugs commonly prescribed in primary care — before prescribing, drug interactions should be checked in the British National Formulary, the online database of HIV drug interactions, or with an HIV specialist.
187
Prognosis of HIV?
ART has improved the prognosis of HIV/AIDS significantly — people living with HIV who are adherent and clinically responding to ART can expect a normal or near-normal life span.
188
ART stands for?
antiretroviral therapy
189
Potential occupational or sexual exposure to HIV is a medical emergency — what should be done?
urgent referral for consideration of post-exposure prophylaxis is required.
190
Primary HIV infection or HIV seroconversion illness occurs in the
first few weeks following infection with HIV (usually between 10 days and 6 weeks) and can be mild or severe.
191
Clinical features associated with primary HIV infection develop in over 60% of people, can be non-specific, and include:
Fever, sore throat, maculopapular rash, malaise, lethargy, arthralgia, myalgia, lymphadenopathy, and oral, genital or perianal ulcers. Less commonly, headache, meningitis, cranial nerve palsies, diarrhoea, and weight loss.
192
Conditions associated with longstanding HIV infection can be subtle and people may remain well for some time before developing another condition. Consider HIV if a person has had more than one of the following in the past 3 years, or has had conditions that are severe or resistant to treatment....
- constitutional symptoms= flu-like symptoms; fever; weight loss; sweats; lymphadenopathy - Opportunistic respiratory infections - neurological and visual problems - increased risk of malignancy - skin conditions - oral conditions - GI conditions - genital conditions= severe or difficult-to-treat genital candida, genital herpes, or genital warts - haematological= unexplained abnormalities on full blood count such as neutropenia, anaemia, thrombocytopenia, or other blood dyscrasias.
193
Conditions associated with longstanding HIV infection= respiratory conditons?
Opportunistic respiratory infections such as pneumocystis pneumonia (PCP), tuberculosis, bacterial lower respiratory tract infections; and occasionally Kaposi's sarcoma or lymphomas can result in symptoms including cough, sweats, breathlessness, and weight loss.
194
Conditions associated with longstanding HIV infection= respiratory conditions: PCP?
life-threatening condition that can be difficult to identify at onset and is typically insidious over several weeks. Symptoms include fever (in most but not all people), persistent dry cough of a few weeks’ duration, increasing breathlessness, decreasing exercise tolerance, chest discomfort, and difficulty in taking a full breath. Signs include fine crackles (although the chest may be clear, especially in early infection) and a drop in oxygen saturation on exertion. PCP can be fatal if diagnosed late.
195
Conditions associated with longstanding HIV infection= respiratory conditions: Tuberculosis (TB) and atypical mycobacterial disease?
TB is a common presenting condition in HIV. Atypical mycobacterial disease (such as Mycobacterium avium intracellulare) is less common and is associated with advanced HIV infection. Symptoms may include fever, night sweats, weight loss, fatigue, diarrhoea, and abdominal pain.
196
Conditions associated with longstanding HIV infection= neuro and visual conditions?
- Cryptococcal meningitis — may present as subacute meningitis with headache and fever, acute confusional state, or cranial nerve palsies. Typical symptoms and signs of meningism may be absent. - Cerebral toxoplasmosis — occurs owing to reactivation of previous toxoplasmosis infection. May present with confusion, headache, personality change, fever, fits, and focal neurological signs. - Cerebral lymphoma (in advanced HIV disease)= May present with confusion, lethargy, personality change, headache, fever, fits, and focal neurological signs. - Cytomegalovirus (CMV) retinitis= occurs owing to reactivation of previously acquired infection and can lead to loss of vision. Prognosis improves with earlier diagnosis. Symptoms include floaters (due to inflammatory cells in the vitreous), reduced vision, flashing lights, and scotomas.
197
HIV= can lead to loss of vision. Prognosis improves with earlier diagnosis. Symptoms include floaters (due to inflammatory cells in the vitreous), reduced vision, flashing lights, and scotomas.
Cytomegalovirus (CMV) retinitis
198
HIV infection is associated with increased risk of malignancy including?
Lymphoma Kaposi's sarcoma Cervical ca
199
HIV= increased risk of ca: lymphoma?
Can present with weight loss, fevers, night sweats, lymphadenopathy, and abdominal masses (lymph nodes, hepatomegaly, or splenomegaly).
200
HIV= increased risk of ca: Kaposi's sarcoma?
Kaposi's sarcoma is the most common tumour in people with HIV infection and typically presents with dark purple or brown intradermal skin lesions that look like bruises but feel firmer. Tumours may occur anywhere on the skin or oropharynx — infiltration of the lungs or gut is rare but can be life threatening.
201
HIV= increased risk of ca: cervical ca?
Abnormal cervical cytology may be a marker for underlying HIV infection.
202
Conditions associated with longstanding HIV infection= skin conditions?
Kaposi’s sarcoma Fungal skin and nail infections Viral infections such as herpes simplex (especially if the ulcers are unusually large or persistent), molluscum contagiosum, shingles (especially if more than one dermatome is affected), and warts. Bacterial infections such as impetigo and folliculitis. Seborrhoeic dermatitis and psoriasis
203
Conditions associated with longstanding HIV infection= oral conditions?
Oral candidiasis= Typically presents with thick white plaques covering the buccal mucosa that can be scraped off. Soreness of the mouth or pain on swallowing (odynophagia) may also be present. Aphthous ulcers Oral hairy leukoplakia Kaposi's sarcoma= Most often affects the hard and soft palate, gingiva, and dorsal tongue with plaques or tumours of variable colour from non-pigmented to brownish-red or purple. Gingivitis= Causes swelling and erythema of the gum margins that are usually painful and bleed on tooth brushing or flossing. Dental abscess= Typically presents with rapid onset of severe dental pain and may be associated with an unpleasant taste in the mouth, fever, and malaise.
204
Conditions associated with longstanding HIV infection= oral conditions- oral hairy leukoplakia?
Typically presents as asymptomatic corrugated whitish, hairy patches on the side of the tongue that cannot be scraped off (in contrast to oral candidiasis) and is pathognomic of immunosuppression.
205
Conditions associated with longstanding HIV infection= GI conditions?
Oesophageal candidiasis= Symptoms include retrosternal pain or dysphagia. Oral candidiasis is also likely to be present Diarrhoea= very common and may be persistent and mild or acute and severe. Infection due to bacteria, protozoa (such as Cryptosporidium), mycobacteria, or viruses; malignancy (such as non-Hodgkin's lymphoma or Kaposi's sarcoma), or the direct effects of HIV can all result in diarrhoea. Often no specific causative organism is identified. Hep B and C= Co-infection with hepatitis B or C is common and increases the risk of cirrhosis and hepatocellular carcinoma.
206
What to do if HIV test comes back positive?
The laboratory is likely to telephone the result through and ask for a repeat sample. Emphasize the positive aspects — effective treatment can help prevent HIV-related illness and ensure that infection is not transmitted to contacts or in pregnancy. Explain the referral process — for further information, see the section on New diagnosis of HIV. Discuss concerns and sources of support. Arrange follow up within the next few days as the person is likely to have additional questions.
207
An indicator condition is any medical condition associated with an undiagnosed HIV seroprevalence ≥1 per 1000. There are two categories of indicator conditions?
Conditions that would be AIDS defining in an individual living with HIV. Non-AIDS-defining conditions associated with an undiagnosed HIV seroprevalence >1 per 1000.
208
HIV= Condoms should still be used even if?
Antiretroviral therapy (ART) is taken regularly and viral load suppressed. The person's partner is also HIV positive (to prevent drug-resistant strains from being transferred).
209
HIV= Pre-exposure prophylaxis (PrEP)?
combination of two antiretroviral drugs that are taken before and after sex to reduce the risk of HIV acquisition – it is offered on a case by case basis to HIV-negative people who are at high risk of HIV and who do not always use condoms. Signpost to a sexual health clinic people who may be eligible for PrEP — baseline HIV testing, counselling on risks and benefits, support to improve adherence, and regular HIV and STI screening is required.
210
Contraceptive choice for women with HIV may be complicated by potential drug interactions with ART — seek specialist advice....
Oral contraceptives and patches may have reduced effectiveness with some ART combinations. Long-acting reversible contraceptives such as the copper intrauterine device (Cu-IUD), the levonorgestrel-releasing intrauterine system (IUS), or depot medroxyprogesterone acetate (DMPA) injection do not appear to be affected by enzyme-inducing drugs.
211
Emergency contraception for women with HIV?
A Cu-IUD is the recommended method of emergency contraception except in women with a CD4 less than 200 cells per microlitre and detectable HIV RNA (owing to potential higher risk of infection post procedure). If progesterone-only emergency contraception is used, a doubling of the standard dose may be advised (off-label).
212
Fertility and assisted conception in pt with HIV?
Specialist fertility services input is recommended for all couples who wish to conceive where one or both partners are living with HIV. Options vary depending on concordance, treatment, and viral suppression and may include donor insemination, sperm washing, or self insemination.
213
Care should be provided through antenatal multi-disciplinary team including an HIV specialist, obstetrician, specialist midwife, and paediatrician. Risk of transmitting HIV from mother to child in pregnancy can be reduced from around 20% to less than 1% by:
Taking ART during pregnancy. Using ART at the time of delivery, together with a short course of ART for the newborn baby. Vaginal delivery for women on ART who have an undetectable viral load or elective Caesarean section for others. Avoidance of breastfeeding — be aware that avoidance of breastfeeding may lead to problems with speculation about, or even disclosure of, the mother’s HIV status. Advice and support should be available.
214
HIV= If the person is not attending specialist services regularly?
Confirm that the patient has capacity to make decisions. Explore their reasons for not attending — problems such as fear of being recognized at a local clinic may be addressed by changing to a geographically different service. Reinforce the benefits of attending specialist care. Consider, after discussion with the person's specialist and the local laboratory, assessing immunity by checking a CD4 count in primary care. Discuss with the person's specialist the option of prophylactic treatment against some opportunistic infections such as pneumocystis pneumonia.
215
Death as a direct result of HIV-infection is uncommon since the introduction of effective antiretroviral therapy (ART). End-stage advanced HIV disease usually occurs in people who...
present late or have co-morbidities. In people taking ART it can be more difficult to identify terminal illness — immunity may recover following a change in treatment regimen but the risk of overwhelming infection remains until this happens. Close communication between secondary and primary care services is particularly important.
216
The following conditions are considered to be AIDS defining when they occur in people living with HIV:
Neoplasms: Cervical cancer. Non-Hodgkin lymphoma. Kaposi’s sarcoma. Bacterial infections: Mycobacterium tuberculosis, pulmonary or extrapulmonary. Mycobacterium avium complex or Mycobacterium kansasii, disseminated or extrapulmonary. Mycobacterium, other species or unidentified species, disseminated or extrapulmonary. Pneumonia, recurrent (two or more episodes in 12 months). Salmonella septicaemia, recurrent. Viral infections: Cytomegalovirus retinitis. Cytomegalovirus, other (except liver, spleen, glands). Herpes simplex, ulcer(s) more than 1 month/bronchitis/pneumonitis. Progressive multifocal leukoencephalopathy. Parasitic infections: Cerebral toxoplasmosis. Cryptosporidiosis diarrhoea, more than 1 month. Isosporiasis, more than 1 month. Atypical disseminated leishmaniasis. Reactivation of American trypanosomiasis (meningoencephalitis or myocarditis). Fungal infections: Pneumocystis pneumonia (PCP). Candidiasis, oesophageal. Candidiasis, bronchial/tracheal/pulmonary. Cryptococcosis, extrapulmonary. Histoplasmosis, disseminated/extrapulmonary. Coccidioidomycosis, disseminated/extrapulmonary. Penicilliosis, disseminated.
217
The immediate treatment of a site exposed to potentially HIV-infected bodily fluids is to clean it thoroughly:
Skin and skin wounds should be washed with soap and water, and mucous membranes irrigated with water. Squeezing the wound to express blood is not recommended. Eyes should be irrigated with saline or water before and after removing contact lenses. Puncture wounds should be encouraged to bleed freely, but should not be sucked. Small wounds and punctures may also be cleansed with an antiseptic, for example an alcohol-based hand hygiene solution.
218
Exposure to HIV is a medical emergency and requires prompt treatment with
course of antiretroviral therapy (ART).
219
Exposure to HIV= Direct the person immediately to an HIV/sexual health clinic or an Accident and Emergency department for consideration of post-exposure prophylaxis following sexual exposure (PEPSE) if:
They are an uninfected sexual partner of a person known to have HIV, to prevent infection after sex without a condom or where the condom has split. PEP is generally no longer recommended if the HIV-positive partner is adherent to ART and has been confirmed as having a sustained (more than 6 months) undetectable plasma HIV viral load (less than 200 copies/ml). They have had unprotected sex with a person in a high-risk group for HIV whose infection status is not known. PEPSE may be offered to victims of sexual assault depending on risk assessment.
220
HIV= PEPSE can be initiated if the person presents within
72 hours of exposure and should be given as early as possible (ideally within 24 hours of exposure). Follow up should be arranged by the prescribing team — HIV testing is recommended 8–12 weeks after exposure. All people seeking PEPSE should be advised to attend for future regular sexual health checks.
221
Correlation of CD4 count (cells per microlitre) with risk of HIV-related opportunistic infections and cancers= 500 and below?
Little risk of infections Hodgkin's lymphoma Cervical cancer
222
Correlation of CD4 count (cells per microlitre) with risk of HIV-related opportunistic infections and cancers= 400 and below?
Bacterial skin infections Recurrent bacterial chest infections Tuberculosis Oropharyngeal candida Fungal infections Seborrhoeic dermatitis Direct HIV effects= Lymphadenopathy, Sweats
223
Correlation of CD4 count (cells per microlitre) with risk of HIV-related opportunistic infections and cancers= 350 and below?
Oral hairy leukoplakia Shingles Pneumocystis pneumonia Persistent herpes simplex infection Non-Hodgkin's lymphoma Direct HIV effects= weight loss
224
Correlation of CD4 count (cells per microlitre) with risk of HIV-related opportunistic infections and cancers= 200 and below?
Oesophageal candida Histoplasmosis Cryptococcal meningitis Cerebral toxoplasmosis Cryptosporidiosis ca= Kaposi's sarcoma Direct HIV effects= diarrhoea, wasting
225
Correlation of CD4 count (cells per microlitre) with risk of HIV-related opportunistic infections and cancers= 100 and below?
Cytomegalovirus infections Atypical mycobacterium infections ca= Primary cerebral lymphoma Direct HIV effects= dementia
226
MRSA stands for what?
Methicillin-resistant Staphylococcus aureus
227
MRSA was one of the first organisms which highlighted what?
dangers of hospital acquired infections
228
Who should be screened for MRSA?
all patients awaiting elective admissions (exceptions include day patients having terminations of pregnancy and ophthalmic surgery. Patients admitted to mental health trusts are also excluded) from 2011 all emergency admissions will be screened
229
How should a pt be screened for MRSA?
nasal swab and skin lesions or wounds the swab should be wiped around the inside rim of a patient's nose for 5 seconds the microbiology form must be labelled 'MRSA screen'
230
Suppression of MRSA from a carrier once identified?
nose: mupirocin 2% in white soft paraffin, tds for 5 days skin: chlorhexidine gluconate, od for 5 days. Apply all over but particularly to the axilla, groin and perineum
231
The following antibiotics are commonly used in the treatment of MRSA infections?
vancomycin teicoplanin linezolid
232
MRSA= Some strains may be sensitive to antibiotics but they should not generally be used alone because resistance may develop, eg?
rifampicin macrolides tetracyclines aminoglycosides clindamycin
233
Relatively new antibiotics such as linezolid, quinupristin/dalfopristin combinations and tigecycline have activity against MRSA but should be reserved for?
resistant cases
234
Staphylococcus aureus?
bacterium that colonizes the skin, nose, or gut of up to a third of the general population — it usually lives on intact skin harmlessly, but can cause infection if invasion through the skin or deeper tissues occurs.
235
Where does staph aureus usually live?
lives on intact skin harmlessly, but can cause infection if invasion through the skin or deeper tissues occurs.
236
Meticillin-resistant S. aureus (MRSA)?
strains of S. aureus that have developed resistance to a number of commonly used antibiotics.
237
Healthcare-associated MRSA (HA-MRSA)?
strains of MRSA identified in people who have had contact with healthcare services — they can present in hospital or in the community
238
There are no clinical features specific to MRSA infection — MRSA can cause the same spectrum of disease as any other strain of S. aureus including?
Skin and soft tissue infections (such as boils, folliculitis, impetigo, cellulitis, and necrotising fasciitis). Urinary tract infection. Pneumonia and bronchiectasis. Joint and bone infections (such as osteomyelitis and septic arthritis). Sepsis and toxic shock syndrome. Infective endocarditis.
239
MRSA should be suspected in all people presenting with potential staphylococcal infection, in particular if:
They have risk factors for MRSA (such as recent hospitalization, previous MRSA infection or colonization, nursing home contact, antibiotic use, chronic illness, surgical wounds, open ulcers, intravenous lines, or urinary catheters). There is no response to first line antibiotics. They have recurrent skin or soft tissue infections or a chronic non-healing ulcer.
240
Diagnosis of MRSA is based on?
thorough clinical assessment supported by confirmatory laboratory results from swabs of exudate (from lesions or wounds), urine samples, or sputum samples.
241
What should be followed in all cases of MRSA (whether a person is known to be infected or colonized with MRSA or not)?
Appropriate infection control measures (in line with local policy) along with careful communication between healthcare professionals.
242
Urgent assessment in secondary care should be arranged if a person has suspected or confirmed MRSA and ?
clinical features of severe or complicated infection or they require surgical intervention
243
Treatment of uncomplicated infections where MRSA is suspected or confirmed (such as antibiotics and wound care) should be?
discussed with a microbiologist or the local infection-control team. Routine treatment with oral or topical antibiotics is not advised, unless directed by microbiology. Follow up (after 48 hours, or sooner if worsening) is recommended to monitor for signs of complications (such as sepsis) and to ensure infection is resolving.
244
Decolonization is not routinely required for asymptomatic carriers of MRSA in the community but may be indicated if?
the person has risk factors (such as a wound or invasive device, or is resident in a care home).
245
There are no clinical features specific to meticillin-resistant Staphylococcus aureus (MRSA) infection — MRSA can cause the same spectrum of disease as other strains of S. aureus, including?
skin & soft tissue infections bone and joint infection pneumonia UTI endocarditis sepsis
246
Giardiasis?
caused by the flagellate protozoan Giardia lamblia. It is spread by the faeco-oral route.
247
Giardiasis RFs?
foreign travel swimming/drinking water from a river or lake male-male sexual contact
248
Giardiasis features?
often asymptomatic non-bloody diarrhoea= steatorrhoea bloating, abdominal pain lethargy flatulence weight loss malabsorption and lactose intolerance can occur
249
Ix for Giardiasis?
stool microscopy for trophozoite and cysts: sensitivity of around 65% stool antigen detection assay: greater sensitivity and faster turn-around time than conventional stool microscopy methods PCR assays are also being developed
250
Tx for giardiasis?
metronidazole
251
H1N1 influenza aka?
swine flu
252
H1N1 influenza (swine flu) outbreak?
first observed in Mexico in early 2009. In June 2009, the WHO declared the outbreak to be a pandemic.
253
The H1N1 virus?
subtype of the influenza A virus and the most common cause of flu in humans. The 2009 pandemic was caused by a new strain of the H1N1 virus.
254
What groups are particularly at risk of H1N1 influenza?
patients with chronic illnesses and those on immunosuppressants pregnant women young children under 5 years old
255
H1N1 influenza features?
flu-like illness: fever greater than 38ºC myalgia lethargy headache rhinitis sore throat cough diarrhoea and vomiting
256
H1N1 influenza= minority of pts may go on to develop what?
an acute respiratory distress syndrome which may require ventilatory support
257
H1N1 influenza= 2 main Tx available?
Oseltamivir (Tamiflu) (oral) Zanamivir (Relenza) (inhaled or IV)
258
H1N1 influenza= Tx- Oseltamivir (Tamiflu)?
oral medication a neuraminidase inhibitor which prevents new viral particles from being released by infected cells common side-effects include nausea, vomiting, diarrhoea and headaches
259
H1N1 influenza= Tx- Zanamivir (Relenza)?
inhaled medication (or IV) also a neuraminidase inhibitor may induce bronchospasm in asthmatics
260
Features of influenza?
fever greater than 38ºC myalgia lethargy headache rhinitis sore throat cough diarrhoea and vomiting
261
Influenza= consider prescribing antiviral treatment for influenza if all of the following apply....
1) The patient is in an at-risk group or is felt to be at risk of developing a serious complication 2) There is circulating influenza nationally- this would mean typically the winter months 3) The patient is able to start treatment within 48 hours from the onset of symptoms
262
Influenza= who is classed as at-risk group or is at risk of developing a serious Cx?
> 65 years old pregnant women chronic disease of respiratory, cardiac, renal, hepatic or neurological nature diabetes immunosuppression morbid obesity.
263
Antivirals for influenza if indicated?
First line: oseltamivir Second line: zanamivir
264
Antivirals for influenza if indicated= 1st line?
oseltamivir
265
Antivirals for influenza if indicated= 2nd line?
zanamivir
266
Influenza is an acute respiratory illness caused by?
RNA viruses of the family Orthomyxoviridae (influenza viruses)
267
How many times of influenza?
3
268
3 types of influenza?
A B C
269
Influenza A?
occurs more frequently and is more virulent. It is responsible for local outbreaks, larger epidemics, and pandemics.
270
Influenza B?
often co-circulates with influenza A during the yearly outbreaks. Generally, influenza B causes less severe clinical illness, although it can still be responsible for outbreaks.
271
Influenza C?
usually causes a mild or asymptomatic infection similar to the common cold
272
Influenza usually occurs in the UK during when?
winter months; typically between December and March
273
Cx of influenza?
Acute bronchitis. Pneumonia. Exacerbations of asthma and chronic obstructive pulmonary disease. Otitis media. Sinusitis.
274
Influenza presents with symptoms appearing around...
2d after exposure
275
Uncomplicated influenza signs and symptoms include?
coryza, nasal discharge, cough, fever, gastrointestinal symptoms, headache, malaise, myalgia, arthralgia, ocular symptoms, and sore throat
276
Complicated influenza is defined by?
signs and symptoms that require hospital admission, involve the lower respiratory tract or central nervous system, or cause significant exacerbation of an underlying medical condition.
277
Mx of influenza?
For otherwise healthy people, antiviral drugs (oseltamivir or zanamivir) are not usually recommended, unless they are at risk of developing serious complications.
278
Mx of influenza= what antiviral is prescribed?
oseltamivir should be prescribed if the national surveillance schemes indicate that influenza virus is circulating, and the person can start treatment within 48 hours.
279
When are antivirals indicated for influenza?
if 'at risk' group antiviral, if the national surveillance schemes indicate that influenza virus is circulating, and the person can start treatment within 48 hours of the onset of symptoms (36 hours in the case of zanamivir in children). People considered to be in an 'at risk' group include: - Those with chronic respiratory, heart, kidney, liver, or neurological disease; diabetes mellitus; or those who are obese or immunosuppressed. - Those over the age of 65 years. - Women who are pregnant (or women up to 2 weeks postpartum). - Children aged under 6 months.
280
Mx of people with influenza if antivirals not needed?
drink adequate fluids, take paracetamol or ibuprofen to relieve symptoms, rest, and stay off work or school until the worst symptoms have resolved (usually about 1 week).
281
Influenza= Post-exposure prophylaxis with an antiviral drug should be started if all of the following apply?
The national surveillance scheme indicates that influenza is circulating. The person has been in close contact with a person (in the same household or residential setting) who has had recent symptoms of influenza. The person is in an 'at risk' group and has not been effectively immunized against influenza. The person is able to start treatment within 48 hours of this contact (for oseltamivir) or 36 hours of this contact (for zanamivir).
282
Influenza= Urgent admission to hospital should be considered?
A complication such as pneumonia occurs. The person has a concomitant disease that may be affected by influenza (for example, type 1 diabetes). There is suspicion of a serious illness other than influenza (for example meningitis).
283
Diagnosis of influenza can only be confirmed by laboratory testing, although the probability that an influenza-like illness is caused by influenza is higher if.....
influenza is known to be circulating and if a person has a high fever
284
Rapid testing for influenza should be undertaken in all people with?
complicated influenza (although often this takes place in hospital). Initiation of antiviral treatment should not be delayed while awaiting laboratory confirmation.
285
Laboratory testing to confirm or exclude influenza is particularly important if ...
an individual develops symptoms despite antiviral prophylaxis, or has a persistent infection despite antiviral treatment, to identify the potential development of antiviral resistance.
286
Symptoms of influenza appear when?
abruptly, around 2d after exposure
287
Complicated influenza is suggested by....
Signs and symptoms that require hospital admission. Presence of a lower respiratory tract infection (hypoxaemia, dyspnoea, and lung infiltrate). Central nervous system involvement. Significant exacerbation of an underlying medical condition.
288
Symptoms of influenza-like illness can be different in infants and children and may include?
Cervical adenopathy. Conjunctival erythema. Diarrhoea and vomiting — GI symptoms are more common in children than in adults. Fatigue. Fever (typically 38–40°C) — children can have a higher maximum temperature. They may also present with undifferentiated fever or febrile seizures. Hyperaemia of oropharynx. Irritability. Laryngotracheobronchitis (croup), bronchiolitis, or bronchitis. Myalgia or myositis — this can affect the calf muscles and be severe. It is a more common complication in children compared to adults. Tachypnoea.
289
Mx of influenza= For uncomplicated influenza in people who were previously healthy?
no antiviral treatment is normally indicated, unless the person is at serious risk of developing serious complications from influenza, then prescribe oral oseltamivir.
290
Mx of influenza= For uncomplicated influenza in people who are in an at risk group (including women who are pregnant), but are not severely immunosuppressed?
prescribe oral oseltamivir. Do not wait for laboratory confirmation.
291
Mx of influenza= For uncomplicated influenza in people who are severely immunosuppressed, and the dominant strain has: A lower risk of oseltamivir resistance (for example, A [H3N2] influenza B)?
prescribe oral oseltamivir
292
Mx of influenza= For uncomplicated influenza in people who are severely immunosuppressed, and the dominant strain has: a higher risk of oseltamivir resistance (for example, A [H1N1])?
prescribe inhaled zanamivir, or if this is unsuitable or inappropriate, prescribe oral oseltamivir and follow up.
293
Advice to help manage influenza?
To drink adequate fluids to avoid dehydration. To take paracetamol or ibuprofen for symptomatic relief. To rest in bed if they feel fatigued. To stay off work or school if they feel unable to attend — for most people, about 1 week will be adequate. That fever and associated systemic symptoms of uncomplicated influenza usually resolve after about 1 week, although some symptoms (such as cough and fatigue) may persist for up to 2 weeks after resolution of fever. About the symptoms of complicated influenza and to seek medical advice should their condition deteriorate.
294
Prophylaxis is normally not considered in at-risk groups who have been vaccinated against seasonal influenza at least ...
14d before exposure
295
Prescribe an antiviral drug for post-exposure prophylaxis if all of the following circumstances apply?
- The national surveillance scheme indicates that influenza is circulating. - The person has been exposed to a person (in the same household or residential setting) with an influenza-like illness. - The person is in an 'at risk' group and has not been adequately protected by vaccination, that is= They have not been vaccinated since the previous influenza season; The vaccination is not well matched to the circulating strain; There has been less than 14 days between vaccination and date of contact with influenza. - The person is able to start treatment within 48 hours of this contact (for oseltamivir) or 36 hours of this contact (for zanamivir). (after these times it is off label so get specialist advice)
296
If post-exposure prophylaxis is indicated, prescribe oral oseltamivir or inhaled zanamivir (as appropriate). For people at risk of complicated influenza (including pregnant women, but excluding severely immunosuppressed people and children aged under 5 years), prescribe:
Oral oseltamivir once daily for 10 days if the identified strain in the index case or dominant circulating strain is lower risk for oseltamivir resistance (for example, influenza A [H3N2], influenza B), or is known to be higher risk for oseltamivir resistance (for example, influenza A [H1N1]). Inhaled zanamivir daily for 10 days if the person has been exposed to suspected or confirmed oseltamivir-resistant influenza.
297
If post-exposure prophylaxis is indicated, prescribe oral oseltamivir or inhaled zanamivir (as appropriate). For severely immunosuppressed adults and children aged 5 years and over, prescribe:
Oral oseltamivir once daily for 10 days if the identified strain in the index case or dominant circulating strain is lower risk for oseltamivir resistance (for example influenza A [H3N2] and influenza B). Inhaled zanamivir daily for 10 days if the identified strain in the index case or dominant circulating strain is higher risk for oseltamivir resistance (for example, influenza A [H1N1]), or if this is unsuitable or inappropriate, prescribe oral oseltamivir once daily for 10 days. Inhaled zanamivir daily for 10 days if the person has been exposed to suspected or confirmed oseltamivir-resistant influenza. If this is unsuitable or inappropriate seek specialist advice.
298
If post-exposure prophylaxis is indicated, prescribe oral oseltamivir or inhaled zanamivir (as appropriate). For children aged under 5 years in at risk groups, including severely immunocompromised children:
Prescribe oral oseltamivir once daily for 10 days if the identified strain in the index case or dominant circulating strain is lower risk for oseltamivir resistance (for example, influenza A [H3N2], influenza B), or is known to be higher risk for oseltamivir resistance (for example, influenza A [H1N1]). If the child has been exposed to suspected or confirmed oseltamivir-resistant influenza, seek specialist advice.
299
If post-exposure prophylaxis is indicated, prescribe oral oseltamivir or inhaled zanamivir (as appropriate). What else?
Arrange for the person to receive influenza immunization if this has not already been done in the present influenza season. Note: the efficacy of the vaccine may be reduced if it is administered within 2 weeks of use of an influenza antiviral agent. Inform the person that although antiviral drugs help prevent influenza, they are not completely effective. Provide advice about symptomatic treatment and when to seek medical attention if influenza develops.
300
Malaria is a disease caused by?
Plasmodium protozoa
301
Malaria is a disease caused by Plasmodium protozoa which is spread by?
female Anopheles mosquito
302
Malaria= 4 different species that cause malaria?
Plasmodium falciparum Plasmodium vivax Plasmodium ovale Plasmodium malariae
303
Most common cause of malaria (nearly all episodes of severe malaria)
Plasmodium falciparum
304
Most common cause of 'benign' malaria?
Plasmodium vivax (most common) also Plasmodium ovale Plasmodium malariae
305
Protective factors from malaria?
- sickle cell trait - G6PD deficiency - HLA-B53 - absence of Duffy antigens
306
Life cycle of the malaria parasite?
1) the mosquito ingests the parasite during blood feeding 2) the mosquito injects the parasite when it bites the human 3) sporozoites to human liver cell then into human blood cell 4) sexual stage= male and female gametocytes form 5) early mosquito stages= gametes to zygote to ookinete 6) oocyst, grows and releases sporozoites repeats
307
Commonest, and most severe, type of malaria?
Falciparum malaria
308
Falciparum malaria typically presents how?
with symptoms suggestive of a flu-like illness. The classical triad of symptoms includes paroxysms of fever, chills, and sweating. These symptoms may occur every 48 hours corresponding to the erythrocytic cycle of the Plasmodium falciparum parasite. Fever is often high, intermittent, and may be accompanied by rigors. Initial manifestations can be non-specific and include malaise, headache, and myalgia, which might be mistaken for a viral syndrome.
309
Falciparum malaria= triad of symptoms?
paroxysms of fever, chills, and sweating
310
Falciparum malaria= triad of symptoms (paroxysms of fever, chills, and sweating) typically occur every 48hrs corresponding to what?
the erythrocytic cycle of the Plasmodium falciparum parasite
311
Falciparum malaria= fever?
The hallmark of malaria, typically cyclical, often accompanied by sweating and sometimes rigors. often high, intermittent, and may be accompanied by rigors
312
Falciparum malaria= initial manifestations?
non-specific and include malaise, headache, and myalgia, which might be mistaken for a viral syndrome
313
Falciparum malaria= general features?
- Fever - GI - Resp - MSK - Neuro - Cardiovascular - Haematological - Renal
314
Falciparum malaria= general features- GI?
anorexia, nausea, vomiting, and abdominal pain are frequent diarrhoea can occasionally be a feature, more commonly in children patients may exhibit mild jaundice and occasional pruritus
315
Falciparum malaria= general features- resp?
Cough and, in some cases, mild tachypnoea may occur, though primary respiratory complications are rare in non-severe cases.
316
Falciparum malaria= general features- MSK?
Generalised body aches and joint pains are common.
317
Falciparum malaria= general features- neuro?
headache is prominent and often severe. dizziness and sleep disturbances may also be observed.
318
Falciparum malaria= general features- cardiovascular?
Tachycardia may be evident, and although hypotension is more typical of severe malaria, it can occasionally be seen in non-severe cases as well.
319
Falciparum malaria= general features- haematological?
thrombocytopaenia is the most significant haematological finding and can occur in the absence of severe disease. mild anaemia may also be present.
320
Falciparum malaria= general features- renal?
While acute kidney injury is associated with severe malaria, non-severe cases might show mild to moderate increases in creatinine or blood urea nitrogen levels.
321
Feature of severe falciparum malaria?
schizonts on a blood film parasitaemia > 2% hypoglycaemia acidosis temperature > 39 °C severe anaemia complications
322
Cx of severe falciparum malaria?
cerebral malaria: seizures, coma acute renal failure: blackwater fever, secondary to intravascular haemolysis, mechanism unknown acute respiratory distress syndrome (ARDS) hypoglycaemia disseminated intravascular coagulation (DIC)
323
Mx of uncomplicated falciparum malaria?
strains resistant to chloroquine are prevalent in certain areas of Asia and Africa artemisinin-based combination therapies (ACTs) as first-line therapy - examples include artemether plus lumefantrine, artesunate plus amodiaquine, artesunate plus mefloquine, artesunate plus sulfadoxine-pyrimethamine, dihydroartemisinin plus piperaquine
324
Mx of complicated falciparum malaria?
a parasite counts of more than 2% will usually need parenteral treatment irrespective of clinical state intravenous artesunate is now recommended by WHO in preference to intravenous quinine if parasite count > 10% then exchange transfusion should be considered shock may indicate coexistent bacterial septicaemia - malaria rarely causes haemodynamic collapse
325
most common cause of non-falciparum malaria?
Plasmodium vivax, with Plasmodium ovale and Plasmodium malariae accounting for the other cases
326
Plasmodium vivax is often found in?
Central America and the Indian Subcontinent whilst Plasmodium ovale typically comes from Africa
327
Malaria= Plasmodium knowlesi?
another non-falciparum species which causes clinical pathology, found predominantly in South East Asia
328
Features of non-falciparum malaria?
general features of malaria: fever, headache, splenomegaly Plasmodium vivax/ovale: cyclical fever every 48 hours. Plasmodium malariae: cyclical fever every 72 hours Plasmodium malariae: is associated with nephrotic syndrome.
329
Non-falciparum malria= Ovale and vivax malaria have a hypnozoite stage and may therefore...
relapse following treatment
330
Tx of non-falciparum malaria?
in areas which are known to be chloroquine-sensitive then WHO recommend either an artemisinin-based combination therapy (ACT) or chloroquine in areas which are known to be chloroquine-resistant an ACT should be used ACTs should be avoided in pregnant women patients with ovale or vivax malaria should be given primaquine following acute treatment with chloroquine to destroy liver hypnozoites and prevent relapse
331
Malaria?
life-threatening illness caused by infection of red blood cells by Plasmodium parasites. Transmission of malaria to humans occurs through the bite of infected female Anopheles mosquitoes.
332
Species of Plasmodium that cause malaria in humans?
Plasmodium falciparum — responsible for the majority of malaria related deaths worldwide. Plasmodium vivax and Plasmodium ovale — these species have dormant liver stages which can cause ‘relapses’ of malaria months or years after initial infection. Plasmodium malariae — if untreated can cause lifelong chronic infection. Plasmodium knowlesi — a malaria parasite of monkeys in South-East Asia which can cause severe and sometimes fatal illness in humans.
333
Prognosis of malaria?
if identified promptly, appropriate treatment is given, and no organ dysfunction has occurred, most people make a rapid and complete recovery. If malaria treatment is delayed or inappropriate, severe or fatal malaria can develop.
334
Suspect malaria in anyone who?
anyone who has returned from or previously visited an area endemic for malaria who is unwell or has a fever or history of fever, regardless of malaria chemoprophylaxis. Most missed malaria infections are misdiagnosed as non-specific viral infections, influenza, gastroenteritis, or hepatitis.
335
The clinical features of malaria are non-specific and include:
Fever, sweats, and/or chills — absence of fever does not exclude the possibility of malaria. Headache. Confusion. General malaise, lethargy, and fatigue — somnolence is more common in children than in adults. Myalgia and arthralgia. Gastrointestinal disturbance (such as nausea, abdominal pain, vomiting, and diarrhoea). Anorexia, poor feeding in children. Jaundice. Sore throat, cough, lower respiratory tract symptoms, and respiratory distress.
336
Symptoms of severe malaria include:
Impaired conscious level, seizures, or prostration (inability to stand or sit). Renal impairment (may present with oliguria). Acidosis (may present with acidotic breathing). Hypoglycaemia — common in pregnant women. Respiratory distress which may be due to pulmonary oedema or acute respiratory distress syndrome (ARDS) – common in pregnant women. Severe anaemia (may present with pallor). Spontaneous bleeding/disseminated intravascular coagulation. Shock. Sepsis – more common in pregnant women. Haemoglobinuria — falciparum can cause severe haemolysis with dark red urine (‘blackwater fever’).
337
Malaria is a medical emergency and immediate admission should be arranged for:
People with suspected severe or complicated malaria. People with suspected falciparum malaria. Pregnant women. Children. People who are older than 65 years of age.
338
All other people suspected of having malaria should be discussed urgently with
infectious disease specialist — where capacity exists for close clinical and parasitological monitoring, clinicians experienced in the management of malaria may treat adults with malaria as outpatients.
339
All cases of malaria must be
notified to Public Health England
340
Risk of severe malaria:
Severe malaria is more likely in children, pregnant women, older people, and immunocompromised people (for example those with splenectomy or HIV/AIDS).
341
Treatment of malaria depends on a variety of factors including...
species of Plasmodium parasite, severity of infection, tolerability of specific drugs, and patterns of drug resistance.
342
Anti-malarial medications are associated with
neurological and psychiatric symptoms Artesunate-type drugs are more efficacious and better tolerated in pregnancy than quinines Treatment failures are rare but have been noted and clinicians should be aware of the possibility
343
Antimalarial drug options for malaria?
Artesunate= Parenteral artesunate is used to treat severe or complicated malaria; Intravenous artesunate can cause haemolysis and follow-up blood tests are required. Quinine= may be used initially to treat severe or complicated malaria if artesunate is unavailable. Artemisinin combination therapy (ACT)= ACT may be used to treat uncomplicated malaria and is the preferred treatment for mixed infection. Atovaquone-proguanil= may be used to treat uncomplicated falciparum malaria if ACT is unavailable. Quinine plus doxycycline= may be used to treat uncomplicated falciparum malaria if ACT is unavailable. Doxycycline should not be given to children younger than 12 years of age. Chloroquine= may be used to treat uncomplicated P. malariae, P. ovale, P. knowlesi, and most cases of P. vivax malaria but use depends upon patterns of resistance and tolerance. Primaquine= only currently effective drug for the eradication of hypnozoites (dormant parasites which persist in the liver after treatment of P. vivax and P. ovale). It is contraindicated in pregnancy and breastfeeding.
344
Malaria= what is essential before treatment with primaquine is started?
Screening for G6PD deficiency is essential before treatment with primaquine is started as it can cause haemolysis in G6PD deficient individuals, which can be fatal. It is contraindicated in pregnancy and breastfeeding.
345
Meningitis= Ix?
LP if contraindicated (any signs of raised ICP) then blood cultures and PCR for meningococcus
346
Meningitis: when is LP contraindicated?
any signs of raised ICP: - focal neuro signs - papilloedema - signif bulging of fontanelle - disseminated intravascular coagulation - signs of cerebral herniation
347
Mx of meningitis?
1) Abx 2) Dexamethasone in all <3m or if LP shows certain features 3) Fluids- Tx any shock 4) Cerebral monitoring= mechanical ventilation if resp impairment 5) public health notification and Abx prophylaxis of contacts
348
Abx choice for meningitis?
>3m= IV cefotaxime (or ceftriaxone) <3m or >50= IV amoxicillin (or ampicillin) + IV cefotaxime
349
When should dexamethasone be given to pts with meningitis?
if <3m or if LP shows= frankly purulent CSF; WBC >1000/microlitre; raised CSF WBC with protein conc >1g/litre; bacteria on gram stain
350
Abx prophylaxis for contacts of meningitis?
ciprofloxacin (preferred) or rifampicin
351
Causes of meningitis if 0-3m
Group B Streptococcus (most common cause in neonates) E. coli Listeria monocytogenes
352
Most common cause of meningitis in neonates?
group B strep
353
Causes of meningitis in 3m-6yrs?
Neisseria meningitidis Streptococcus pneumoniae Haemophilus influenzae
354
Causes of meningitis in 6yrs-60yrs?
Neisseria meningitidis Streptococcus pneumoniae
355
Causes of meningitis in >60yrs?
Streptococcus pneumoniae Neisseria meningitidis Listeria monocytogenes
356
Causes of meningitis in immunosuppressed?
Listeria monocytogenes
357
Cx of meningitis?
sensorineural hearing loss (most common) seizures focal neurological deficit infective= sepsis, intracerebral abscess pressure= brain herniation, hydrocephalus
358
Most common cause of meningitis?
sensorineural hearing loss
359
Pts with meningococcal meningitis are at risk of what?
Waterhouse-Friderichsen syndrome (adrenal insufficiency secondary to adrenal haemorrhage).
360
Pts with meningococcal meningitis are at risk of Waterhouse-Friderichsen syndrome- what is this?
(adrenal insufficiency secondary to adrenal haemorrhage)
361
CSF analysis in meningitis= bacterial findings?
1) cloudy 2) glucose low (<1/2 plasma) 3) protein high (>1g/l) 4) white cells= 10-5000 polymorphs/mm3 5) opening pressure= high (>20)
362
CSF analysis in meningitis= viral findings?
1) clear/cloudy 2) glucose normal (60-80% of plasma glucose) 3) protein normal/high 4) white cells= 15-1000 lymphocytes/mm3 5) opening pressure= normal/high
363
CSF analysis in meningitis= TB findings?
1) slight cloudy, fibrin web 2) glucose low (<1/2 plasma) 3) protein high (>1g/l) 4) white cells= 30-300 lymphocytes/mm3 5) opening pressure= high
364
CSF analysis in meningitis= fungal findings?
1) cloudy 2) glucose low (<1/2 plasma) 3) protein high (>1g/l) 4) white cells= 20-200 lymphocytes/mm3 5) opening pressure= high/very high
365
What is sometimes used in Ix TB meningitis?
The Ziehl-Neelsen stain is only 20% sensitive in the detection of tuberculous meningitis and therefore PCR is sometimes used (sensitivity = 75%)
366
What viral cause of meningitis has a low glucose level not normal?
mumps and herpes encephalitis
367
CSF: 1) cloudy 2) glucose low (<1/2 plasma) 3) protein high (>1g/l) 4) white cells= 20-200 lymphocytes/mm3 5) opening pressure= high/very high
fungal meningitis
368
CSF: 1) slight cloudy, fibrin web 2) glucose low (<1/2 plasma) 3) protein high (>1g/l) 4) white cells= 30-300 lymphocytes/mm3 5) opening pressure= high
TB meningitis
369
CSF: 1) clear/cloudy 2) glucose normal (60-80% of plasma glucose) 3) protein normal/high 4) white cells= 15-1000 lymphocytes/mm3 5) opening pressure= normal/high
viral meningitis
370
CSF: 1) cloudy 2) glucose low (<1/2 plasma) 3) protein high (>1g/l) 4) white cells= 10-5000 polymorphs/mm3 5) opening pressure= high (>20)
bacterial meningitis
371
The investigation and management of suspected bacterial meningitis are usually...
intertwined given the potential negative impact of delayed antibiotic treatment
372
If patients are in a pre-hospital setting (for example a GP surgery) and meningococcal disease is suspected then do what?
give IM benzylpenicillin as long as doesn't delay transit to hospital
373
All suspected meningitis cases should be...
urgently transferred to hospital
374
Meningitis= steps in Ix and Mx?
1) A to E approach 2) senior review if any warning signs 3) consider LP 4) Mx
375
Meningitis= steps in Ix and Mx: 1) A to E?
Airway Breathing Circulation Disability: GCS, ; focal neurological signs; seizures; papilloedema;
376
Meningitis= steps in Ix and Mx: 2) senior review if what warning signs are present?
examples: rapidly progressive rash poor peripheral perfusion respiratory rate < 8 or > 30 / min or pulse rate < 40 or > 140 / min pH < 7.3 or WBC< 4 *109/L or lactate > 4 mmol/L GCS < 12 or a drop of 2 points poor response to fluid resuscitation
377
Meningitis= steps in Ix and Mx: 3) deciding whether/when to do LP?
delay if contraindicated LPs require an aseptic technique and are potentially technical difficult - this means they make take time and delay other treatment on the other hand, having a CSF sample can be very useful in confirming the diagnosis and guiding antibiotic treatment as always, patient safety means that if there is any doubt IV antibiotics should be given as a priority
378
Meningitis= steps in Ix and Mx: when should LP be delayed?
signs of severe sepsis or a rapidly evolving rash severe respiratory/cardiac compromise significant bleeding risk signs of raised intracranial pressure= focal neurological signs; papilloedema; continuous or uncontrolled seizures; GCS ≤ 12
379
Meningitis= steps in Ix and Mx: 4) categories of Mx?
Mx of pts without indication for delayed LP Mx of pts with signs of raised intracranial pressure Mx of pts with signs of severe sepsis or rapidly evolving rash
380
Mx of meningitis in pts without indication for delayed LP?
1) IV access= bloods and blood cultures 2) LP within 1hr (if not start Abx) 3) IV Abx 4) IV dexamethasone CT not normally indicated
381
Meningitis= what if LP is not indicated for delay (so is done)?
if this cannot be done within the first hour, IV antibiotics should be given after blood cultures have been taken
382
Meningitis= IV dexamethasone?
consider adjunctive Tx with dexamethasone (particularly if pneumococcal meningitis suspected in adults), preferably starting before or with first dose of antibacterial, but no later than 12 hours after starting antibacterial; avoid dexamethasone in septic shock, meningococcal septicaemia, or if immunocompromised, or in meningitis following surgery
383
Meningitis= IV dexamethasone- when to NOT give?
avoid dexamethasone in septic shock, meningococcal septicaemia, or if immunocompromised, or in meningitis following surgery'
384
Meningitis Mx= in pt with signs of raised ICP?
1) get critical care input 2) secure airway + high-flow oxygen 3) IV access → take bloods and blood cultures 4) IV dexamethasone 5) IV antibiotics 6) arrange neuroimaging
385
Meningitis Mx= in pts with signs of severe sepsis or rapidly evolving rash?
1) get critical care input 2) secure airway + high-flow oxygen 3) IV access → take bloods and blood cultures 4) IV fluid resuscitation 5) IV antibiotics as above
386
Meningitis= bloods that are taken should be tested for what?
full blood count renal function glucose lactate clotting profile CRP
387
Meningitis= if an LP has been performed what should the CSF be tested for?
glucose, protein, microscopy and culture lactate meningococcal and pneumococcal PCR enteroviral, herpes simplex and varicella-zoster PCR consider investigations for TB meningitis
388
Initial empirical Abx therapy in meningitis?
3m-50yrs= IV cefotaxime (or ceftriaxone) <3m= IV cefotaxime + amoxicillin (or ampicillin) >50yrs= IV cefotaxime (or ceftriaxone) + amoxicillin (or ampicillin)
389
Abx for Meningococcal meningitis?
IV benzylpenicillin or cefotaxime (or ceftriaxone)
390
Abx for Pneumococcal meningitis?
IV cefotaxime (or ceftriaxone)
391
Abx for Meningitis caused by Haemophilus influenzae?
IV cefotaxime (or ceftriaxone)
392
Abx for Meningitis caused by Listeria?
IV amoxicillin (or ampicillin) + gentamicin
393
If the patient has a history of immediate hypersensitivity reaction to penicillin or to cephalosporins the BNF recommends using what Abx in meningitis?
chloramphenicol
394
Meningitis= Prophylaxis needs to be offered to who?
households and close contacts of patients affected with meningococcal meningitis. Prophylaxis should also be offered to people who have been exposed to respiratory secretion, regardless of the closeness of contact.
395
Meningitis risk to contacts?
risk to contacts is highest in the first 7 days but persists for at least 4 weeks
396
people who have been exposed to a patient with confirmed bacterial meningitis should be given prophylactic antibiotics if they have close contact within...
7d before onset
397
What else should be offered to close contacts of meningitis as well as prophylactic Abx?
meningococcal vaccination should be offered to close contacts when serotype results are available, including booster doses to those who had the vaccine in infancy
398
Prophylaxis for pneumococcal meningitis?
no prophylaxis is generally needed. There are however exceptions to this. If a cluster of cases of pneumococcal meningitis occurs the HPA have a protocol for offering close contacts antibiotic prophylaxis.
399
Meningitis?
inflammation of the leptomeninges and the cerebrospinal fluid of the subarachnoid space
400
Viral meningitis?
inflammation attributed to a viral agent
401
Viral vs bacterial meningitis severity?
viral may be considered to be a more benign condition and is much more common. Approximately 3,000 cases of confirmed viral meningitis are reported yearly, however, the actual number of cases is likely to be much higher, as patients often do not present to medical services.
402
Causes of viral meningitis?
non-polio enteroviruses e.g. coxsackie virus, echovirus mumps herpes simplex virus (HSV), cytomegalovirus (CMV), herpes zoster viruses HIV measles
403
RFs for viral meningitis?
patients at the extremes of age (< 5 years and the elderly) immunocompromised, e.g. patients with renal failure, with diabetes intravenous drug users
404
CP of viral beningitis?
common features: - headache - evidence of neck stiffness - photophobia (often milder than the photophobia experienced by a patient with bacterial meningitis) - confusion - fevers less common features: - focal neurological deficits on examination - seizures: suggests a meningoencephalitis
405
What should be done in pts to confirm diagnosis of viral meningitis?
LP viral PCR may demonstrate and underlying organism
406
LP findings in viral meningitis?
Opening Pressure= 10 - 20 cm³ H²O (10 - 20 cm³ H²O) Cell count= 10-300 cells/µL (0 - 5 cells/µL) Cell differential= Lymphocytes (0 - 5 cells/µL lymphocyte-predominant) Glucose= 2.8 - 4.2 mmol/L or 2/3 serum glucose mmol/L ( 2.8 - 4.2 mmol/L or 2/3 paired serum glucose mmol/L) Protein= 0.5 - 1 g/dL (0.15 - 0.45 g/L)
407
Mx of viral meningitis?
whilst awaiting the results of the LP, Tx should be supportive and if there is any question of bacterial meningitis or of encephalitis, the patient should be commenced on broad-spectrum Abx with CNS penetration e.g. ceftriaxone and aciclovir intravenously. This is particularly the case if the patient has risk factors e.g. elderly, immunocompromised generally speaking, viral meningitis is self-limiting, with symptoms improving over the course of 7 - 14 days and complications are rare in immunocompetent patients aciclovir may be used if the patient is suspected of having meningitis secondary to HSV
408
What may be used if pt is suspected of having meningitis secondary to HSV?
aciclovir
409
if there is any question of bacterial meningitis or of encephalitis, the patient should be commenced on what?
broad-spectrum antibiotics with CNS penetration e.g. ceftriaxone and aciclovir intravenously. This is particularly the case if the patient has risk factors e.g. elderly, immunocompromised
410
Bacterial meningitis is a life-threatening condition that can affect all ages, but is most common in...
babies and children
411
Bacterial meningitis transmission occurs through what?
close contact, droplets, or direct contact with respiratory secretions
412
Prognosis of bacterial meningitis?
With prompt and adequate antimicrobial treatment and supportive therapy, the outcome of acute bacterial meningitis is excellent. The case-fatality rates for bacterial meningitis are 4–10% in children and 25% in adults.
413
Complications are more common following what type of meningitis?
pneumococcal meningitis and occur in about 30% of people compared with 7% with meningococcal meningitis.
414
Factors that affect prognosis of bacterial meningitis?
Age — fatality rates are higher at extremes of age. The causative organism. Presence of comorbidities. Severity at presentation.
415
Bacterial meningitis should be strongly suspected in people with all the symptoms in the red flag combinations:
Fever. Headache. Neck stiffness. Altered level of consciousness or cognition (including confusion or delirium).
416
Meningococcal disease should be strongly suspected in people with any of these red flag symptoms:
Haemorrhagic, non-blanching rash with lesions larger than 2 mm (purpura). Rapidly progressive and/or spreading non-blanching petechial or purpuric rash. Any symptoms and signs of bacterial meningitis.
417
Type of rash pt MAY get in meningitis?
Haemorrhagic, non-blanching rash with lesions larger than 2 mm (purpura). Rapidly progressive and/or spreading non-blanching petechial or purpuric rash.
418
CP of bacterial meningitis?
Non-specific symptoms: fever, nausea and vomiting, lethargy, irritable or unsettled mood, refusal of food and drink, headache, muscle ache or joint pain, and respiratory symptoms such as a cough. More specific symptoms and signs: stiff neck, altered mental state (confusion, delirium and drowsiness, impaired consciousness), non-blanching rash, back rigidity, bulging fontanelle (in children younger than 2 years of age), photophobia, Kernig's sign, Brudzinski's sign, coma, paresis, focal neurological deficit, and seizures.
419
stiff neck, altered mental state (confusion, delirium and drowsiness, impaired consciousness), non-blanching rash, back rigidity, bulging fontanelle (in children younger than 2 years of age), photophobia, Kernig's sign, Brudzinski's sign, coma, paresis, focal neurological deficit, and seizures
bacterial meningitis
420
GP= Intravenous or intramuscular ceftriaxone or benzylpenicillin should be given to people with strongly suspected:
Bacterial meningitis if there is likely to be a clinically significant delay in transfer to hospital. Meningococcal disease as soon as possible, unless this will delay transfer to hospital.
421
S&S of bacterial meningitis in babies, children and young people?
Fever, headache, neck stiffness, and altered level of consciousness or cognition (including confusion or delirium) Fever and neck stiffness are less common in babies. Headache and neck stiffness are harder to identify in babies and young children Bulging fontanelle In babies and young children with an open fontanelle Fever, headache, neck stiffness and altered level of consciousness or cognition are the red flag combination for bacterial meningitis Fever is less common in babies Ask the child or young person (or their family members or carers) if they have taken antipyretics, because this may make fever harder to identify Ask the child or young person (or their family members or carers) if they have taken antipyretics, because this may make ill appearance harder to identify Non-blanching petechial or purpuric rash= Mainly in meningococcal disease; Check all over the body and look for petechiae in the conjunctivae; May be difficult to see on brown, black or tanned skin Pale, mottled skin or cyanosis Irritability, lethargy agitated, aggressive or subdued. Ask family members or carers about changes in the child or young person's behaviour Weak, high-pitched or continuous cry Babies and children and young people with cognitive impairment or communication difficulties may not be able to report headache Tachypnoea, apnoea, and grunting. Non-specific signs of illness, including sepsis and meningitis in babies
422
S&S of bacterial meningitis in adults?
Fever is less common in older adults Headache and neck stiffness are harder to identify in adults with cognitive impairment Neck stiffness is harder to identify in adults with dementia or arthritis Altered level of consciousness or cognition may be missed in young adults and older adults Non-blanching petechial or purpuric rash= Mainly in meningococcal meningitis and meningococcal disease (with or without meningococcal meningitis). Check all over the body and look for petechiae in the conjunctivae. May be difficult to see on brown, black or tanned skin Pale, mottled skin or cyanosis. May be difficult to see on brown, black or tanned skin. Lethargy in older adults. Bacterial meningitis may be missed in older adults with delirium or altered consciousness. In young people and young adults, altered behaviour may be incorrectly assumed to be caused by alcohol or substance misuse, and bacterial meningitis can be missed as a result.
423
Bacterial meningitis= neck stiffness may be harder to identify in who?
adults with cognitive impairment, communication difficulties, dementia or arthritis children and young people with cognitive impairment or communication difficulties
424
Describe meningitis rash?
Non-blanching petechial or purpuric rash
425
Non-blanching petechial or purpuric rash is mainly in what?
meningitis caused by meningococcal bacteria (Neisseria meningitidis) this type can lead to meningococcal septicemia (meningococcemia)
426
Fever in meningitis?
Ask the person (or their family members or carers) if they have taken antipyretics, because this may make fever harder to identify Fever is a particular concern for babies at the following levels: 39°C or higher in children aged 3 to 6 months 38°C or higher in children younger than 3 months
427
Children and young people with bacterial meningitis commonly present with?
non-specific symptoms and signs, including fever, vomiting, irritability, reduced feeding in babies, and upper respiratory tract symptoms. These may be difficult to distinguish from other viral infections. Some children with bacterial meningitis present with seizures.
428
Children and young people with more specific symptoms and signs are more likely to have what type of meningitis?
bacterial meningitis or meningococcal septicaemia, and the symptoms and signs may become more severe and more specific over time.
429
Classical signs of meningitis (neck stiffness, bulging fontanelle, high pitched cry) are often absent in who?
infants with bacterial meningitis.
430
Meningitis= When a non-blanching rash is present, it may appear as a?
Petechial rash (red or purple non-blanching macules smaller than 2 mm in diameter). Purpuric (haemorrhagic) rash (spots larger than 2 mm in diameter) — this may be absent in the early phase of the illness and may initially be blanching or macular in nature.
431
How to assess meningitis rash?
Examine the whole body systematically (including nappy areas) for rash and unusual skin colour — particularly for non-blanching rashes and petechiae. Advise to look for any changes in the rash, as it can change from blanching to non-blanching. Consider checking for non-blanching rashes using the 'glass test'. Be aware that the glass test should not be used solely for diagnosing bacterial meningitis and meningococcal septicaemia. A rash may be hard to detect on brown, black or tanned skin (even when using the glass test). Check paler areas of the body (such as the soles of the feet or palms of the hands) or the conjunctivae or palate.
432
Glass test for meningitis?
This involves pressing the side of a glass or tumbler firmly against the rash to see if the rash fades or loses colour under pressure. A petechial or purpuric rash does not fade. Be aware that the glass test should not be used solely for diagnosing bacterial meningitis and meningococcal septicaemia.
433
The risk of meningococcal disease is high in a child or young person with petechiae if:
The petechiae start to spread. The rash becomes purpuric. There are signs of bacterial meningitis. There are signs of meningococcal septicaemia. The child or young person appears unwell.
434
meningococcal disease vs meningococcal septicemia?
Meningococcal septicaemia is a type of blood poisoning that is caused by the same type of bacteria that cause the most common form of bacterial meningitis. Meningococcal meningitis and septicaemia are together known as meningococcal disease.
435
Meningitis= features of shock?
Capillary refill time of more than 2 seconds, cold hands and feet. Unusual skin colour. Tachycardia and/or hypotension. Respiratory symptoms or breathing difficulty. Leg pain. Toxic/moribund state. Altered mental state/decreased conscious level. Poor urine output.
436
Dose of IM benxylpenicillin for meningitis presentation in GP?
Children aged 1-11 months — 300 mg. Children aged 1–9 years — 600 mg. Adults and children aged 10 years or over — 1200 mg.
437
Dose of IM ceftriaxone (if benzylpenicillin not given) for meningitis presentation in GP?
Children aged 1 month–11 years (body-weight up to 50 kg) — 80 mg/kg (intramuscularly). Maximum dose 2000 mg. Children 9–11 years (body-weight 50 kg and above) — 2000 mg. Adults and children aged 12–17 years — 2000 mg.
438
Necrotising fasciitis?
rapidly spreading, life-threatening bacterial infection that destroys skin, fat, and muscle tissue. It is commonly referred to as a "flesh-eating disease." medical emergency
439
Necrotising fasciitis is difficult to...
recognise in the early stages
440
Necrotising fasciitis can be classified according to what?
the causative organism type 1 & type 2
441
Necrotising fasciitis type 1?
caused by mixed anaerobes and aerobes (often occurs post-surgery in diabetics). This is the most common type
442
Necrotising fasciitis type 2?
caused by Streptococcus pyogenes
443
Necrotising fasciitis RFs?
skin factors: recent trauma, burns or soft tissue infections diabetes mellitus= the most common preexisting medical condition; particularly if the patient is treated with SGLT-2 inhibitors intravenous drug use immunosuppression
444
Necrotising fasciitis most commonly affected site?
the perineum (Fournier's gangrene)
445
Fournier's gangrene?
necrotising fasciitis affecting he perineum
446
Features of necrotising fasciitis?
acute onset pain, swelling, erythema at the affected site often presents as rapidly worsening cellulitis with pain out of keeping with physical features extremely tender over infected tissue with hypoaesthesia to light touch skin necrosis and crepitus/gas gangrene are late signs fever and tachycardia may be absent or occur late in the presentation
447
Late signs of necrotising fasciitis?
skin necrosis and crepitus/gas gangrene
448
necrotising fasciitis often presents with what?
rapidly worsening cellulitis with pain out of keeping with physical features
449
Mx of necrotising fasciitis?
urgent surgical referral debridement intravenous antibiotics
450
Prognosis of necrotising fasciitis?
average mortality of 20%
451
Who to speak to for notifiable diseases?
The 'Proper Officer' at the Local Health Protection Team needs to be notified. They in turn will notify the Health Protection Agency on a weekly basis. HIV notified different.
452
In April 2010 the following diseases were removed from the list of notifiable diseases?
Dysentery Ophthalmia neonatorum Leptospirosis Relapsing fever
453
List of notifiable diseases?
Acute encephalitis Acute infectious hepatitis Acute meningitis Acute poliomyelitis Anthrax Botulism Brucellosis Cholera COVID-19 Diphtheria Enteric fever (typhoid or paratyphoid fever) Food poisoning Haemolytic uraemic syndrome (HUS) Infectious bloody diarrhoea Invasive group A streptococcal disease Legionnaires Disease Leprosy Malaria Measles Meningococcal septicaemia Mumps Plague Rabies Rubella Severe Acute Respiratory Syndrome (SARS) Scarlet fever Smallpox Tetanus Tuberculosis Typhus Viral haemorrhagic fever (VHF) Whooping cough Yellow fever
454
Neutropenic sepsis?
relatively common complication of cancer therapy, usually as a consequence of chemotherapy
455
When does neutropenic sepsis commonly occur?
7-14d after chemotherapy
456
How is neutropenic sepsis defined?
neutrophil count of < 0.5 * 109 in a patient who is having anticancer treatment and has one of the following: - a temperature higher than 38ºC or - other signs or symptoms consistent with clinically significant sepsis
457
neutrophil count of < 0.5 * 109 in a patient who is having anticancer treatment and has one of the following: - a temperature higher than 38ºC or - other signs or symptoms consistent with clinically significant sepsis diagnosis?
neutropenic sepsis
458
Cause of neutropenic sepsis?
coagulase-negative, Gram-positive bacteria are the most common cause, particularly Staphylococcus epidermidis this is probably due to the use of indwelling lines in patients with cancer
459
Neutropenic sepsis prophylaxis?
if it is anticipated that patients are likely to have a neutrophil count of < 0.5 * 109 as a consequence of their treatment they should be offered a fluoroquinolone
460
Mx of neutropenic sepsis?
antibiotics must be started immediately, do not wait for the WBC following this initial treatment patients are usually assessed by a specialist and risk-stratified to see if they may be able to have outpatient treatment
461
Mx of neutropenic sepsis= initial empirical Abx therapy?
piperacillin with tazobactam (Tazocin) many units add vancomycin if the patient has central venous access but NICE do not support this approach
462
Mx of neutropenic sepsis= following empirical tazocin Abx, if pt is still febrile and unwell after 48hrs then?
alternative antibiotic such as meropenem is often prescribed +/- vancomycin if patients are not responding after 4-6 days the Christie guidelines suggest ordering investigations for fungal infections (e.g. HRCT), rather than just starting therapy antifungal therapy blindly there may be a role for G-CSF in selected patients
463
What is neutropenic sepsis?
potentially life-threatening complication of neutropenia. It is defined as a temperature of greater than 38°C or any symptoms and/or signs of sepsis, in a person with an absolute neutrophil count of 0.5 x 109/L or lower.
464
Febrile neutropenia?
most common complication of anticancer treatment, and describes the presence of fever in a person with neutropenia.
465
Neutropenic sepsis= There are multiple possible causes of neutropenia such as?
cytotoxic chemotherapy and other immunosuppressive drugs, stem cell transplantation, infections, bone marrow disorders such as aplastic anaemia and myelodysplastic syndromes, and nutritional deficiencies. The risk of infection and/or sepsis increases with severe and/or prolonged neutropenia, and a rapid decline in neutrophil count.
466
Possible complications of neutropenic sepsis include?
death, organ failure, invasive and atypical infection, coagulopathy, encephalopathy and delirium, and long term physical, psychological and/or cognitive sequelae.
467
A diagnosis of neutropenic sepsis should be suspected in any person with known neutropenia or risk factors for neutropenia, and/or risk factors for neutropenic sepsis, who becomes unwell. For example, if the person?
Has confirmed infection, or symptoms or signs indicating possible infection (may be minimal, atypical, or absent). Has a temperature greater than 38°C (may be afebrile or have a low temperature). Has clinical features of possible sepsis (may be minimal, atypical, or absent). Appears unwell or there is concern from a relative or carer that there is a change in appearance or behaviour.
468
Urgent assessment of a person with suspected neutropenic sepsis should include:
Evaluation for physiological symptoms and signs to identify the risk of serious complications.
469
Management of a person with suspected neutropenic sepsis
should include implementation of the 'Sepsis Six' bundle of care within the first hour following recognition of sepsis by: Arranging emergency transfer to hospital (usually by 999 ambulance) if the person is critically unwell. Arranging emergency transfer to the local oncology or haematology unit, or medical assessment unit, if the person is clinically stable, depending on local referral pathways.
470
Management of a person with a confirmed diagnosis of neutropenic sepsis following hospital discharge should include:
Liaising with the person's specialist if there is any uncertainty or concern regarding the clinical presentation, such as persistent fever. Providing advice on the nature of sepsis, what to expect during recovery after sepsis, and sources of information and support. Providing information on how and when to seek specialist advice on any symptoms or concerns, and when to seek emergency care, for example if there is fever, signs of infection, or the person is feeling unwell. Assessing and managing any complications following sepsis.
471
Neutropenic sepsis= Chills, shivers, rigors, and/or a temperature greater than 38°C. Note: people with neutropenic sepsis may not present with fever and may instead present with....
hypothermia. In addition, medication such as corticosteroids may mask an elevated temperature.
472
Sepsis?
life-threatening organ dysfunction caused by dysregulated host response to an infection
473
Sepsis definition?
life-threatening organ dysfunction caused by a dysregulated host response to infection
474
Septic shock?
a more severe form sepsis, technically defined as 'in which circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than with sepsis alone'
475
Sepsis vs septic shock?
sepsis: life-threatening organ dysfunction caused by a dysregulated host response to infection septic shock: a more severe form sepsis, technically defined as 'in which circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than with sepsis alone'
476
Sepsis= Adult patients outside of ICU with suspected infection are identified as being at heightened risk of mortality if they have....
quickSOFA (qSOFA) score meeting >= 2 of the following criteria: respiratory rate of 22/min or greater, altered mentation, or systolic blood pressure of 100mmHg or less
477
Sepsis= qSOFA score?
Respiratory rate > 22/min Altered mentation Systolic blood pressure < 100 mm Hg Within an ICU setting a full SOFA score is often used.
478
Sepsis= what does the qSOFA score mean?
Adult patients outside of ICU with suspected infection are identified as being at heightened risk of mortality if they have quickSOFA (qSOFA) score meeting >= 2
479
Sepsis= red flag criteria?
Responds only to voice or pain/ unresponsive Acute confusional state Systolic B.P <= 90 mmHg (or drop >40 from normal) Heart rate > 130 per minute Respiratory rate >= 25 per minute Needs oxygen to keep SpO2 >=92% Non-blanching rash, mottled/ ashen/ cyanotic Not passed urine in last 18 h/ UO < 0.5 ml/kg/hr Lactate >=2 mmol/l Recent chemotherapy
480
Sepsis= amber flag criteria?
Relatives concerned about mental status Acute deterioration in functional ability Immunosuppressed Trauma/ surgery/ procedure in last 6 weeks Respiratory rate 21-24 Systolic B.P 91-100 mmHg Heart rate 91-130 OR new dysrhythmia Not passed urine in last 12-18 hours Temperature < 36ºC Clinical signs of wound, device or skin infection
481
Sepsis= What needs to be identified and treated and the patient supported regardless of the cause or severity?
the underlying cause
482
Clearly, the underlying cause of the patient's sepsis needs to be identified and treated and the patient supported regardless of the cause or severity. If however any of the red flags are present then what should be started straight away?
sepsis 6
483
Sepsis 6?
1) Give oxygen 2) Take blood cultures 3) Give broad spectrum Abx 4) Give IV fluid challenge= bolus of 500ml crystalloid (saline) over less than 15mins 5) Measure serum lactate 6) Measure hourly urine output
484
septic shock: a more severe form sepsis, technically defined as 'in which circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than with sepsis alone'. these patients can be clinically identified by what?
a vasopressor requirement to maintain a MAP ≥ 65mmHg and serum lactate >2mmol/L in the absence of hypovolemia
485
To help identify and categorise patients the Sequential (Sepsis-Related) Organ Failure Assessment Score (SOFA) is increasingly used. The score grades....
abnormality by organ system and accounts for clinical interventions. However, laboratory variables, namely, PaO2, platelet count, creatinine level, and bilirubin level, are needed for full computation.
486
Sepsis SOFA score= PaO2 /FI O2?
score 0= >400 score 1= <400 score 2= <300 score 3= <200 score 4= <100
487
Sepsis SOFA score= Platelets x103 microlitres?
score 0= >150 score 1= <150 score 2= <100 score 3= <50 score 4= <20
488
Sepsis SOFA score= Bilirubin µmol/L?
score 0= 20 score 1= 20-32 score 2= 33-101 score 3= 102-204 score 4= >204
489
Sepsis SOFA score= Cardiovascular?
score 0= MAP >70mmHg score 1= MAP 70mmHg score 2= Dopamine <5 or dobutamine (any dose) score 3= Dopamine 5.1-15 or epinephrine 0.1 or norepinephrine 0.1 score 4= Dopamine >15 or epinephrine >0.1 or norepinephrine >0.1
490
Sepsis SOFA score= GCS?
score 0= 15 score 1= 13-14 score 2= 10-12 score 3= 6-9 score 4= <6
491
Sepsis SOFA score= Creatinine µmol/L?
score 0= <110 score 1= 110-170 score 2= 171-299 score 3= 300-440 score 4= >440
492
Sepsis SOFA score= Urine output ml/day?
score 0= >500 score 1= >500 score 2= >500 score 3= <500 score 4= <200
493
Sepsis SOFA score= what score reflects an overall mortality risk of approximately 10% in a general hospital population with suspected infection?
2 or more
494
Sepsis= Even patients presenting with modest dysfunction can deteriorate further, emphasizing the seriousness of this condition and the need for...
prompt and appropriate intervention, if not already being instituted
495
Definition of sepsis?
syndrome defined as life-threatening organ dysfunction due to a dysregulated host response to infection
496
Septic shock definition?
subset of sepsis, which describes circulatory, cellular, and metabolic abnormalities that are associated with a greater risk of mortality than sepsis alone
497
Sepsis is thought to be what type of response?
multifactorial response to an infecting pathogen that may be amplified by host factors (such as genetics, age, and co-morbidities), the pathogen (type, virulence, and burden), and the environment.
498
Most common sites of infection that lead to sepsis?
respiratory, gastrointestinal, renal, and genitourinary tracts
499
RFs for sepsis?
extremes of age; people who are frail, immunocompromised, or immunosuppressed; people who have had recent trauma or surgery; people with a breach in skin integrity; and women who are pregnant, are post-partum, or have had a recent termination of pregnancy or miscarriage
500
Cx of sepsis?
organ failure, recurrent or secondary infection, and death
501
When should sepsis be considered?
any person presenting with: - Symptoms or signs indicating possible infection causing significant illness or deterioration. These may be non-specific and non-localized, such as general malaise, agitation, or behavioural change. - One or more risk factor(s) for sepsis, and who looks unwell. - Concern from a relative or carer that there is a change in appearance or behaviour.
502
Urgent assessment for pt with sepsis should include?
Evaluation for physiological symptoms and signs to identify markers of increased risk of severe illness or death. Use of a sepsis risk stratification tool to assess the risk of clinical deterioration from sepsis.
503
Mx of suspected sepsis may include= 999 to hospital if pt is....
high risk of severe illness or death from sepsis, or moderate-to-high risk in certain clinical situations
504
Mx of suspected sepsis may include= managing in primary care when?
if they are at high risk of severe illness or death from sepsis, but transfer of care to hospital would be unnecessarily burdensome or inappropriate, for example people who are very frail or approaching the end of life they are at low risk of severe illness or death from sepsis, and providing safety-netting information.
505
Mx of suspected sepsis may include= managing what?
any underlying condition and arranging follow-up in primary care, if there are any moderate-to-high risk criteria for severe illness or death from sepsis, and a definitive diagnosis has been identified, and this can be treated in primary care.
506
Management of a person with a confirmed diagnosis of sepsis following hospital discharge may include:
Providing the person and/or carers with advice on the nature of sepsis, what to expect during recovery, and sources of information and support. Assessing and managing any complications following sepsis, such as anxiety and/or post-traumatic stress disorder; persistent fatigue; or chronic pain.
507
People with sepsis may present with non-specific, non-localized clinical features — for example, general malaise, agitation, or behavioural change. Older children vs infants & neonates?
Older children may present with a focus of infection, while infants and neonates usually present with non-specific symptoms and signs.
508
Pt with sepsis may not present with raised core temp, but may present with what...
lowered core temp
509
Hypotension is a presenting feature in 40% of people with sepsis, but be aware that...
normal blood pressure does not exclude sepsis.
510
High vs moderate to high risk criteria?
High risk of severe illness or death from sepsis if they meet any of the relevant high risk criteria. Moderate to high risk of severe illness or death from sepsis if they meet any of the relevant moderate to high risk criteria.
511
High risk criteria for sepsis in child under 5?
No response to social cues; Appears ill to a healthcare professional; Does not wake, or if roused does not stay awake; Weak high pitched or continuous cry Resp: - any= Grunting; Apnoea; Oxygen saturation of less than 90% in air or increased oxygen requirement over baseline - <1yrs= RR 60+ - 1-2yrs= RR 50+ - 3-4yrs= RR 40+ Circulation: - any= HR <60 - <1yrs= HR 160+ - 1-2yrs= HR 150+ - 3-4yrs= HR 140+ Skin= Mottled or ashen appearance; Cyanosis of skin, lips, or tongue; Non-blanching rash of skin or purpric rash Temp: - any= <36C - <3m= 38C+
512
Moderate to high risk criteria for sepsis in child under 5?
Not responding normally to social cues; No smile; Wakes only with prolonged stimulation; Decreased activity; Parent or carer concern that child is behaving differently from usual Resp: - Oxygen saturation of less than 92% in air or increased oxygen requirement over baseline; Nasal flaring - <1yr= RR 50-59 - 1-2yrs= RR 40-49 - 3-4yrs= RR 35-39 Circulation: - Capillary refill time of 3 seconds or more; Reduced urine output; For catheterized patients, passed less than 1 ml/kg of urine per hour - <1yrs= HR 150-159 - 1-2yrs= HR 140-149 - 3-4yrs= HR 130-139 Skin: - Pallor of skin, lips, or tongue Temp: - 3-6m= 39C + Other= leg pain, cold hands or feet
513
High risk criteria for sepsis in child 5-11yrs?
Objective evidence of altered behaviour or mental state; Appears ill to a healthcare professional; Does not wake or if roused does not stay awake Resp: - any= Oxygen saturation of less than 90% in air or increased oxygen requirement over baseline - 5yrs= RR 29+ - 6-7yrs= RR 27+ - 8-11yrs= RR 25+ Circulation: - any= HR <60 - 5yrs= HR 130+ - 6-7yrs= HR 120+ - 8-11yrs= HR 115+ Skin= Mottled or ashen appearance; Cyanosis of skin, lips, or tongue; Non-blanching rash of skin
514
Moderate to high risk criteria for sepsis in child 5-11yrs?
Not behaving normally; Decreased activity; Parent or carer concern that the child is behaving differently from usual Resp: - any= Oxygen saturation of less than 92% in air or increased oxygen requirement over baseline - 5yrs= RR 24-28 - 6-7yrs= RR 24-26 - 8-11yrs= RR 22-24 Circulation: - any= Capillary refill time of 3 seconds or more; Reduced urine output; For catheterized patients, passed less than 1 ml/kg of urine per hour - 5yrs= HR 120-129 - 6-7rs= HR 110-119 - 8-11yrs= HR 105-114 Tympanic T <36 Leg pain; cold hands or feet
515
High risk criteria for sepsis in children 12-15yrs?
Objective evidence of new altered mental state Resp= Raised respiratory rate: 25 breaths per minute or more; New need for oxygen (40% FiO2 or more) to maintain saturation more than 92% (or more than 88% in known chronic obstructive pulmonary disease) BP= Systolic blood pressure 90 mmHg or less or systolic blood pressure more than 40 mmHg below normal Circulation= Raised heart rate: more than 130 beats per minute; Not passed urine in previous 18 hours; For catheterized patients, passed less than 0.5 ml/kg of urine per hour Mottled or ashen appearance; Cyanosis of skin, lips, or tongue; Non-blanching petechial or purpuric rash
516
Moderate to high risk criteria for sepsis in children 12-15yrs?
History from patient, friend, or relative of new onset of altered behaviour or mental state; History of acute deterioration of functional ability; Impaired immune system (illness or drugs including oral steroids); Trauma, surgery, or invasive procedures in the last 6 weeks RR 21-24 Systolic blood pressure 91–100 mmHg Raised heart rate: 91–130 beats per minute (for pregnant women 100–130 beats per minute) or new onset arrhythmia; Not passed urine in the past 12–18 hours; For catheterized patients, passed 0.5–1 ml/kg of urine per hour Tympanic temperature less than 36°C Signs of potential infection, including redness, swelling, or discharge at surgical site or breakdown of wound
517
Bloods in sepsis?
Blood gas including glucose and lactate measurement — hypoglycaemia may result from depleted glycogen stores; hyperglycaemia may result from the stress response to sepsis; hyperlactataemia is a non-specific indicator of cellular or metabolic stress and is a marker of illness severity, with a higher level predictive of higher mortality rates. Blood culture — ideally done before antibiotic administration, to identify a primary bacteraemia. FBC — white cell count may be high or low; thrombocytopenia may indicate disseminated intravascular coagulation (DIC). CRP — may indicate infection and/or inflammation. Creatinine, urea, and electrolytes — may indicate dehydration and/or acute kidney injury. LFTs — increased bilirubin or alanine aminotransferase (ALT) levels may indicate cholestasis or other liver dysfunction. Clotting screen — if abnormal may indicate coagulopathy/DIC. Urine analysis and culture, CXR, and additional investigations depending on the person's clinical presentation — this may allow identification of the source of infection, pathogen(s) and sensitivities, and subsequent tailoring and/or de-escalation of antibiotic therapy if appropriate. Source control to eliminate a focus of infection may be possible, such as abscess drainage, debridement of infected tissue, removal of infected devices or foreign bodies, or surgery.RP
518
Sepsis Mx= Transfer to critical care may be needed to assess the need for.....
central venous access and initiation of inotropes (increase cardiac output by increasing cardiac contractility) or vasopressors (increase blood pressure by increasing peripheral vascular resistance), to maintain perfusion pressure.
519
Staphylococcal toxic shock syndrome?
severe systemic reaction to staphylococcal exotoxins, the TSST-1 superantigen toxin. It came to prominence in the early 1980s following a series of cases related to infected tampons.
520
Staphylococcal toxic shock syndrome= came to prominence in the early 1980s following a series of cases related to what?
infected tampons
521
Staphylococcal toxic shock syndrome= Centers for Disease Control and Prevention diagnostic criteria?
fever: temperature > 38.9ºC hypotension: systolic blood pressure < 90 mmHg diffuse erythematous rash desquamation of rash, especially of the palms and soles involvement of three or more organ systems: e.g. gastrointestinal (diarrhoea and vomiting), mucous membrane erythema, renal failure, hepatitis, thrombocytopenia, CNS involvement (e.g. confusion)
522
Mx of Staphylococcal toxic shock syndrome?
removal of infection focus (e.g. retained tampon) IV fluids IV antibiotics
523
Surgical site infections may occur following what?
breach in tissue surfaces and allow normal commensals and other pathogens to initiate infection. They are a major cause of morbidity and mortality.
524
Surgical site infections (SSI) comprise up to ....% of all healthcare-associated infections and at least 5% of patients undergoing surgery will develop an SSI as a result.
20%
525
In many cases of surgical site infection, the organisms come from what?
pts own body
526
In many cases, the organisms are derived from the patient's own body. Measures that may increase the risk of surgical site infection (SSI) include what?
Shaving the wound using a razor (disposable clipper preferred) Using a non-iodine impregnated incise drape if one is deemed to be necessary Tissue hypoxia Delayed administration of prophylactic antibiotics in tourniquet surgery
527
Prevent surgical site infection preop?
Don't remove body hair routinely If hair needs removal, use electrical clippers with a single-use head (razors increase infection risk) Abx prophylaxis if: - placement of prosthesis or valve - clean-contaminated surgery - contaminated surgery Use local formulary: - Aim to give single-dose IV antibiotic on anaesthesia - If a tourniquet is to be used, give prophylactic antibiotics earlier
528
Prevent surgical site infection preop- when to give Abx?
Abx prophylaxis if: - placement of prosthesis or valve - clean-contaminated surgery - contaminated surgery Use local formulary: - Aim to give single-dose IV antibiotic on anaesthesia - If a tourniquet is to be used, give prophylactic antibiotics earlier
529
Surgical site infection prevention intraoperatively?
Prepare the skin with alcoholic chlorhexidine (Lowest incidence of SSI) Cover surgical site with dressing A recent meta analysis has confirmed that administration of supplementary oxygen does not reduce the risk of wound infection. In contrast to previous individual RCTs Wound edge protectors do not appear to confer benefit
530
Surgical site infection: prevention post op?
Tissue viability advice for management of surgical wounds healing by secondary intention.
531
Hepatitis A?
typically a benign, self-limiting disease, with a serious outcome being very rare
532
Hepatitis A= incubation period?
2-4w
533
Hepatitis A= type of virus?
RNA picornavirus
534
Hepatitis A= transmission?
faecal-oral spread, often in institutions
535
Hepatitis A= does it cause chronic disease?
no
536
Hepatitis A= features?
- flu-like prodrome - abdominal pain: typically right upper quadrant - tender hepatomegaly - jaundice - deranged liver function tests
537
- flu-like prodrome - abdominal pain: typically right upper quadrant - tender hepatomegaly - jaundice - deranged liver function tests
?hep A
538
Hepatitis A= Cx?
rare and there is no increased risk of hepatocellular ca
539
Hepatitis A= immunisation?
an effective vaccine is available after the initial dose a booster dose should be given 6-12 months later
540
Hepatitis A= who should be vaccinated (based on Green book guidelines)?
men who have sex with men people travelling to or going to reside in areas of high or intermediate prevalence, if aged > 1 year old people with chronic liver disease patients with haemophilia injecting drug users individuals at occupational risk: laboratory worker; staff of large residential institutions; sewage workers; people who work with primates
541
Hepatitis B= type of virus?
double-stranded DNA hepadnavirus
542
Hepatitis B= how is it spread?
exposure to infected blood or body fluids, including vertical transmission from mother to child
543
Hepatitis B= incubation period?
6-20w
544
Hepatitis B= features?
fever, jaundice, elevated liver transaminases
545
Hepatitis B= Cx?
chronic hepatitis (5-10%). fulminant liver failure (1%) hepatocellular carcinoma glomerulonephritis polyarteritis nodosa cryoglobulinaemia
546
'Ground-glass' hepatocytes may be seen on light microscopy?
chronic hepatitis due to hep B
547
Hep B causing chronic hepatitis may show what on light microscopy?
'Ground-glass' hepatocytes
548
Hepatitis B= who is vaccinated?
- children at 2,3 & 4m - a risks groups
549
Hepatitis B= at risks groups that should be vaccinated?
healthcare workers, intravenous drug users, sex workers, close family contacts of an individual with hepatitis B, individuals receiving blood transfusions regularly, chronic kidney disease patients who may soon require renal replacement therapy, prisoners, chronic liver disease patients
550
Hepatitis B= vaccine contains what?
HBsAg adsorbed onto aluminium hydroxide adjuvant and is prepared from yeast cells using recombinant DNA technology
551
Hepatitis B= how effective is the vaccine?
around 10-15% of adults fail to respond or respond poorly to 3 doses of the vaccine. Risk factors include age over 40 years, obesity, smoking, alcohol excess and immunosuppression
552
Hepatitis B= when is testing for anti-HBs recommended?
only recommended for those at risk of occupational exposure (i.e. Healthcare workers) and patients with chronic kidney disease. In these patients anti-HBs levels should be checked 1-4 months after primary immunisation
553
Hepatitis B= Anti-HBs level (mIU/ml) >100?
Indicates adequate vaccine response, no further testing required. Should still receive booster at 5 years
554
Hepatitis B= Anti-HBs level (mIU/ml) 10-100?
Suboptimal response to vaccine - one additional vaccine dose should be given. If immunocompetent no further testing is required
555
Hepatitis B= Anti-HBs level (mIU/ml) <10?
Non-responder to vaccine. Test for current or past infection. Give further vaccine course (i.e. 3 doses again) with testing following. If still fails to respond then HBIG would be required for protection if exposed to the virus.
556
Management of hepatitis B?
pegylated interferon-alpha used to be the only treatment available NICE still advocate the use of pegylated interferon firstl-line other antiviral medications are increasingly used with an aim to suppress viral replication (not in a dissimilar way to treating HIV patients) examples include tenofovir, entecavir and telbivudine (a synthetic thymidine nucleoside analogue)
557
Hepatitis B= Mx?
pegylated interferon-alpha
558
Hepatitis B= Mx- how does pegylated interferon-alpha work?
reduces viral replication in up to 30% of chronic carriers
559
Hepatitis B= Mx with pegylated interferon-alpha, a better response to Tx is predicted in who?
female, < 50 years old, low HBV DNA levels, non-Asian, HIV negative, high degree of inflammation on liver biopsy
560
Hepatitis B= who are offered screening for hep B?
all pregnant women
561
Hepatitis B= babies born to mothers who are chronically infected with hepatitis B or to mothers who've had acute hepatitis B during pregnancy should receive what?
complete course of vaccination + hepatitis B immunoglobulin studies are currently evaluating the role of oral antiviral treatment (e.g. Lamivudine) in the latter part of pregnancy there is little evidence to suggest caesarean section reduces vertical transmission rates
562
Hepatitis B= can it be transmitted via breastfeeding?
NO (HIV can)
563
Hepatitis B serology= HBsAg stands for?
hep B surface antigen
564
Hepatitis B serology= HBsAg is what?
the first marker to appear and causes the production of anti-HBs
565
Hepatitis B serology= first marker to appear?
HBsAg
566
Hepatitis B serology= HBsAg normally means what?
acute disease (present for 1-6m)
567
Hepatitis B serology= what usually means acute disease (present for 1-6m)?
HBsAg
568
Hepatitis B serology= what implies chronic disease (i.e. infective)?
HBsAg present for >6m
569
Hepatitis B serology= HBsAg present for >6m means what?
chronic disease (i.e. infective)
570
Hepatitis B serology= Anti-HBs stands for?
Hepatitis B surface antibody
571
Hepatitis B serology= Anti-HBs means what?
implies immunity (either exposure or immunisation); negative in chronic disease
572
Hepatitis B serology= Anti-HBs in chronic disease?
negative
573
Hepatitis B serology= what indicates immunity (either exposure or immunisation) and is negative in chronic disease?
Anti-HBs
574
Hepatitis B serology= Anti-HBc stands for?
Hepatitis B core antibody
575
Hepatitis B serology= Anti-HBc means what?
previous (or current) infection. IgM anti-HBc appears during acute or recent hepatitis B infection and is present for about 6 months. IgG anti-HBc persists
576
Hepatitis B serology= Anti-HBc IgA and IgG?
IgM anti-HBc appears during acute or recent hepatitis B infection and is present for about 6 months. IgG anti-HBc persists
577
Hepatitis B serology= what indicates previous (or current) infection?
Anti-HBc
578
Hepatitis B serology= HbeAg stands for?
Hepatitis B virus (HBV) e antigen is a small polypeptide, which exists in a free form in the serum of individuals during the early phase of hepatitis B infection, soon after hepatitis B virus surface antigen (HBsAg) becomes detectable.
579
Hepatitis B serology= HbeAg means wha?
results from breakdown of core antigen from infected liver cells as is, therefore, a marker of infectivity. Marker of HBV replication and infectivity
580
Hepatitis B serology= wha is a marker of HBV replication and infectivity?
HbeAg
581
Hepatitis B serology= previous immunisation results?
anti-HBs positive, all others negative
582
Hepatitis B serology= previous hepatitis B (> 6 months ago), not a carrier?
anti-HBc positive, HBsAg negative
583
Hepatitis B serology= previous hepatitis B, now a carrier?
anti-HBc positive, HBsAg positive
584
Hepatitis B serology= way to remember?
HBsAg = ongoing infection, either acute or chronic if present > 6 months anti-HBc = caught, i.e. negative if immunized
585
It is thought how many people are chronically infected with hep C?
200,000 in UK
586
Hepatitis C= at risk groups?
intravenous drug users and patients who received a blood transfusion prior to 1991 (e.g. haemophiliacs)
587
Hepatitis C= type of virus?
RNA flavivirus
588
Hepatitis C= incubation period?
6-9w
589
Hepatitis C= transmission?
IVDU most common the risk of transmission during a needle stick injury is about 2% the vertical transmission rate from mother to child is about 6%. The risk is higher if there is coexistent HIV the risk of transmitting the virus during sexual intercourse is probably less than 5%
590
Hepatitis C= can mothers with hep C still breastfeed?
yes
591
Hepatitis C= is there a vaccine?
no
592
Hepatitis C= features after expsoure?
only 30% have features - transient rise in serum aminotransferaes/jaundice - fatigue - arthralgia
593
Hepatitis C= Ix?
HCV RNA Ix of choice for acute infection whilst patients will eventually develop anti-HCV antibodies it should be remembered that patients who spontaneously clear the virus will continue to have anti-HCV antibodies
594
Hepatitis C= prognosis?
around 15-45% of patients will clear the virus after an acute infection (depending on their age and underlying health) and hence the majority (55-85%) will develop chronic hepatitis C
595
Hepatitis C= chronic hep C?
persistence of HCV RNA in the blood for 6m
596
Hepatitis C= potential Cx of chronic hep C?
rheumatological problems: arthralgia, arthritis eye problems: Sjogren's syndrome cirrhosis (5-20% of those with chronic disease) hepatocellular cancer cryoglobulinaemia: typically type II (mixed monoclonal and polyclonal) porphyria cutanea tarda (PCT): it is increasingly recognised that PCT may develop in patients with hepatitis C, especially if there are other factors such as alcohol abuse membranoproliferative glomerulonephritis
597
Hepatitis C= Mx of chronic infection- Tx depends on what?
the viral genotype so this should be tested prior to Tx
598
Hepatitis C= Mx of chronic infection- how effective is Tx?
clearance rates of around 95%
599
Hepatitis C= Mx of chronic infection- aim of Tx?
sustained virological response (SVR) defined as undetectable serum HCV RNA 6m after the end of therapy
600
Hepatitis C= Mx of chronic infection- the aim of Tx is to achieve a sustained virological response (SVR), what does this mean?
undetectable serum HCV RNA 6m after the end of therapy
601
Hepatitis C= Mx of chronic infection?
combination of protease inhibitors (e.g. daclatasvir + sofosbuvir or sofosbuvir + simeprevir) with or without ribavirin are used
602
Hepatitis C= Mx of chronic infection- what are the complications of treatment: ribavirin?
side-effects: haemolytic anaemia, cough. Women should not become pregnant within 6 months of stopping ribavirin as it is teratogenic
603
Hepatitis C= Mx of chronic infection- what are the complications of treatment: interferon alpha (no longer recommended)?
side-effects: flu-like symptoms, depression, fatigue, leukopenia, thrombocytopenia
604
Hepatitis C & pregnancy= are women screened for hep C in the antenatal period?
no
605
Hepatitis C & pregnancy= vertical transmission risk?
vertical transmission rate from mother to child is about 6%. The risk is higher if there is a high viral load or coexistent HIV
606
Hepatitis C & pregnancy= Mx- no definitive guidelines for Mx but based on expert reviews....
standard drug therapy cannot be used in pregnancy due to concerns about teratogenicity HCV-positive pregnant women should be monitored throughout pregnancy HCV RNA and LFTs should be done as early as possible into prenatal care to assess the risk of transmission and degree of liver disease if pruritic or they develop jaundice, suspect intrahepatic cholestasis of pregnancy and perform LFTs. invasive procedures should be minimised in mother and fetus to prevent vertical transmission not routine to offer c-section
607
Hepatitis C & pregnancy= what increases the risk of passing on the virus?
exposure to maternal blood eg. due to perineal tears
608
Hepatitis C & pregnancy= can women breastfeed?
yes
609
Hepatitis D= type of virus?
single stranded RNA (it is an incomplete virus) requires hepatitis B surface antigen to complete its replication and transmission cycle.
610
Hepatitis D= how is it transmitted?
similar to hep B- exchange of bodily fluids (through blood-to-blood contact or sexual contact)
611
Hepatitis D= what is it?
an incomplete RNA virus that requires hepatitis B surface antigen to complete its replication and transmission cycle.
612
612
Hepatitis D= pts may be infected with what at the same time as hep D?
hep B
612
Hepatitis D= what is needed to complete its replication and transmission cycle?
hep B
613
Hepatitis D= co-infection definition?
Hepatitis B and Hepatitis D infection at the same time.
614
Hepatitis D= superinfection definition?
A hepatitis B surface antigen positive patient subsequently develops a hepatitis D infection.
615
Hepatitis D= superinfection (have hep B then get hep D) is associated with what?
high risk of fulminant hepatitis (acute liver failure), chronic hepatitis and cirrhosis
616
Hepatitis D= diagnosis?
Diagnosis is made via reverse polymerase chain reaction of hepatitis D RNA
617
Hepatitis D= Tx?
Interferon but poor evidence base.
618
Hepatitis E= type of virus?
RNA hepevirus
619
Hepatitis E= how is it spread?
faecal-oral route
620
Hepatitis E= incubation period?
3-8w
621
Hepatitis E= where is it common?
Central and South-East Asia, North and West Africa and Mexico
622
Hepatitis E= causes a similar disease to what?
hep A but carries a significant mortality (about 20%) during pregnancy
623
Hepatitis E= does it cause chronic disease?
does not cause chronic disease or an increased risk of hepatocellular cancer
624
Hepatitis E= is there a vaccine?
currently in development but not yet in widespread use
625
Definition of hep A?
inflammation of the liver caused by infection with the hepatitis A virus. Transmission is through the faecal-oral route.
626
Is hep A common?
uncommon in the UK and usually presents as sporadic cases, community-wide outbreaks (from person-to-person transmission), or point-of-source outbreaks (related to contaminated food).
627
What hepatitis causes chronic liver disease?
B and C
628
Prognosis of hep A?
usually a self-limiting illness with a good prognosis — unlike hepatitis B and C, it does not cause chronic liver disease. Complications include relapsing hepatitis (in about 15% of infected symptomatic people) and, rarely, acute liver failure (in less than 0.1% of people).
629
The clinical features of acute hepatitis A are common to all forms of viral hepatitis, and are characterized by different phases:
The prodromal phase includes flu-like symptoms, gastrointestinal symptoms (such as anorexia, nausea, vomiting, and abdominal right upper quadrant discomfort), and occasionally headache, cough, pharyngitis, constipation, diarrhoea, itch, and urticaria. There may be no specific signs on examination. The icteric phase includes jaundice, pale stools, and dark urine (if there is cholestasis); pruritus; fatigue; anorexia; nausea; and vomiting — symptoms often improve once jaundice occurs. Hepatomegaly, splenomegaly, lymphadenopathy, and hepatic tenderness may be present on examination. The convalescent phase includes malaise and hepatic tenderness.
630
Confirmed Hep A is defined by what?
Meeting the clinical case definition and having IgM and IgG antibodies to hepatitis A. Having hepatitis A RNA (HAV RNA) detected regardless of clinical features. Being asymptomatic with no recent history of immunisation, but having anti-HAV IgM in oral fluid or serum, and having an epidemiological link to a confirmed hepatitis A case.
631
Management of a person with confirmed or probable hepatitis A infection includes?
Admission to hospital if they are severely unwell. Provision of symptomatic supportive care if admission is not indicated. Notifying the local Health Protection Unit promptly. Providing information and advice about hepatitis A, including the need to avoid alcohol during the acute illness. Offering referral to a genito-urinary medicine clinic or drug rehabilitation centre, if appropriate. Arranging follow up and monitoring liver function and prothrombin time, at a frequency dependent on clinical judgement, the person's symptoms, and liver function test results. Advising the person to seek medical attention if their symptoms worsen.
632
Prevention of transmission of hepatitis A involves advising:
The person to avoid work, school, or nursery, until they are no longer infectious (typically 7 days after the onset of jaundice or 7 days after the onset of symptoms if there is no history of jaundice). The person and all close contacts about thorough hand washing after using the toilet, changing nappies, and helping with child toileting; ensuring good general personal hygiene; avoiding handling food; thorough hand washing before food preparation; practising safe sex until they are no longer infectious; and avoiding sharing drug paraphernalia.
633
People at high risk of hepatitis A infection should be offered...
hepatitis A vaccination if they are not already immune
634
Hep A= The clinical features of the icteric phase of hepatitis (usually lasts 1–3 weeks but can be more prolonged) include:
Jaundice, pale stools, and dark urine if cholestasis — jaundice may occur in 70-80% of infected adults. Pruritus — common in the icteric phase. Fatigue, anorexia, nausea, and vomiting — symptoms often improve once jaundice occurs. Hepatomegaly and right upper quadrant tenderness — often present on examination; hepatomegaly may occur in up to 80% of symptomatic people. Splenomegaly and lymphadenopathy occur less commonly.
635
The clinical features of the convalescent phase of hepatitis A may include...
malaise, anorexia, muscle weakness, and hepatic tenderness. Recovery usually takes about a month in young people but may take up to 6 months in others. Complications are more likely in people with pre-existing liver disease and older people. Hepatitis A does not cause chronic liver disease and following clearance of infection lifelong immunity is acquired.
636
HAV-IgM antibodies are typically present... HAV-IgG....
HAV-IgM antibodies are typically present 5-10 days before the onset of symptoms, peak within a month of illness, and usually remain positive for 45-60 days but can persist for 6 months or more. HAV-IgG antibodies are typically detectable at or just before the onset of symptoms and then persist to provide lifelong immunity.
637
Positive HAV-IgM, and positive HAV-IgG
acute hepatitis A infection is likely.
638
Hep A= A high IgG reactivity and a moderate level of IgM
suggests hepatitis A infection in the recent past rather than current acute infection.
639
Positive HAV-IgM, and negative HAV-IgG
gM result may be a false positive.
640
Negative HAV-IgM, and positive HAV-IgG
uggests past hepatitis A infection or immunity from previous vaccination.
641
Hep A= Serology results should be interpreted in the broader context of...
Timing of illness onset —if serology is taken in the first 5 days after the onset of symptoms, there is a small risk of a false negative result — serology should be repeated. The age of the person — false IgM results are more likely in older people, a group likely to have had hepatitis A in childhood. Co-morbidities — HAV IgM serology may not be reliable in patients who are significantly immunocompromised — consider referring for HAV PCR. Risk factors for hepatitis A. Results of liver function tests (see below)
642
LFTs in hep A?
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels may be significantly increased (usually between 500 and 10,000 IU/L). Bilirubin may be elevated (usually between 85.5 and 171 micromols/L, but can reach up to 500 micromols/L). Alkaline phosphatase is generally less than 2x the upper limit of normal, but higher if there is cholestasis. Prothrombin time may be prolonged (3 seconds or more suggests severe hepatitis and 50 seconds or more suggests acute liver failure).
643
The usual schedule for monovalent hepatitis A vaccines is a single dose (provides protection for up to 12 months) and then
a booster dose 6-12 months later if the person remains at long-term risk of contracting hepatitis A.
644
For pregnant women with acute hepatitis A infection, inform the midwifery/obstetric team of the diagnosis and advise the woman that...
Infection in early pregnancy is not thought to increase the risk of congenital malformation in the infant. They may be at increased risk of preterm labour if infection occurs in the second or third trimester and should seek urgent medical advice if symptoms develop or they are concerned. Breastfeeding is not known to pose a specific risk — thorough hand washing and personal hygiene should be maintained.
645
Hep A Mx= Follow-up at least every 1 to 2 weeks...
Consider more frequent follow-up if the person is symptomatic, and/or has jaundice, and depending on the results of liver function tests). Repeat liver function tests until amino-transferase levels are normal (usually 4–12 weeks). Seek specialist advice if the person has significantly abnormal liver function tests or coagulation screen, or if liver function appears to be worsening. Advise the person to seek medical attention if symptoms worsen (particularly if they include vomiting and dehydration) and to be aware of the signs of hepatic decompensation (change in personality or level of consciousness). Admit the person to hospital if they become severely unwell.
646
If a person presents who has been in contact with someone with known hepatitis A infection...
Contact the local Health Protection Unit (HPU) immediately, who will advise on further management if the person has not previously received the hepatitis A vaccine. This may include giving hepatitis A vaccination and/or arranging for the administration of human normal immunoglobulin, depending on the timing and circumstances of contact, as well as other factors including the person's age and co-morbidities.
647
Hepatitis B is an infectious disease of the liver caused by the hepatitis B virus (HBV) — transmission occurs through...
transmission occurs through contact with infected blood or body fluids. In areas of low endemicity (such as the UK), most HBV infections are acquired in adulthood through sexual transmission or sharing of contaminated injecting drug use equipment. In areas of high endemicity, HBV infection is predominantly acquired through perinatal transmission or horizontal transmission among young children.
648
Hepatitis B can be acute or chronic. In England, the prevalence of chronic HBV is estimated to be 0.45% — most chronic HBV infections in the UK are acquired where?
overseas in endemic countries prior to arrival in the UK. Most acute HBV infections in the UK are acquired through sexual transmission and injecting drug use.
649
Diagnosis of acute infection of hep B is based on detection of...
hepatitis B surface antigen (HBsAg) and IgM antibodies to hepatitis B core antigen (anti-HBc).
650
CP of hep B?
Children, in particular infants and younger children, are usually asymptomatic during acute infection. Up to a third of adults develop symptoms (which may include fever, malaise, right upper quadrant abdominal pain and jaundice) with acute infection. Jaundice occurs in about 10% of younger children and in 30-50% of adults. When present, symptoms usually last between 1 and 6 weeks. Hepatitis B surface antigen (HBsAg) is cleared in around 95% of immunocompetent adults. Fulminant hepatitis occurs in fewer than 1% of people but can be fatal.
651
Chronic hepatitis B is defined as
persistence of HBsAg for six months or more after acute infection with hepatitis B virus.
652
Chronic hep B= Chronic infection develops in
90% of infants infected perinatally (if not vaccinated); 20-50% of children infected between one and five years of age and about 5% of immunocompetent adults. Most people with chronic hepatitis B infection are asymptomatic. Approximately 20-25% of people with chronic HBV infection develop progressive liver disease, which can lead to cirrhosis and increased risk of hepatocellular cancer.
653
Hepatitis B immunisation should be offered to:
Infants, as part of the routine childhood immunisation programme. People at high risk of exposure to the virus or complications of the disease. People potentially exposed to HBV through accidental inoculation (such as needlestick or other ‘sharp’, bites, or scratch injuries) or contamination of mucous membranes or non-intact skin — hepatitis B immunoglobulin (HBIG) prophylaxis may also be indicated. Babies born to pregnant women living with Hepatitis B — HBIG prophylaxis may also be indicated.
654
Management of a person with hepatitis B infection includes...
Admission if severely unwell. Referral to a liver specialist for further investigation, treatment (where indicated) and follow-up. Offering symptomatic supportive treatment (rest, pain relief, and treatment of nausea and itch) if needed while the person is awaiting referral. Notifying the Health Protection Unit. Offering advice on avoidance of alcohol and prevention of transmission of infection. Offering referral to a genito-urinary medicine clinic and/or drug rehabilitation agency, if appropriate.
655
CP of hep B= acute infection?
A prodromal illness that includes fever, arthralgia, or a rash (that may appear about 2 weeks before the onset of jaundice, then resolves). Non-specific malaise (which may be profound), fatigue, nausea, and poor appetite. Right upper quadrant abdominal pain. Jaundice (with dark urine and/or pale stools if cholestasis is present) — occurs in about 10% of younger children and in 30-50% of adults. Extrahepatic manifestations such as glomerulonephritis, vasculitis, and polyarteritis.
656
CP of hep B= chronic infection?
there are often no physical signs or symptoms. After many years of infection, depending on the severity and duration, signs of chronic liver disease may develop, such as: Spider naevi. Finger clubbing. Jaundice. Palmar erythema. Hepatosplenomegaly. In severe cases thin skin, bruising, ascites, liver flap, and encephalopathy.
657
Hep B CP= what to be aware of?
Acute hepatitis B infection is asymptomatic in almost all infants and children and 10-50% of adults. Fulminant hepatitis is a rare complication of acute hepatitis B infection (affects less than 1% of people). If present, however, it can progress rapidly to life-threatening liver failure with coagulopathy, encephalopathy, and cerebral oedema.
658
LFTs in acute hep b vs chronic?
In acute hepatitis B: - ALT and AST levels may be significantly increased (usually between 500 and 10,000 IU/L). - Bilirubin may be elevated (can reach up to 500 micromols/L). - ALP is usually less than twice the upper limit of normal but can be higher in the presence of cholestasis. - Prothrombin time may be prolonged (5 seconds or more suggests severe hepatitis and 50 seconds or more suggests acute liver failure). In chronic hepatitis B: - For most, the only indicator is a mildly elevated serum AST level; in many, liver enzymes will be normal.
659
Diagnosis of hepatitis B virus (HBV) is based upon the presence of what?
serological markers (antigens and antibodies) in plasma or serum
660
Hepatitis B Surface Antigen (HBsAg)?
indicates presence of viral envelope and suggests that the person is infectious. It rises during the incubation period and may be cleared early in the course of the disease. It is undetectable in around 10% of people by the time the test is performed. Chronic HBV infection is indicated by the persistence of serum HBsAg for more than 6 months.
661
Hepatitis B e antigen (HBeAg)?
detectable in the serum during both the early phases of acute infection and some chronic infections. Usually associated with relatively high levels of virus replication. People with chronic HBV tend to be more infectious if HBeAg is detected. If HBeAg has been cleared, anti-HBe is usually detected, and infectivity is lower.
662
Antibody to HBeAg (Anti-HBe)?
present following clearance of HBeAg from the plasma. Disappearance of HBeAg, development of anti-HBe, and a decline in HBV-DNA, indicates control of viral replication and predict resolution of acute hepatitis B.
663
Antibody to HBcAg (anti-HBc)?
indicates current or previous HBV infection. Appears at the onset of symptoms in acute infection and generally persists for life. May be absent very early in acute infection.
664
IgG antibody to hepatitis core antigen (anti-HBc IgG)?
generally persists for life and is indicative of past infection.
664
IgM antibody to hepatitis core antigen (anti-HBc IgM)?
indicates recent (within the last six months) HBV infection. Quantification may be useful to distinguish between acute and chronic infection. It is usually replaced gradually by immunoglobulin G (IgG) anti-HBc.
665
Antibody to HBsAg (anti-HBs)?
indicates recovery from and immunity to HBV. Anti-HBs without anti-HBc is a marker of immunisation. Anti-HBs is quantified to measure vaccination response.
666
Other tests for hep B other than serology (presence of antigens and antibodies)?
Additional tests include quantification of HBV DNA (often referred to as HBV viral load), and HBV core avidity testing: High levels of HBV DNA are associated with a greater risk of progression to cirrhosis and hepatocellular cancer. Core avidity testing can differentiate between acute and chronic core IgM infection.
667
Hep B steps to test?
Initial testing should ideally include (at least) HBsAg and anti-HBc. Further tests (such as Hepatitis B e antigen, or antibody status (anti-HBe); HBV DNA level; IgM antibody to hepatitis B core antigen (anti-HBc IgM) may be required depending on the findings. Positive HBsAg and positive anti-HBc IgM confirm an acute infection, particularly if supported by clinical suspicion and raised ALT. Positive HBsAg and anti-HBc (total or IgG) but negative anti-HBc IgM confirm a chronic infection. Different combinations of antibodies and antigens, alongside other findings, can indicate the phase of a chronic infection which is used in determining appropriate treatment options.
668
Hepatitis B serology: HBsAg= + Anti-HBs= - HBeAg= + Anti-HBe= - Anti-HBcc= + IgM anti-HBc= + HBV DNA= + ALT= elevated
Acute hep B
669
Hepatitis B serology: HBsAg= - Anti-HBs= +/- HBeAg= - Anti-HBe= +/- Anti-HBcc= + IgM anti-HBc= - HBV DNA= - ALT= normal
immunity following infection
670
Hepatitis B serology: HBsAg= - Anti-HBs= + HBeAg= - Anti-HBe= - Anti-HBcc= - IgM anti-HBc= - HBV DNA= - ALT= normal
immunity due to vaccination
671
Hepatitis B serology: HBsAg= + Anti-HBs= - HBeAg= +/- Anti-HBe= +/- Anti-HBcc= + IgM anti-HBc= - HBV DNA= + ALT= elevated
Chronic hep B - active
672
Hepatitis B serology: HBsAg= + Anti-HBs= - HBeAg= - Anti-HBe= + Anti-HBcc= + IgM anti-HBc= - HBV DNA= undetectable or low ALT= normal
Chronic hep B- inactive carrier
673
Fees for Hepatitis B vaccination?
Hepatitis B vaccine is not routinely available free of charge. People requesting vaccination against hepatitis B in relation to travel abroad may be charged. Vaccination indicated for treatment (for example, following a human bite) or to address a lifestyle-related risk (such as injected drug use) must be offered free of charge. Combination hepatitis A and B vaccines must be offered free of charge, but should only be used where protection against both illnesses is clinically indicated. Where a person is at occupational risk of hepatitis B, it is the responsibility of their employer (or themselves if self-employed) to arrange and fund immunization.
674
Hep B= If treatment of nausea is required, options include:
Metoclopramide (for people aged over 20 years for a maximum duration of treatment 5 days) or cyclizine, if liver impairment is mild.
675
Hep B= If treatment of itch is required, options include:
Simple measures (such as maintaining a cool, well-ventilated environment, wearing loose clothing, and avoiding hot baths or showers). Chlorphenamine at night — avoid in severe liver impairment.
676
Ensure pregnant women (and women planning to become pregnant) with acute or chronic hepatitis B infection are aware that:
The infant should be immunised against hepatitis B from birth — there is a 90% risk of the infant contracting hepatitis B unless immunisation takes place at birth. There may be an increased risk of preterm delivery and low infant birth weight. Breastfeeding is safe providing the infant has been immunised.
677
Ensure hepatitis serology is repeated after 6 months in all people found to be HBsAg positive to detect or exclude chronic hepatitis B infection. All people with chronic hepatitis B infection require regular
regular review by a liver specialist. The frequency of monitoring depends on a number of factors, such as serology results (which collectively indicate the phase of disease), the person's age, and whether they are taking antiviral drugs. Specialist follow-up is required to: - Monitor serology. - Screen for complications including hepatocellular cancer. - Assess the person's need for treatment on an ongoing basis (depending on the findings of any tests and assessments). Antivirals initiated in secondary care may subsequently be prescribed in primary care as part of a shared care arrangement.
678
Refer all people found to be HBsAg positive to
hepatologist, gastroenterologist or infectious disease specialist (depending on local service provision), to consider the need for additional treatment, follow up, and monitoring.
679
Hep B= While awaiting referral: Advise the person to:
Seek medical attention urgently if symptoms worsen (particularly if they include vomiting and dehydration) or do not improve within 4 weeks and to be aware of the signs of hepatic decompensation such as confusion or change in level of consciousness. Avoid drinking alcohol as this can increase the risk of cirrhosis and hepatocellular cancer in people with chronic hepatitis B. Take steps to minimize the risk of transmission to partners and contacts. The person should: - Avoid sharing items that might be contaminated with small amounts of blood (such as toothbrushes, razors, and scissors). - Avoid unprotected sexual intercourse. - Avoid sharing needles and other drug-injecting equipment. For further information on injecting drug use, see the CKS topic on Opioid dependence. - Not donate blood or semen, or carry an organ donor card. Be aware that treatments that affect the immune system (such as chemotherapy or immunosupressants) can cause recurrence and they may need prophylaxisis while on these medications.
680
Hepatitis C infection is a
slow, progressive disease of the liver caused by the hepatitis C virus (HCV). It is an important, underdiagnosed, and undertreated cause of morbidity and mortality in the UK.
681
HCV causes both acute and chronic infection= acute vs chronic?
Acute infection refers to the period immediately following incubation to within 6 months of acquiring infection. Chronic infection follows acute infection in about 55–85% of people, and refers to the continued presence of HCV 6 months or more after acquiring infection.
682
HCV is transmitted by?
contact with infected blood. Parenteral spread accounts for the majority of cases in the UK, through sharing of needles or other injecting paraphernalia, blood transfusion (pre 1990s), re-use or inadequate sterilization of medical equipment, needlestick injury, and exposure to infected blood by other means (for example sharing a razor with an infected person). Less common routes include sexual transmission and vertical transmission (from mother to baby).
683
Complications of chronic hepatitis C infection include...
cirrhosis, liver failure, and hepatocellular carcinoma.
684
Testing for hepatitis C should be offered or considered if there are:
Risk factors for hepatitis C. Clinical features of possible HCV infection, such as fatigue, arthralgia, and jaundice. Abnormal liver function tests.
685
HCV infection is diagnosed with ...
antibody test (which indicates if a person has ever been infected with HCV) and HCV ribonucleic acid (RNA) test (to check if HCV infection is active and for genotype analysis). If hepatitis C is suspected in an immunocompetent person, blood should be tested for HCV antibodies. If the antibody test is positive, or in immunocompromised people, blood should be tested for HCV RNA. A person has active hepatitis C if they have a positive HCV antibody test and positive HCV RNA test.
686
if a person has suspected acute hepatitis C infection then
Same-day assessment or immediate specialist advice should be sough
687
if a person has suspected chronic hepatitis C infection then...
Urgent referral to a specialist should be arranged for ongoing management and monitoring.
688
who should be notified about cases of suspected acute viral hepatitis.
The local Health Protection Team
689
Primary care management of a person with hepatitis C includes:
Ensuring the person is attending specialist appointments. Offering sources of information and support. Advising on measures to reduce the risk of disease progression, such as reducing alcohol consumption and stopping smoking. Advising on measures to prevent the spread of the infection, such as not sharing razors, toothbrushes, toiletries, or other items that may be contaminated with blood. Advising on the risk of sexual transmission, which is greater in people with multiple partners, in people co-infected with HIV, and with risky sexual practices (for example anal sex). Encouraging the person to inform injecting or sexual contacts, so that they can be tested for hepatitis C. Monitoring for adverse effects of specialist drug treatment (for example hypoglycaemia). Offering people at continued risk of a blood-borne infection immunization against hepatitis A and B.
690
Hep C= Clinical features may include?
Non-specific fatigue, myalgia, anxiety, depression, poor memory or concentration (may be indicative of chronic hepatitis C infection). Nausea and vomiting. Right upper quadrant abdominal pain. Jaundice (with dark urine and/or pale stools if cholestasis). Signs of chronic liver disease (in advanced chronic hepatitis C). Note that only 25–35% of people experience symptoms in the early stages of infection, and infection occurs after an incubation period. Therefore, a person may not connect their present symptoms to the time of risk exposure.
691
The following people will usually be routinely screened by specialist services for hep C?
People who intend to donate blood or organs/tissue. People with end-stage chronic kidney disease requiring renal replacement therapy. Healthcare workers who perform invasive or exposure-prone procedures (for example surgeons).
692
Is routine screening of pregnant women for HCV infection recommended?
no However, testing is recommended if the woman is at increased risk for HCV infection. They should be tested at their prenatal visits. If the initial results in pregnant women with on-going risk factors for hepatitis C infection are negative, this should be repeated later on in the third trimester.
693
Offer hepatitis screening to asymptomatic people who are at high risk of hepatitis C virus (HCV) infection, such as...
People who have ever injected drugs. People who received a blood transfusion before 1991 or blood products before 1986, when screening of blood donors for hepatitis C infection, or heat treatment for inactivation of viruses were introduced. People born or brought up in a country with an intermediate or high prevalence (2% or greater) of chronic hepatitis C, including Africa, Asia, the Caribbean, Central and South America, Eastern and Southern Europe, the Middle East, and the Pacific islands. Babies born to mothers infected with hepatitis C. Prisoners, including young offenders. Looked-after children and young people, including those living in care homes. People living in hostels for the homeless or sleeping on the streets. HIV-positive men who have sex with men. Close contacts of someone known to be chronically infected with hepatitis C, including family members, close friends, household contacts, or sexual partners.
694
Consider testing people who are at increased risk of HCV infection, particularly if they have non-specific or unexplained symptoms and signs. This includes?
People who have ever snorted or smoked drugs (such as cocaine), particularly if they have shared straws or pipes. People who are at risk through sharing of contaminated items, such as razors or toothbrushes. Healthcare workers who have been accidentally exposed to blood where there is a risk of hepatitis C (for example needlestick injuries). People who have received medical, cosmetic, or dental treatment (or any other invasive treatment) in countries where hepatitis C is common and infection control may be poor (including people who have received blood transfusion products that have not been screened for hepatitis C). People who have had tattoos, body piercing, acupuncture, or electrolysis, where unsterilized equipment may have been used (especially consider tattooing and piercing received in the UK before the mid 1980s or in other countries at any time). People who have tested positive for hepatitis B or HIV — HIV-positive men who have sex with men should be offered regular testing for hepatitis C.
695
HCV infection is diagnosed with...
an antibody test (which indicates if a person has ever been infected with HCV) and HCV ribonucleic acid (RNA) test (to check if HCV infection is active and for genotype analysis).
696
HCV infection is diagnosed with an antibody test (which indicates if a person has ever been infected with HCV) and HCV ribonucleic acid (RNA) test (to check if HCV infection is active and for genotype analysis). In immunocompetent people....
send a plain (clotted) blood sample for testing for antibodies to HCV. Detection of antibodies indicates resolved or current HCV infection. If the antibody test is positive, test a second blood sample to confirm the diagnosis. Consider taking an additional blood sample at the same time as the first sample if venepuncture is difficult (for example if the person injects drugs). If the antibody test is negative, consider repeating it (especially if the person is at high risk of infection). Repeat the antibody test at an appropriate time if the last risk exposure occurred within the 3–6 month 'window period' of the test, as it can take at least 3 months for antibodies to become detectable. Seek specialist advice if there is uncertainty about the optimal time to repeat the test.
697
HCV infection is diagnosed with an antibody test (which indicates if a person has ever been infected with HCV) and HCV ribonucleic acid (RNA) test (to check if HCV infection is active and for genotype analysis). If the antibody test is positive, or in immunocompromized people....
If the HCV RNA test is positive, send a repeat sample for confirmation. A positive HCV RNA result means the person has current infection with active hepatitis C, which will require specialist antiviral treatment. If the HCV RNA result is negative, repeat the test after a period of 6 months. If the negative result is confirmed, this means the person has a previously resolved HCV infection, but they are not immune to future HCV infection. Give information and advice on measures to prevent re-infection.
698
HCV infection is diagnosed with an antibody test (which indicates if a person has ever been infected with HCV) and HCV ribonucleic acid (RNA) test (to check if HCV infection is active and for genotype analysis). If a healthcare professional has, or may have, sustained an occupational exposure to HCV (for example, from a needlestick injury)....
Advise that they will need HCV antibody testing at 12 and 24 weeks, and HCV RNA testing at 6, 12, and 24 weeks. This should be arranged through their Occupational Health department.
699
HCV infection is diagnosed with an antibody test (which indicates if a person has ever been infected with HCV) and HCV ribonucleic acid (RNA) test (to check if HCV infection is active and for genotype analysis). If the person has equivocal results, or there is uncertainty in the interpretation of results...
seek specialist advice
700
HCV infection is diagnosed with an antibody test (which indicates if a person has ever been infected with HCV) and HCV ribonucleic acid (RNA) test (to check if HCV infection is active and for genotype analysis). If the person tests negative for HCV but remains at increased risk of infection...
offer annual testing for HCV.
701
People with hepatitis C virus (HCV) infection should be under the care of a
hepatologist or specialist gastroenterologist.
702
If acute hepatitis C virus (HCV) infection is suspected (hepatitis C antibody positive with clinical features of acute hepatitis and/or a likely recent source of transmission is identified):
Arrange a same-day assessment or seek immediate specialist advice.
703
If chronic HCV infection is suspected (hepatitis C antibody positive and ribonucleic acid positive with no clinical features of acute hepatitis):
Arrange an urgent referral. Confirm the person's address and telephone number at the time of referral, and use the practice's address for correspondence if necessary, for example if the person frequently changes address, has an insecure address, or is homeless.
704
All people under specialist services for hepatitis C management should be offered integrated multidisciplinary care (including specialist nurse input) to maximise their uptake of, and retention in, services and to provide ongoing monitoring and support. Around 15–45% of people with acute hepatitis C virus (HCV) infection will...
spontaneously clear the virus within 6 months of infection without any treatment
705
Hep C spontaneuous resolution?
(defined as loss of HCV ribonucleic acid [RNA] within the first 6 months) occurs, no antiviral treatment is necessary
706
Mx of acute hep C?
If spontaneous resolution (defined as loss of HCV ribonucleic acid [RNA] within the first 6 months) occurs, no antiviral treatment is necessary [BASHH, 2017a]. If needed, treatment should be started promptly. There is clear evidence that treatment given during the acute phase is more likely to clear infection and reduces the risk of chronic HCV infection and progression of liver disease than treatment in the chronic phase [BASHH, 2017a]. Treatment should be the same as for chronic infection [BMJ, 2019].
707
All people with chronic HCV infection should be considered for antiviral therapy, which is always initiated by a specialist....
The goal of treatment is to eradicate the virus, achieve a sustained virological response (SVR), and prevent disease progression [Ahmad, 2017; BMJ, 2019]. SVR (undetectable HCV RNA in the blood 12 weeks after treatment completion) is considered equivalent to a cure. The treatment regimen and duration will depend on the HCV genotype, viral load, severity of liver disease, prior HCV treatment history, the presence of comorbidities, and the person's ability to tolerate treatment. Interferon-based treatment regimens are no longer recommended for HCV infection [Ahmad, 2017], as direct-acting antivirals (DAAs) are now considered first-line treatment. DAAs target different stages in the HCV lifecycle and are successful for over 90% of people with HCV infection. The treatment is usually a once daily, oral tablet regimen for either 8 or 12 weeks and is most effective when given before the onset of cirrhosis. DAAs are well tolerated with minimal adverse effects and result in high rates of SVR.
708
Specialist investigations are carried out to assess the state of infection and the progression of liver disease in hep C. These may include?
Blood tests may include: Viral load — to assess response to treatment. Clotting studies — clotting may be affected if there is significant liver damage. Autoantibodies — which are non-specific markers for autoimmune disease. Transient elastography can be offered to diagnose cirrhosis. If unsuitable, liver biopsy can be offered. Liver ultrasound is carried out in people with advanced fibrosis or cirrhosis to screen for hepatocellular cancer. Ultrasound cannot accurately assess the degree of inflammation or liver fibrosis, or predict the prognosis. Liver biopsy may be considered in individual cases, for example to assess the extent of liver damage caused by inflammation, fibrosis, or cirrhosis; to identify iron overload; and to exclude other causes of liver damage.
709
Follow up for hep C in primary care?
Ensure the person is attending specialist appointments, and provide appropriate support if needed to help the person attend. Provide the person with sources of information and support on hepatitis C and its treatment. Monitor the person for adverse effects of specialist treatment, and manage appropriately. - Hypoglycaemia — monitor glucose levels closely in people with diabetes during treatment with direct-acting antivirals (DAAs), particularly within the first 3 months of treatment, and modify diabetes treatment when necessary. Concurrent treatment with antidiabetic drugs may result in symptomatic hypoglycaemia. - Fluctuations of international normalised ratio (INR) — monitor INR closely in people on anticoagulant treatment and, if necessary, adjust the dose of the anticoagulant. Changes in liver function due to treatment with DAAs may result in fluctuations of INR values. Give the person ongoing lifestyle advice to reduce the risk of disease progression, such as stopping smoking. Offer all people at continued risk of a blood-borne infection immunization against hepatitis A and B (available free on the NHS for this indication).
710
Amoebiasis?
caused by Entamoeba histolytica (an amoeboid protozoan) and spread by the faecal-oral route. It is estimated that 10% of the world's population is chronically infected. Infection can be asymptomatic, cause mild diarrhoea or severe amoebic dysentery. Amoebiasis also causes liver and colonic abscesses.
711
Amoebic dysentery?
profuse, bloody diarrhoea there may be a long incubation period stool microscopy may show trophozoites if examined within 15 minutes or kept warm (known as a 'hot stool')
712
Amoebic dysentery Tx?
oral metronidazole a 'luminal agent' (to eliminate intraluminal cysts) is recommended usually as well e.g. diloxanide furoate
713
Amoebic liver abscess?
usually a single mass in the right lobe (may be multiple). The contents are often described as 'anchovy sauce'
714
Amoebic liver abscess features?
fever right upper quadrant pain systemic symptoms e.g. malaise hepatomegaly
715
Amoebic liver abscess Ix?
ultrasound serology is positive in > 95%
716
Amoebic liver abscess Mx?
oral metronidazole a 'luminal agent' (to eliminate intraluminal cysts) is recommended usually as well e.g. diloxanide furoate
717
Anthrax?
caused by Bacillus anthracis, a Gram positive rod. It is spread by infected carcasses. It is also known as Woolsorters' disease. Bacillus anthracis produces a tripartite protein toxin - protective antigen - oedema factor: a bacterial adenylate cyclase which increases cAMP - lethal factor: toxic to macrophages
718
Features of anthrax?
causes painless black eschar (cutaneous 'malignant pustule', but no pus) typically painless and non-tender may cause marked oedema anthrax can cause gastrointestinal bleeding
719
Mx of anthrax?
initial management of cutaneous anthrax is ciprofloxacin further treatment is based on microbiological investigations and expert advice
720
Recommended Abx for exacerbations of chronic bronchitis?
Amoxicillin or tetracycline or clarithromycin
721
Recommended Abx for uncomplicated CAP?
Amoxicillin (Doxycycline or clarithromycin in penicillin allergic, add flucloxacillin if staphylococci suspected e.g. In influenza)
722
Recommended Abx for pneumonia possibly caused by atypical pathogens?
Clarithromycin
723
Recommended Abx for HAP?
Within 5 days of admission: co-amoxiclav or cefuroxime More than 5 days after admission: piperacillin with tazobactam OR a broad-spectrum cephalosporin (e.g. ceftazidime) OR a quinolone (e.g. ciprofloxacin)
724
Recommended Abx for lower UTI?
Trimethoprim or nitrofurantoin. Alternative: amoxicillin or cephalosporin
725
Recommended Abx for acute pyelonephritis?
Broad-spectrum cephalosporin or quinolone
726
Recommended Abx for acute prostatitis?
Quinolone or trimethoprim
727
Recommended Tx for impetigo?
Topical hydrogen peroxide, oral flucloxacillin or erythromycin if widespread
728
Recommended Abx for cellulitis?
Flucloxacillin (clarithromycin, erythromycin or doxycycline if penicillin-allergic)
729
Recommended Abx for cellulitis near the eyes or nose?
Co-amoxiclav (clarithromycin, + metronidazole if penicillin-allergic)
730
Recommended Abx for erysipelas?
Flucloxacillin (clarithromycin, erythromycin or doxycycline if penicillin-allergic)
731
Recommended Abx for animal or human bite?
Co-amoxiclav (doxycycline + metronidazole if penicillin-allergic)
732
Recommended Abx for mastitis during breast feeding?
Flucloxacillin
733
Recommended Abx for throat infections?
Phenoxymethylpenicillin (erythromycin alone if penicillin-allergic)
734
Recommended Abx for sinusitis?
Phenoxymethylpenicillin
735
Recommended Abx for otitis media?
Amoxicillin (erythromycin if penicillin-allergic)
736
Recommended Abx for otitis externa?
Flucloxacillin (erythromycin if penicillin-allergic) combined topical antibiotic and corticosteroid is generally used for mild/moderate cases of otitis externa
737
Recommended Abx for periapical or periodontal abscess?
Amoxicillin
738
Recommended Abx for Gingivitis: acute necrotising ulcerative?
Metronidazole
739
Recommended Abx for gonorrhoea?
Intramuscular ceftriaxone
740
Recommended Abx for chlamydia?
Doxycycline or azithromycin
741
Recommended Abx for PID?
Oral ofloxacin + oral metronidazole or intramuscular ceftriaxone + oral doxycycline + oral metronidazole
742
Recommended Abx for syphilis?
Benzathine benzylpenicillin or doxycycline or erythromycin
743
Recommended Abx for bacterial vaginosis?
Oral or topical metronidazole or topical clindamycin
744
Recommended Abx for c diff?
First episode: oral vancomycin Second or subsequent episode of infection: oral fidaxomicin
745
Recommended Abx for Campylobacter enteritis?
Clarithromycin
746
Recommended Abx for salmonella (non-typhoid)?
Ciprofloxacin
747
Recommended Abx for shigellosis?
Ciprofloxacin
748
Antibiotics: protein synthesis inhibitors= list some?
aminoglycosides tetracyclines chloramphenicol clindamycin macrolides
749
Antibiotics: protein synthesis inhibitors= aminoglycosides MOA?
Binds to 30S subunit causing misreading of mRNA
750
Antibiotics: protein synthesis inhibitors= aminoglycosides adverse effects?
Nephrotoxicity, Ototoxicity
751
Antibiotics: protein synthesis inhibitors= tetracyclines adverse effects?
Discolouration of teeth, photosensitivity
752
Antibiotics: protein synthesis inhibitors= tetracyclines MOA?
Binds to 30S subunit blocking binding of aminoacyl-tRNA
753
Antibiotics: protein synthesis inhibitors= chloramphenicol MOA?
Binds to 50S subunit, inhibiting peptidyl transferase
754
Antibiotics: protein synthesis inhibitors= chloramphenicol adverse effects?
Aplastic anaemia
755
Antibiotics: protein synthesis inhibitors= clindamycin adverse effects?
common cause of c diff
756
Antibiotics: protein synthesis inhibitors= clindamycin MOA?
Binds to 50S subunit, inhibiting translocation (movement of tRNA from acceptor site to peptidyl site)
757
Antibiotics: protein synthesis inhibitors= macrolides MOA?
Binds to 50S subunit, inhibiting translocation (movement of tRNA from acceptor site to peptidyl site)
758
Antibiotics: protein synthesis inhibitors= macrolides adverse effects?
Nausea (especially erythromycin), P450 inhibitor, prolonged QT interval
759
Antibiotics: protein synthesis inhibitors= macrolides commonly used in who?
pts who are allergic to penicillin
760
Antibiotics: protein synthesis inhibitors= macrolides examples?
Azithromycin Clarithromycin Erythromycin Fidaxomicin
761
Antibiotics: protein synthesis inhibitors= tetracyclines examples?
doxycycline lymecycline
762
Antibiotics: protein synthesis inhibitors= aminoglycosides examples?
gentamicin, tobramycin, amikacin, neomycin, plazomicin, paromomycin, and streptomycin
763
Antifungal agents= list some?
azoles amphotericin B terbinafine griseofulvin flucytosine caspofungin nystatin
764
Antifungal agents= Azoles MOA?
Inhibits 14α-demethylase which produces ergosterol
765
Antifungal agents= Azoles adverse effects?
P450 inhibition Liver toxicity
766
Antifungal agents= Azoles examples?
Clotrimazole Fluconazole Itraconazole
767
Drug class is metrondiazole?
Abx (NOT ANTIFUNGAL)
768
Antifungal agents= Amphotericin B MOA?
Binds with ergosterol forming a transmembrane channel that leads to monovalent ion (K+, Na+, H+ and Cl) leakage
769
Antifungal agents= Amphotericin B adverse effects?
Nephrotoxicity, flu-like symptoms, hypokalaemia, hypomagnaseamia
770
Antifungal agents= Amphotericin B used for?
systemic fungal infections
771
Antifungal agents= Terbinafine MOA?
Inhibits squalene epoxidase
772
Antifungal agents= Terbinafine commonly used in?
oral form to treat fungal nail infections
773
Antifungal agents= Griseofulvin MOA?
Interacts with microtubules to disrupt mitotic spindle
774
Antifungal agents= Griseofulvin adverse effects?
Induces P450 system, teratogenic
775
Induces P450 system meaning?
When a substance "induces" the P450 system, it essentially triggers the body to produce more of these enzymes, increasing their activity level. This can be clinically important because if a person takes multiple medications, one of which induces the P450 system, it can lead to decreased effectiveness of other drugs that are metabolized by the same enzymes.
776
Antifungal agents= Flucytosine MOA?
Converted by cytosine deaminase to 5-fluorouracil, which inhibits thymidylate synthase and disrupts fungal protein synthesis
777
Antifungal agents= Flucytosine adverse effects?
vomiting
778
Antifungal agents= Caspofungin?
Inhibits synthesis of beta-glucan, a major fungal cell wall component
779
Antifungal agents= Caspofungin adverse effects?
Flushing
780
Antifungal agents= nystatin MOA?
Binds with ergosterol forming a transmembrane channel that leads to monovalent ion (K+, Na+, H+ and Cl) leakage
781
Antifungal agents= nystatin can only be used how?
As very toxic can only be used topically (e.g. for oral thrush)
782
Aspergilloma?
a mycetoma (mass-like fungus ball) which often colonises an existing lung cavity (e.g. secondary to tuberculosis, lung cancer or cystic fibrosis).
783
Aspergilloma features?
Usually asymptomatic but features may include cough haemoptysis (may be severe)
784
Aspergilloma Ix?
chest x-ray containing a rounded opacity. A crescent sign may be present high titres Aspergillus precipitins
785
Bacillus cereus?
gram-positive rod, which is highly adaptable to extremes of pH and oxygen levels. It is chiefly associated with food poisoning but may also be associated with nosocomial infection in the immunocompromised.
786
Bacillus cereus found where?
Due to its relative environmental resilience, members of the B. cereus group are almost ubiquitous in nature: they are found in soil, fresh water and salt water. They also frequently considered a transient commensal organism in the human GI tract. Isolates have even been found in disinfectant alcohol hand gel. B. cereus is often considered a contaminant when grown from a blood culture or other sterile site, but is also a significant cause of infection in immunosuppressed patients, intravenous drug users and neonates.
787
Bacillus cereus commonly causes what?
Significant exposures to B. cereus occur most commonly in the context of food poisoning. Under-cooked or reheated rice is most classically associated with B. cereus . The bacterial exotoxin cereulide is stable at for short periods of very high temperatures such as in stir frying.
788
Under-cooked or reheated rice is most classically associated with...
Bacillus cereus
789
B. cereus causes two distinct food poisoning syndromes?
An emetic syndrome resulting from ingestion of the heat-stable toxin cereulide. Disease can occur from toxin ingestion even if the bacteria are killed during cooking. Symptoms typically occur between 0.5 and 6 hours of ingestion. Diarrhoea symptoms may also occur. A diarrhoeal syndrome associated with separate exotoxins such as haemolysin BL. Patients typically complain of crampy abdominal pain and diarrhoea. Usual onset time 8-16 hours. Symptoms typically resolve within 24 hours in both syndromes. In immunosuppressed patients: bacteraemia, endocarditis, musculoskeletal and CNS infection may occur.
790
Bacillus cereus Mx?
rarely required for food poisoning syndrome. Most strains produce beta-lactamase and vancomycin is suggested as the empiric antibiotic of choice in some guidelines.
791
Clostridium botulinum (Botulism)?
gram positive anaerobic bacillus 7 serotypes A-G produces botulinum toxin, a neurotoxin which irreversibly blocks the release of acetylcholine may result from eating contaminated food (e.g. tinned) or intravenous drug use neurotoxin often affects bulbar muscles and autonomic nervous system
792
Clostridium botulinum (Botulism) features?
patient usually fully conscious with no sensory disturbance flaccid paralysis diplopia ataxia bulbar palsy
793
Clostridium botulinum (Botulism) Tx?
botulism antitoxin and supportive care antitoxin is only effective if given early - once toxin has bound its actions cannot be reversed
794
Cat scratch disease?
generally caused by the Gram negative rod Bartonella henselae
795
Cat scratch disease features?
fever history of a cat scratch regional lymphadenopathy headache, malaise
796
Cholera is caused by what?
by Vibro cholerae - Gram negative bacteria contaminated water
797
Cholera features?
profuse 'rice water' diarrhoea dehydration hypoglycaemia
798
Cholera Mx?
oral rehydration therapy antibiotics: doxycycline, ciprofloxacin
799
Gram-positive cocci examples?
staphylococci + streptococci (including enterococci)
800
Gram-negative cocci examples?
Neisseria meningitidis + Neisseria gonorrhoeae, also Moraxella catarrhalis
801
Gram-positive rods (bacilli) examples?
mnemonic = ABCD L Actinomyces Bacillus anthracis (anthrax) Clostridium Diphtheria: Corynebacterium diphtheriae Listeria monocytogenes
802
Gram-negative rods (bacilli) examples?
Escherichia coli Haemophilus influenzae Pseudomonas aeruginosa Salmonella sp. Shigella sp. Campylobacter jejuni
803
Classify types of bacteria into gram +ve and -ve cocci and bacilli (rods)?
Gram-positive cocci = staphylococci + streptococci (including enterococci) Gram-negative cocci = Neisseria meningitidis + Neisseria gonorrhoeae, also Moraxella catarrhalis Gram-positive rods (bacilli) = ABCD L Actinomyces Bacillus anthracis (anthrax) Clostridium Diphtheria: Corynebacterium diphtheriae Listeria monocytogenes Remaining organisms are Gram-negative rods, e.g.: Escherichia coli Haemophilus influenzae Pseudomonas aeruginosa Salmonella sp. Shigella sp. Campylobacter jejuni
804
Clostridia type of bacteria?
gram-positive, obligate anaerobic bacilli.
805
List examples of Clostridia?
C. perfringens: - produces α-toxin, a lecithinase, which causes gas gangrene (myonecrosis) and haemolysis - features include tender, oedematous skin with haemorrhagic blebs and bullae. Crepitus may present on palpation C. botulinum: - typically seen in canned foods and honey prevents acetylcholine (ACh) - release leading to flaccid paralysis C. difficile: - causes pseudomembranous colitis, typically seen after the use of broad-spectrum antibiotics - produces both an exotoxin and a cytotoxin C. tetani: - produces an exotoxin (tetanospasmin) that prevents the release of glycine from Renshaw cells in the spinal cord causing a spastic paralysis
806
Cryptosporidiosis?
commonest protozoal cause of diarrhoea in the UK. Two species, Cryptosporidium hominis and Cryptosporidium parvum account for the majority cases. Cryptosporidiosis is more common in immunocompromised patients (e.g. HIV) and young children.
807
Cryptosporidiosis features?
watery diarrhoea abdominal cramps fever in immunocompromised patients, the entire gastrointestinal tract may be affected resulting in complications such as sclerosing cholangitis and pancreatitis
808
Cryptosporidiosis diagnosis?
stool: modified Ziehl-Neelsen stain (acid-fast stain) of the stool may reveal the characteristic red cysts of Cryptosporidium
809
Cryptosporidiosis Mx?
is largely supportive for immunocompetent patients if the patient has HIV and is not on antiretroviral therapy then this should be started and often will be enough to resolve the infection nitazoxanide may be used for immunocompromised patients rifaximin is also sometimes used for immunocompromised patients/patients with severe disease
810
Cutaneous larva migrans?
dermatological condition prevalent in tropical and subtropical regions, largely attributable to cutaneous penetration and subsequent migration of nematode larvae, primarily from the Ancylostoma genus (e.g. Ancyclostoma braziliense). Typically, the transmission vectors are faecal-contaminated soil or sand, posing significant risks to individuals with a history of barefoot beach visits or direct soil contact.
811
CP of Cutaneous larva migrans?
intensely pruritic, 'creeping', serpiginous, erythematous cutaneous eruption that advances over time. Symptoms can last for weeks to months, potentially leading to secondary bacterial infection due to excessive scratching. Diagnosis is typically clinical, based on exposure history and characteristic skin manifestations.
812
Tx of Cutaneous larva migrans?
anthelmintic agents, such as ivermectin or albendazole. Topical therapy with thiabendazole can also be effective, although it's generally less preferred due to a lower efficacy rate and higher side effect profile.
813
Prevention of Cutaneous larva migrans?
largely involve patient education about appropriate protective measures, particularly avoiding direct skin contact with potentially contaminated soil. Given the zoonotic nature of cutaneous larva migrans, public health measures for animal defecation control can also contribute to reducing the prevalence of this condition.
814
Cytomegalovirus (CMV)?
one of the herpes viruses. It is thought that around 50% of people have been exposed to the CMV virus although it only usually causes disease in the immunocompromised, for example people with HIV or those on immunosuppressants following organ transplantation.
815
Cytomegalovirus (CMV) pathophysiology?
infected cells have a 'Owl's eye' appearance due to intranuclear inclusion bodies
816
Cytomegalovirus (CMV) patterns of disease?
Congenital CMV infection CMV mononucleosis CMV retinitis CMV encephalopathy CMV penumonitis CMV colitis
817
Cytomegalovirus (CMV) only causes disease in who?
in the immunocompromised, for example people with HIV or those on immunosuppressants following organ transplantation.
818
Congenital CMV?
features include growth retardation, pinpoint petechial 'blueberry muffin' skin lesions, microcephaly, sensorineural deafness, encephalitiis (seizures) and hepatosplenomegaly
819
CMV mononucleosis?
infectious mononucelosis-like illness may develop in immunocompetent individuals
820
CMV retinitis?
common in HIV patients with a low CD4 count (< 50) presents with visual impairment e.g. 'blurred vision'. Fundoscopy shows retinal haemorrhages and necrosis, often called 'pizza' retina IV ganciclovir is the treatment of choice
821
CMV encephalopathy?
seen in patients with HIV who have low CD4 counts
822
Dengue fever?
viral infection that can progress to viral haemorrhagic fever (other examples include yellow fever, Lassa fever, Ebola).
823
Dengue fever aetiology?
dengue virus is a RNA virus of the genus Flavivirus transmitted by the Aedes aegypti mosquito incubation period of 7 days
824
Dengue fever can be classified how?
dengue fever: without warning signs with warning signs severe dengue (dengue haemorrhagic fever)
825
Dengue fever CP?
fever headache (often retro-orbital) myalgia, bone pain and arthralgia ('break-bone fever') pleuritic pain facial flushing (dengue) maculopapular rash haemorrhagic manifestations e.g. positive tourniquet test, petechiae, purpura/ecchymosis, epistaxis 'warning signs' include: abdominal pain hepatomegaly persistent vomiting clinical fluid accumulation (ascites, pleural effusion)
826
Severe dengue (dengue haemorrhagic fever) CP?
this is a form of disseminated intravascular coagulation (DIC) resulting in: thrombocytopenia & spontaneous bleeding around 20-30% of these patients go on to develop dengue shock syndrome (DSS)
827
Dengue fever Ix?
typically blood results= leukopenia, thrombocytopenia, raised aminotransferases diagnostic tests: - serology - nucleic acid amplification tests for viral RNA - NS1 antigen test
828
Dengue fever Tx?
entirely symptomatic e.g. fluid resuscitation, blood transfusion etc no antivirals are currently available
829
Diphtheria is caused by what?
Gram positive bacterium Corynebacterium diphtheriae
830
Diphtheria pathophysiology?
releases an exotoxin encoded by a β-prophage exotoxin inhibits protein synthesis by catalyzing ADP-ribosylation of elongation factor EF-2 Diphtheria toxin commonly causes a 'diphtheric membrane' on tonsils caused by necrotic mucosal cells. Systemic distribution may produce necrosis of myocardial, neural and renal tissue
831
Diphtheria possible presentations?
recent visitors to Eastern Europe/Russia/Asia sore throat with a 'diphtheric membrane' - grey, pseudomembrane on the posterior pharyngeal wall bulky cervical lymphadenopathy - may result in a 'bull neck' appearanace neuritis e.g. cranial nerves heart block
832
Diphtheria Ix?
culture of throat swab: uses tellurite agar or Loeffler's media
833
Diphtheria Mx?
intramuscular penicillin diphtheria antitoxin
834
only DNA virus that is not double-stranded?
parovirus
835
DNA viruses= herpesviruses: structure, envelope and examples/importance?
Double-stranded, linear Enveloped Herpes simplex virus, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus
836
DNA viruses= hepadnavirus: structure, envelope and examples/importance?
Double-stranded, circular Enveloped Hepatitis B virus
837
DNA viruses= Adenovirus: structure, envelope and examples/importance?
Double-stranded, linear Naked Common cold, conjunctivitis
838
DNA viruses= Parovirus: structure, envelope and examples/importance?
Single-stranded, linear Naked Parvovirus B19
839
DNA viruses= Papillomavirus: structure, envelope and examples/importance?
Double-stranded, circular Naked HPV
840
DNA viruses= Poxvirus: structure, envelope and examples/importance?
Double-stranded, linear Enveloped Smallpox, molluscum contagiosum
841
DNA viruses= Polyomavirus: structure, envelope and examples/importance?
Double-stranded, circular Naked JC virus (progressive multifocal leukoencephalopathy)
842
Types of DNA viruses?
HHAPPPPy! - Hepadna; Herpes; Adeno; Pox; Parvo; Papilloma; Polyoma
843
Ebola virus?
part of the Filoviridae virus family and causes a rare but often fatal disease. The average fatality rate during previous outbreaks is 50%. The most recent outbreak in West Africa is the largest known outbreak, mainly centred around Guinea, Sierra Leone and Liberia.
844
How is ebola virus spread?
through human-to-human transmission via direct contact (through broken skin or mucous membranes) with the blood, secretions, organs or other bodily fluids of infected people, and with surfaces and materials (e.g. bedding, clothing) contaminated with these fluids. This puts healthcare workers at particular risk and appropriate precautions should be taken.
845
CP of ebola virus?
The incubation period is 2 to 21 days, and patients are not infectious until they develop symptoms. First symptoms are the sudden onset of fever fatigue, muscle pain, headache and sore throat. This is followed by vomiting, diarrhoea, rash, symptoms of impaired kidney and liver function, and in some cases, both internal and external bleeding.
846
Consider Ebola virus in the following patients:
Ebola should be suspected in patients presenting to primary care services who have a fever of 37.5°C OR have a history of fever in the past 24 hours AND have recently visited any of the affected areas (see maps) within the previous 21 days OR Have a fever of 37.5°C OR have a history of fever in the past 24 hours AND have cared for/come into contact with body fluids of/handled clinical specimens (blood, urine, faeces, tissues, laboratory cultures) from an individual or laboratory animal known or strongly suspected to have VHF.
847
Mx of ebola?
If a patient reports these symptoms over the telephone, they should be advised not to attend the surgery. If they do attend the surgery then they should be isolated in a single room to limit contact with staff/other patients. If the GP elicits the possibility of VHF during their consultation, they should avoid further physical contact and keep the patient isolated in their room. In all of these cases PHE should be contacted for further advice.
848
Enteric fever (typhoid/paratyphoid) = types?
The Salmonella group contains many members, most of which cause diarrhoeal diseases. They are aerobic, Gram-negative rods which are not normally present as commensals in the gut. Typhoid and paratyphoid are caused by Salmonella typhi and Salmonella paratyphi (types A, B & C) respectively. They are often termed enteric fevers, producing systemic symptoms such as headache, fever, arthralgia.
849
Enteric fever (typhoid/paratyphoid) = transmission?
typhoid is transmitted via the faecal-oral route (also in contaminated food and water)
850
Enteric fever (typhoid/paratyphoid) = features?
initially systemic upset (headache, fever, arthralgia) relative bradycardia abdominal pain, distension constipation: although Salmonella is a recognised cause of diarrhoea, constipation is more common in typhoid rose spots: present on the trunk in 40% of patients, and are more common in paratyphoid
851
Enteric fever (typhoid/paratyphoid) = Cx?
osteomyelitis (especially in sickle cell disease where Salmonella is one of the most common pathogens) GI bleed/perforation meningitis cholecystitis chronic carriage (1%, more likely if adult females)
852
Enteroviruses?
positive-sense single stranded RNA viruses. The family contains the Coxsackievirus, echovirus and rhinovirus as well as others. It is the most common cause of viral meningitis in the adult population but can cause a range of different diseases, in both adults and children. Although the range of diseases caused by these viruses is broad, notable disease entities include Hand, Foot and Mouth disease, herpangina and pericarditis.
853
Malignancies associated with EBV infection?
Burkitt's lymphoma Hodgkin's lymphoma nasopharyngeal carcinoma HIV-associated central nervous system lymphomas
854
Non-malginant condition associated with EBV infection?
hairy leukoplakia
855
Giardiasis?
caused by the flagellate protozoan Giardia lamblia. It is spread by the faeco-oral route.
856
Giardiasis RFs?
foreign travel swimming/drinking water from a river or lake male-male sexual contact
857
Giardiasis features?
often asymptomatic non-bloody diarrhoea steatorrhoea bloating, abdominal pain lethargy flatulence weight loss malabsorption and lactose intolerance can occur
858
Giardiasis Ix?
stool microscopy for trophozoite and cysts: sensitivity of around 65% stool antigen detection assay: greater sensitivity and faster turn-around time than conventional stool microscopy methods PCR assays are also being developed
859
Giardiasis Tx?
metronidazole
860
Gram-positive bacteria will turn...
purple/blue following the gram staining. Microscopy will then reveal the shape, either cocci or rods.
861
Identifying gram-positive bacteria= Rods (bacilli)?
Actinomyces Bacillus antracis Clostridium Corynebacterium diphtheriae Listeria monocytogenes
862
Identifying gram-positive bacteria= Cocci?
makes catalase: Staphylococci does not make catalase: Streptococci
863
Identifying gram-positive bacteria= Staphylococci?
makes coagulase: S. aureus does not make coagulase: S. epidermidis (novobiocin sensitive), S. saprophyticus (novobiocin resistant)
864
Identifying gram-positive bacteria= Streptococci?
partial haemolysis (green colour on blood agar): α-haemolytic complete haemolysis (clear): β-haemolytic no haemolysis: γ-haemolytic
865
Identifying gram-positive bacteria= α-haemolytic streptococci?
optochin sensitive: S. pneumoniae optochin resistant: Viridans streptococci
866
Identifying gram-positive bacteria= β-haemolytic streptococci?
bacitracin sensitive: Group A: S. pyogenes bacitracin resistant: Group B: S. agalactiae
867
When to recommend to get flu vaccine?
between september and early november as flue season typically starts middle of november
868
Types of flu virus?
A, B and C A and B most common
869
Who gets the flu vaccine?
Children, elderly and at risk groups. Remember that the type of vaccine given routinely to children and the one given to the elderly and at risk groups is different (live vs. inactivated) - this explains the different contraindications
870
A new NHS influenza vaccination programme for children was announced in 2013. There are three key things to remember about the children's vaccine:
it is given intranasally the first dose is given at 2-3 years, then annually after that it is a live vaccine (cf. injectable vaccine below) children who were traditionally offered the flu vaccine (e.g. asthmatics) will now be given intranasal vaccine unless this is inappropriate, for example if they are immunosuppressed. In this situation the inactivated, injectable vaccine should be given only children aged 2-9 years who have not received an influenza vaccine before need 2 doses it is more effective than the injectable vaccine
871
Contraindications to flu vaccine?
immunocompromised aged < 2 years current febrile illness or blocked nose/rhinorrhoea current wheeze (e.g. ongoing viral-induced wheeze/asthma) or history of severe asthma (BTS step 4) egg allergy pregnancy/breastfeeding if the child is taking aspirin (e.g. for Kawasaki disease) due to a risk of Reye's syndrome
872
Side-effects of flu vaccine?
blocked-nose/rhinorrhoea headache anorexia
873
Flu vaccine = Current vaccines are trivalent and consist of...
two subtypes of influenza A and one subtype of influenza B.
874
The Department of Health recommends annual influenza vaccination for all people older than 65 years, and those older than 6 months if they have:
chronic respiratory disease (including asthmatics who use inhaled steroids) chronic heart disease (heart failure, ischaemic heart disease, including hypertension if associated with cardiac complications) chronic kidney disease chronic liver disease: cirrhosis, biliary atresia, chronic hepatitis chronic neurological disease: (e.g. Stroke/TIAs) diabetes mellitus (including diet controlled) immunosuppression due to disease or treatment (e.g. HIV) asplenia or splenic dysfunction pregnant women adults with a body mass index >= 40 kg/m² Other at risk individuals include: - health and social care staff directly involved in patient care (e.g. NHS staff) - those living in long-stay residential care homes - carers of the elderly or disabled person whose welfare may be at risk if the carer becomes ill (at the GP's discretion)
875
The influenza vaccine= important things to know
it is an inactivated vaccine, so cannot cause influenza. A minority of patients however develop fever and malaise which may last 1-2 days should be stored between +2 and +8ºC and shielded from light contraindications include hypersensitivity to egg protein. in adults the vaccination is around 75% effective, although this figure decreases in the elderly it takes around 10-14 days after immunisation before antibody levels are at protective levels
876
Invasive aspergillosis?
systemic Aspergillus infection (Aspergillus fumigatus, Aspergillus flavus, and Aspergillus terreus) that is a leading cause of death in immunocompromised patients.
877
Invasive aspergillosis RFs?
HIV Leukaemia Following broad-spectrum antibiotics
878
Lemierre's syndrome?
infectious thrombophlebitis of the internal jugular vein. It most often occurs secondary to a bacterial sore throat caused by Fusobacterium necrophorum leading to a peritonsillar abscess. A combination of spread of the infection laterally from the abscess and compression lead to thrombosis of the IJV.
879
Lemierre's syndrome CP?
Patients will present with a history of bacterial sore throat followed by neck pain, stiffness and tenderness (may be mistaken for meningitis) and systemic involvement (fevers, rigors, etc). Septic pulmonary emboli may also occur.
880
Leprosy?
a granulomatous disease primarily affecting the peripheral nerves and skin. It is caused by Mycobacterium leprae.
881
Features of leprosy?
patches of hypopigmented skin typically affecting the buttocks, face, and extensor surfaces of limbs sensory loss
882
What determines the type of leprosy a pt will develop?
The degree of cell mediated immunity
883
Types of leprosy= Low degree of cell mediated immunity → ???
lepromatous leprosy ('multibacillary') - extensive skin involvement - symmetrical nerve involvement
884
Types of leprosy= High degree of cell mediated immunity → ???
tuberculoid leprosy ('paucibacillary') - limited skin disease - asymmetric nerve involvement → hypesthesia - hair loss
885
Mx of leprosy?
WHO-recommended triple therapy: rifampicin, dapsone and clofazimine
886
Leptospirosis?
caused by the spirochaete Leptospira interrogans (serogroup L. icterohaemorrhagiae), classically being spread by contact with infected rat urine.
887
Leptospirosis epidemiology?
leptospirosis is commonly seen in questions referring to sewage workers, farmers, vets or people who work in an abattoir however, on an international level, leptospirosis is far more common in the tropics so should be considered in the returning traveller
888
Leptospirosis= what should always be considered in high-risk patients with hepatorenal failure?
Weil's disease
889
Leptospirosis features?
the early phase is due to bacteraemia and lasts around a week: - may be mild or subclinical - fever - flu-like symptoms - subconjunctival suffusion (redness)/haemorrhage second immune phase may lead to more severe disease (Weil's disease): - acute kidney injury (seen in 50% of patients) - hepatitis: jaundice, hepatomegaly - aseptic meningitis
890
Leptospirosis Ix?
serology: antibodies to Leptospira develop after about 7 days PCR culture= growth may take several weeks so limits usefulness in diagnosis; blood and CSF samples are generally positive for the first 10 days; urine cultures become positive during the second week of illness
891
Leptospirosis Mx?
mild-moderate disease: doxycycline or azithormycin severe disease: IV benzylpencillin
892
Metronidazole?
type of antibiotic that works by forming reactive cytotoxic metabolites inside the bacteria.
893
Metronidazole adverse effects?
disulfiram-like reaction with alcohol increases the anticoagulant effect of warfarin
894
Nematodes= types?
Ancylostoma braziliense Strongyloides stercoralis Toxocara canis
895
Nematodes= Ancylostoma braziliense?
most common cause of cutaneous larva migrans common in Central and Southern America
896
Nematodes= Strongyloides stercoralis?
acquired percutaneously (e.g. walking barefoot) causes pruritus and larva currens - this has a similar appearance to cutaneous larva migrans but moves through the skin at a far greater rate abdo pain, diarrhoea, pneumonitis may cause Gram negative septicaemia due carrying of bacteria into bloodstream eosinophilia sometimes seen management: thiabendazole, albendazole. Ivermectin also used, particularly in chronic infections
897
Nematodes= Toxocara canis?
commonly acquired by ingesting eggs from soil contaminated by dog faeces commonest cause of visceral larva migrans other features: eye granulomas, liver/lung involvement
898
Non-gonococcal urethritis (NGU, sometimes referred to as non-specific urethritis)?
term used to describe the presence of urethritis when a gonococcal bacteria are not identifiable or the initial swab. A typical case would be a male who presented to a GUM clinic with a purulent urethral discharge and dysuria. A swab would be taken in clinic, microscopy performed which showed neutrophils but no Gram-negative diplococci (i.e. no evidence of gonorrhoea). Clearly, this patient requires immediate treatment prior to waiting for the Chlamydia test to come back and hence an initial diagnosis of NGU is made.
899
Non-gonococcal urethritis (NGU, sometimes referred to as non-specific urethritis)= causes?
No cause is found in around half of cases. Possible causative organisms include: Chlamydia trachomatis most common cause Mycoplasma genitalium thought to cause more symptoms than Chlamydia less common causes: - Ureaplasma urealyticum - Trichomonas vaginalis - Escherichia coli
900
Non-gonococcal urethritis (NGU, sometimes referred to as non-specific urethritis)= Mx?
contact tracing the BNF and British Association for Sexual Health and HIV (BASHH) both recommend either oral azithromycin or doxycycline
901
Norovirus?
also known as the winter vomiting bug, is one of the most common causes of gastroenteritis in the UK according to NHS England. 1 in 5 cases of infectious gastroenteritis are caused by norovirus, with 685 million cases per year worldwide.
902
Norovirus- type of virus?
It is a genus that encompasses a range of non encapsulated RNA virus species
903
Norovirus symptoms?
Develop within 15 - 50 hours of infection (quoted from the European Centre of Disease Control and Prevention), with patients experiencing nausea, vomiting, and diarrhoea, which may be accompanied by headaches, low-grade fevers, and myalgia. The majority of patients experience both vomiting and diarrhoea 10 - 22% reported a headache and up to 47% of patients reported fevers (Clinical Microbiology Reviews, Norovirus, January 2015)
904
Norovirus transmission?
Faecal-oral route, with the virus becoming aerosolized when the patient vomits or when a toilet containing infected bodily fluids (vomit or faeces) is flushed. Viral particles are transmitted directly to surrounding potential hosts and to surrounding surfaces, from which they can be transmitted by cross-contamination (for example a patient visitor touching the patient environment, then eating without first washing their hands). Infection may also be transmitted from an infected individual in the process of direct physical contact, or contact with food preparation. The virus enters the cell via host receptor-mediated endocytosis and replicates in the small intestine. Norovirus is highly contagious, the European Centre of Disease Control and Prevention estimates that only 10 - 100 viral particles are required to cause an active infection. Norovirus is not at present considered to be a notifiable disease in the UK.
905
Limiting transmission of norovirus?
Isolation of infected strongly recommended where possible, particularly in areas where the risk of person to person transmission is high, for example, in hospitals schools, and care facilities Good hand hygiene using soap and water is essential Alcohol hand gel has been shown to be less effective in reducing transmission
906
Diagnosis of norovirus?
Clinical history and stool culture viral PCR (polymerase chain reaction).
907
Norovirus differential diagnoses?
Features most suggestive of norovirus include sudden onset vomiting, relatively short duration of symptoms and contact with others with similar symptoms. Rotavirus, E. coli and Salmonella infections will all cause similar clinical pictures, however, there are some important differentiating features. Salmonella infection has an incubation period of 6 - 72 hours and is often the result of contact with contaminated animal products, for example, unpasteurized eggs or milk. Unlike norovirus, salmonella gastroenteritis can cause bloody diarrhoea and patients often have a high fever. Rotavirus gastroenteritis causes symptoms very similar to those of norovirus, but predominantly affects children under the age of 5 years. E. coli infection, like Norovirus, causes vomiting and diarrhoea but has a longer incubation period (between 3-4 days but can be up to 10 days following pathogen exposure) and unlike Norovirus, E Coli infection commonly causes severe abdominal cramping and frequently causes bloody diarrhoea.
908
Norovirus resolution and potential Cx?
The infection is self-limiting in immunocompetent patients and symptoms generally resolve within 72 hours Dehydration and electrolyte imbalances may arise as a result of vomiting and diarrhoea, leading to significant morbidity and mortality and patients should be managed supportively with rehydration and electrolyte supplementation where necessary.
909
Pseudomonas aeruginosa?
an aerobic Gram-negative rod. It causes a number of clinically important infections in humans: - chest infections (especially in cystic fibrosis) - skin: burns, wound infections, 'hot tub' folliculitis - otitis externa (especially in diabetics who may develop malignant otitis externa) - urinary tract infections
910
Pseudomonas aeruginosa lab features?
Gram-negative rod non-lactose fermenting oxidase positive
911
Pseudomonas aeruginosa pathophysiology?
produces both an endotoxin (causes fever and shock) and exotoxin A (inhibits protein synthesis by catalyzing ADP-ribosylation of elongation factor EF-2)
912
Pyrexia of unknown origin (PUO)?
a prolonged febrile illness with temperatures exceeding 38.3°C on several occasions over a period of at least 3 weeks, with no established diagnosis after one week of inpatient investigation.
913
Pyrexia of unknown origin (PUO) classification?
Classical PUO: Often related to infections, malignancies, or non-infectious inflammatory diseases. Hospital-acquired PUO: Fevers that develop in hospitalized patients, commonly due to nosocomial infections, thromboembolic diseases, or drug fevers. Neutropenic PUO: Observed in neutropenic patients, typically those undergoing chemotherapy, where febrile episodes are predominantly due to infections. HIV-associated PUO: In patients with HIV, where fever can be attributed to various opportunistic infections, malignancies, or HIV itself.
914
Pyrexia of unknown origin (PUO) causes?
Infections (30%): - Tuberculosis - Abscess Malignancies (20%) - Lymphoma - Hypernephroma - Leukaemia - Atrial myxoma Non-infectious inflammatory diseases -Systemic lupus erythematosus - Temporal arteritis - Rheumatoid arthritis. Miscellaneous (50%) - Drug fevers - Factitious fever
915
Pyrexia of unknown origin (PUO) diagnostic approach?
History and physical examination: Focus on travel history, occupational exposures, animal exposures, past medical history, and medication use. Laboratory tests: Initial tests include full blood count, ESR/CRP, HIV test, blood cultures, urine analysis, and chest radiography. Imaging: CT scans, MRI, and PET scans to identify hidden abscesses, malignancies Biopsies and specialised tests: Depending on the clinical suspicion, targeted biopsies, bone marrow examination
916
Pyrexia of unknown origin (PUO) Mx?
Many patients can undergo evaluation in an outpatient setting given the prolonged nature of the symptoms Empirical antibiotic therapy is generally not used, unless the patient is suspected of having a potentially life-threatening infection
917
Pyrexia of unknown origin (PUO) prognosis?
Up to 50% of patients with classic FUO remain without a diagnosis after extensive evaluation The majority who remain undiagnosed have a good prognosis
918
Q fever?
caused by Coxiella burnetii, a rickettsia. The source of infection is typically an abattoir, cattle/sheep or it may be inhaled from infected dust
919
Features of Q fever?
typically prodrome: fever, malaise causes pyrexia of unknown origin transaminitis atypical pneumonia endocarditis (culture-negative)
920
Mx of Q fever?
doxycycline
921
Rabies?
viral disease that causes an acute encephalitis. The rabies virus is classed as a RNA rhabdovirus (specifically a lyssavirus) and has a bullet-shaped capsid. The vast majority of cases are caused by dog bites but it may also be transmitted by bat, raccoon and skunk bites.
922
How serious is rabies?
If untreated then nearly always fatal. Rabies is estimated to still kill around 25,000-50,000 people across the world each year. The vast majority of the disease burden falls on people in poor rural areas of Africa and Asia. Children are particularly at risk.
923
Rabies pathophysiology?
After entry, the virus replicates in muscle tissue near the site of the bite before entering the peripheral nervous system. It then travels up to the central nervous system, where it causes encephalitis, leading to severe neurological symptoms. The virus eventually reaches the salivary glands, facilitating transmission.
924
Features of rabies?
prodrome: headache, fever, agitation hydrophobia: water-provoking muscle spasms hypersalivation Negri bodies: cytoplasmic inclusion bodies found in infected neurons
925
Mx of rabies?
now considered to be 'no risk' of developing rabies following an animal bite in the UK and the majority of developed countries. Following an animal bite in at-risk countries: - the wound should be washed - if an individual is already immunised then 2 further doses of vaccine should be given - if not previously immunised then human rabies immunoglobulin (HRIG) should be given along with a full course of vaccination. If possible, the dose should be administered locally around the wound
926
RSV associated condition?
bronchiolitis
927
Parainfluenza virus associated condition?
croup
928
Rhinovirus associated condition?
common cold
929
Influenza virus associated condition?
flu
930
strep pneumoniae associated condition?
most common cause of CAP
931
Haemophilus influenzae associated condition?
CAP Most common cause of bronchiectasis exacerbations Acute epiglottitis
932
Staph aureus associated condition?
pneumonia, esp following influenza
933
Mycoplasma pneumoniae associated condition?
Atypical pneumonia Flu-like symptoms classically precede a dry cough. Complications include haemolytic anaemia and erythema multiforme
934
Legionella pneumophilia associated condition?
Atypical pneumonia Classically spread by air-conditioning systems, causes dry cough. Lymphopenia, deranged liver function tests and hyponatraemia may be seen
935
Pneumocystis jiroveci associated condition?
Common cause of pneumonia in HIV patients. Typically patients have few chest signs and develop exertional dyspnoea
936
Mycobacterium tuberculosis associated condition?
Causes tuberculosis. A wide range of presentations from asymptomatic to disseminated disease are possible. Cough, night sweats and weight loss may be seen.
937
Rifampicin?
an antibiotic which is used to treat a variety of infections. It is frequently used to treat tuberculosis (in combination with other medications). Rifampicin can also be used for prophylaxis in those who have had close contact with tuberculosis or meningitis.
938
Rifampicin MOA?
inhibits bacterial DNA dependent RNA polymerase preventing transcription of DNA into mRNA
939
Rifampicin adverse effects?
potent CYP450 liver enzyme inducer hepatitis orange secretions flu-like symptoms
940
Way to remember RNA viruses?
'CALL PICO and FLAVA. There's a RETRO TOGA party with lots of CORONAs'
941
Only double-stranded RNA virus?
Reoviridae
942
List some RNA viruses?
Reoviridae Picornaviridae Caliciviridae Togaviridae Arenaviridae Flaviviridae Orthomyxoviridae Paramyxoviridae Bunyaviridae Rhabdoviridae Filoviridae Coronaviridae Hepeviridae
943
RNA viruses: family= Reoviridae structure, envelope, capsid symmetry, examples?
Reoviridae Double-stranded, linear Naked Icosahedral Reovirus, Rotavirus
944
RNA viruses: family= Picornaviridae structure, envelope, capsid symmetry, examples?
Single-stranded +, linear Naked Icosahedral Enterovirus, Rhinovirus, Poliovirus, Coxsackie
945
RNA viruses: family= Caliciviridae structure, envelope, capsid symmetry, examples?
Single-stranded +, linear Naked Icosahedral Norwalk virus
946
RNA viruses: family= Togaviridae structure, envelope, capsid symmetry, examples?
Single-stranded +, linear Enveloped Icosahedral Rubella virus
947
RNA viruses: family= Arenaviridae structure, envelope, capsid symmetry, examples?
Single-stranded -, circular Enveloped Helical Lymphocytic choriomeningitis virus
948
RNA viruses: family= Flaviviridae structure, envelope, capsid symmetry, examples?
Single-stranded +, linear Enveloped Icosahedral Dengue virus, Hepatitis C virus, Yellow fever virus
949
RNA viruses: family= Orthomyxoviridae structure, envelope, capsid symmetry, examples?
Single-stranded -, linear Enveloped Helical Influenzavirus A, Influenzavirus B, Influenzavirus C,
950
RNA viruses: family= Paramyxoviridae structure, envelope, capsid symmetry, examples?
Single-stranded -, linear Enveloped Helical Measles virus, Mumps virus, Respiratory syncytial virus
951
RNA viruses: family= Bunyaviridae structure, envelope, capsid symmetry, examples?
Single-stranded -, circular Enveloped Helical California encephalitis virus, Hantavirus
952
RNA viruses: family= Rhabdoviridae structure, envelope, capsid symmetry, examples?
Single-stranded -, linear Enveloped Helical Rabies virus
953
RNA viruses: family= Filoviridae structure, envelope, capsid symmetry, examples?
Single-stranded -, linear Enveloped Helical Ebola virus, Marburg virus
954
RNA viruses: family= Coronaviridae structure, envelope, capsid symmetry, examples?
Single-stranded +, linear Enveloped Helical Corona virus
955
RNA viruses: family= Hepeviridae structure, envelope, capsid symmetry, examples?
Single-stranded +, linear Naked Icosahedral Hepatitis E virus
956
Schistosomiasis (bilharzia)?
a parasitic flatworm infection. The three main species of schistosome are S. mansoni, S. japonicum and S. haematobium.
957
Schistosomiasis (bilharzia)= acute infection symptoms?
Acute symptoms typically only develop in people who travel to endemic areas, as they don't have any immunity to the worms. Acute manifestations may include: - swimmers' itch - acute schistosomiasis syndrome (Katayama fever)= fever, urticaria/angioedema, arthralgia/myalgia, cough, diarrhoea, eosinophilia
958
Schistosomiasis (bilharzia)= chronic infections: Schistosoma haematobium?
These worms deposit egg clusters (pseudopapillomas) in the bladder, causing inflammation. The calcification seen on x-ray is actually calcification of the egg clusters, not the bladder itself. Depending on the site of these pseudopapillomas in the bladder, they can cause an obstructive uropathy and kidney damage.
959
Schistosomiasis (bilharzia)= chronic infections: Schistosoma haematobium- presentation?
This typically presents as a 'swimmer's itch' in patients who have recently returned from Africa. Schistosoma haematobium is a risk factor for squamous cell bladder cancer. Features: - frequency - haematuria - bladder calcification
960
Schistosomiasis (bilharzia)= chronic infections: Schistosoma haematobium- Ix?
for asymptomatic patients serum schistosome antibodies are generally preferred for symptomatic patients the gold standard for diagnosis is urine or stool microscopy looking for eggs
961
Schistosomiasis (bilharzia)= chronic infections: Schistosoma haematobium- Mx?
single oral dose of praziquantel
962
Schistosomiasis (bilharzia)= chronic infections: Schistosoma mansoni and Schistosoma japonicum?
These worms mature in the liver and then travel through the portal system to inhabit the distal colon. Their presence in the portal system can lead to progressive hepatomegaly and splenomegaly due to portal vein congestion. These species can also lead to complications of liver cirrhosis, variceal disease and cor pulmonale.
963
Schistosomiasis (bilharzia)= chronic infections: Schistosoma intercalatum and Schistosoma mekongi?
These are less prevalent than the other three forms, but are both attributed to intestinal schistosomiasis.
964
What is an abscess?
collection of pus encapsulated by a pyogenic membrane.
965
A spinal epidural abscess (SEA)?
a collection of pus that is superficial to the dura mater (of the meninges) that cover the spinal cord. It is an emergency requiring urgent investigation and treatment to avoid progressive spinal cord damage.
966
A spinal epidural abscess (SEA)- how do they form?
In SEA, bacteria enters the spinal epidural space by contiguous spread from adjacent structures (e.g. discitis), haematogenous spread from concomitant infection (e.g. bacteraemia from IVDU), or by direct infection (e.g. spinal surgery). Immunosuppression is another major risk factor, which may be caused by congenital immune disorders, acquired immune disorders (such as HIV, diabetes or alcoholism or by iatrogenic means (e.g. chemotherapy or steroids).
967
A spinal epidural abscess (SEA)- cause?
most typically bacterial and the most common causative micro-organism is Staphylococcus aureus
968
A spinal epidural abscess (SEA)- presentation?
fever back pain focal neurological deficits according to the segment of the cord affected.
969
A spinal epidural abscess (SEA)- Ix?
Bloods (including inflammatory markers, HIV, Hep B, Hep C, and preoperative blood tests (coagulation and group and screen)) Blood cultures Infection screen (including chest x-ray and urine culture): If the primary source of infection is not clear, a wide search for sources requires investigations including echocardiography and dental x-rays. MRI whole spine (the entire spine is imaged since skip lesions may be present)
970
A spinal epidural abscess (SEA)- Mx?
All patients will require a long-term course of antibiotics which is at first broad spectrum but maybe later refined based on culture results. Patients with large or compressive abscesses, patients with significant or progressive neurological deficits or those who are not responding to antibiotics alone are considered for surgical evacuation of the abscess.
971
Staphylococci?
common type of bacteria that are often found normal commensal organisms but may also cause invasive disease
972
Staphylococci- 3 main facts?
Gram-positive cocci facultative anaerobes produce catalase
973
Staphylococci= 2 main types?
Staphylococcus aureus Staphylococcus epidermidis
974
Staphylococci= Staphylococcus aureus?
* Coagulase-positive * Causes skin infections (e.g. cellulitis), abscesses, osteomyelitis, toxic shock syndrome
975
Staphylococci= Staphylococcus epidermidis?
* Coagulase-negative * Cause of central line infections and infective endocarditis
976
Streptococci?
gram-positive cocci
977
Streptococci can be divided into what types?
alpha and beta haemolytic types
978
Streptococci= Alpha haemolytic streptococci (partial haemolysis)?
The most important alpha haemolytic Streptococcus is Streptococcus pneumoniae (pneumococcus). Pneumococcus is a common cause of pneumonia, meningitis and otitis media. Another clinical example is Streptococcus viridans
979
Streptococci= Beta haemolytic streptococci (complete haemolysis)- These can be subdivided into groups?
A-H Only groups A, B & D are important in humans.
980
Streptococci= Beta haemolytic streptococci (complete haemolysis)- group A?
most important organism is Streptococcus pyogenes responsible for erysipelas, impetigo, cellulitis, type 2 necrotizing fasciitis and pharyngitis/tonsillitis immunological reactions can cause rheumatic fever or post-streptococcal glomerulonephritis erythrogenic toxins cause scarlet fever
981
Streptococci= Beta haemolytic streptococci (complete haemolysis)- group B?
Streptococcus agalactiae may lead to neonatal meningitis and septicaemia
982
Streptococci= Beta haemolytic streptococci (complete haemolysis)- group D?
Enterococcus
983
Strongyloides stercoralis?
a human parasitic nematode worm. The larvae are present in soil and gain access to the body by penetrating the skin. Infection with Strongyloides stercoralis causes strongyloidiasis.
984
Strongyloides stercoralis= features?
diarrhoea abdominal pain/bloating papulovesicular lesions where the skin has been penetrated by infective larvae e.g. soles of feet and buttocks larva currens: pruritic, linear, urticarial rash if the larvae migrate to the lungs a pneumonitis similar to Loeffler's syndrome may be triggered
985
Strongyloides stercoralis= Tx?
ivermectin and albendazole are used
986
Sulfonamides MOA?
class of drug that work by inhibiting dihydropteroate synthetase
987
Antibiotic sulfonamides?
sulfamethoxazole
988
sulfonamides= co-trimoxazole?
a combination of sulfamethoxazole + trimethoprim that is used in the management of Pneumocystis jiroveci pneumonia sulfadiazine sulfisoxazole
989
examples of non-antibiotic sulfonamides?
sulfasalazine sulfonylureas
990
Adverse effects of co-trimoxazole (sulfonamides) include?
hyperkalaemia headache rash (including Steven-Johnson Syndrome)
991
Organisms causing common surgical infections?
Staphylococcus aureus Streptococcus pyogenes Escherichia coli Campylobacter jejuni Helicobacter pylori
992
Organisms causing common surgical infections= Staphylococcus aureus?
Facultative anaerobe Gram-positive coccus Haemolysis on blood agar plates Catalase positive 20% population are long term carriers Exo and entero toxin may result in toxic shock syndrome and gastroenteritis respectively Ideally treated with penicillin although many strains now resistant through beta-lactamase production. In the UK less than 5% of isolates are sensitive to penicillin. Resistance to methicillin (and other antibiotics) is mediated by the mec operon, essentially penicillin binding protein is altered and resistance to this class of antibiotics ensues Common cause of cutaneous infections and abscesses
993
Organisms causing common surgical infections= Streptococcus pyogenes?
Gram-positive, forms chain like colonies, Lancefield Group A Streptococcus Produces beta haemolysis on blood agar plates Rarely part of normal skin microflora Catalase negative Releases a number of proteins/ virulence factors into host including hyaluronidase, streptokinase which allow rapid tissue destruction Releases superantigens such as pyogenic exotoxin A which results in scarlet fever Remains sensitive to penicillin, macrolides may be used as an alternative.
994
Organisms causing common surgical infections= Escherichia coli?
Gram-negative rod Facultative anaerobe, non-sporing Wide range of subtypes and some are normal gut commensals Some subtypes such as 0157 may produce lethal toxins resulting in haemolytic-uraemic syndrome Enterotoxigenic E-Coli produces an enterotoxin (ST enterotoxin) that results in large volume fluid secretion into the gut lumen (Via cAMP activation) Enteropathogenic E-Coli binds to intestinal cells and cause structural damage, this coupled with a moderate (or in the case of enteroinvasive E-Coli significant) invasive component produces enteritis and large volume diarrhoea together with fever. They are resistant to many antibiotics used to treat gram positive infections and acquire resistance rapidly and are recognised as producing beta-lactamases
995
Organisms causing common surgical infections= Campylobacter jejuni?
Curved, Gram-negative, non-sporulating bacteria One of the commonest causes of diarrhoea worldwide Produces enteritis which is often diffuse and blood may be passed Remains a differential for right iliac fossa pain with diarrhoea Self-limiting infection so antibiotics are not usually advised. However, the quinolones are often rapidly effective.
996
Organisms causing common surgical infections= Helicobacter pylori?
Gram-negative, helix-shaped rod, microaerophilic Produces hydrogenase that can derive energy from hydrogen released by intestinal bacteria Flagellated and mobile Those carrying the cag A gene may cause ulcers It secretes urease that breaks down gastric urea> Carbon dioxide and ammonia> ammonium>bicarbonate (simplified!) The bicarbonate can neutralise the gastric acid. Usually, colonises the gastric antrum and irritates resulting in increased gastrin release and higher levels of gastric acid. These patients will develop duodenal ulcers. In those with more diffuse H-Pylori infection, gastric acid levels are lower and ulcers develop by local tissue damage from H-Pylori- these patients get gastric ulcers. Diagnosis may be made by serology (approx. 75% sensitive). Biopsy urease test during endoscopy probably the most sensitive. In patients who are colonised 10-20% risk of peptic ulcer, 1-2% risk gastric cancer, <1% risk MALT lymphoma.
997
Tetanus?
caused by the tetanospasmin exotoxin released from Clostridium tetani. Tetanus spores are present in soil and may be introduced into the body from a wound, which is often unnoticed. Tetanospasmin prevents the release of GABA, In developed countries, tetanus may be seen in intravenous drug users.
998
Tetanus= features?
prodrome fever, lethargy, headache trismus (lockjaw) risus sardonicus: facial spasms opisthotonus (arched back, hyperextended neck) spasms (e.g. dysphagia)
999
Tetanus= Mx?
supportive therapy including ventilatory support and muscle relaxants intramuscular human tetanus immunoglobulin for high-risk wounds (e.g. compound fractures, delayed surgical intervention, significant degree of devitalised tissue) metronidazole is now preferred to benzylpenicillin as the antibiotic of choice
1000
prodrome fever, lethargy, headache trismus (lockjaw) risus sardonicus: facial spasms opisthotonus (arched back, hyperextended neck) spasms (e.g. dysphagia)
?tetanus
1001
Tetracyclines?
class of antibiotics which are commonly used in clinical practice.
1002
Tetracyclines= examples?
doxycycline tetracycline
1003
doxycycline tetracycline are examples of what?
tetracyclines
1004
Tetracyclines= MOA?
protein synthesis inhibitors binds to 30S subunit blocking binding of aminoacyl-tRNA
1005
Tetracyclines= mechanism of resistance?
increased efflux of the bacteria by plasmid-encoded transport pumps, ribosomal protection
1006
Tetracyclines= indications?
acne vulgaris Lyme disease Chlamydia Mycoplasma pneumoniae
1007
Tetracyclines= adverse effects?
discolouration of teeth: therefore should not be used in children < 12 years of age photosensitivity angioedema black hairy tongue
1008
Tetracyclines= can they be given to pregnant women?
should not be given to women who are pregnant or breastfeeding due to the risk of discolouration of the infant's teeth.
1009
Toxoplasma gondii (Toxoplasmosis)?
an obligate intracellular protozoan that infects the body via the gastrointestinal tract, lung or broken skin. It's oocysts release trophozoites which migrate widely around the body including to the eye, brain and muscle. The usual animal reservoir is the cat, although other animals such as rats carry the disease.
1010
Toxoplasmosis= features in immunocompetent pts?
Most infections are asymptomatic. Symptomatic patients usually have a self-limiting infection, often having clinical features resembling infectious mononucleosis (fever, malaise, lymphadenopathy). Other less common manifestations include meningoencephalitis and myocarditis.
1011
Toxoplasmosis= Ix and Mx in immunocompetent pts?
Serology is the investigation of choice. No treatment is usually required unless the patient has a severe infection or is immunosuppressed.
1012
Toxoplasmosis= HIV/immunosuppressed pts?
Cerebral toxoplasmosis accounts for around 50% of cerebral lesions in patients with HIV: - constitutional symptoms, headache, confusion, drowsiness - CT: usually single or multiple ring-enhancing lesions, mass effect may be seen - management: pyrimethamine plus sulphadiazine for at least 6 weeks Immunosuppressed patients may also develop a chorioretinitis secondary to toxoplasmosis.
1013
Congenital toxoplasmosis?
Congenital toxoplasmosis is due to transplacental spread from the mother. It causes a variety of effects to the unborn child including neurological damage: - cerebral calcification - hydrocephalus - chorioretinitis ophthalmic damage: - retinopathy - cataracts
1014
Trimethoprim?
antibiotic, mainly used in the management of urinary tract infections
1015
Trimethoprim MOA?
interferes with DNA synthesis by inhibiting dihydrofolate reductase may, therefore, interact with methotrexate, which also inhibits dihydrofolate reductase
1016
Trimethoprim adverse effects?
myelosuppression transient rise in creatinine: trimethoprim competitively inhibits the tubular secretion of creatinine resulting in a temporary increase which reverses upon stopping the drug trimethoprim blocks the ENaC channel in the distal nephron, causing a hyperkalaemic distal RTA (type 4). It also inhibits creatinine secretion, often leading to an increase in creatinine by around 40 points (but not necessarily causing AKI)
1017
Trimethoprim= why does it cause a transient rise in creatinine?
competitively inhibits the tubular secretion of creatinine resulting in a temporary increase which reverses upon stopping the drug trimethoprim blocks the ENaC channel in the distal nephron, causing a hyperkalaemic distal RTA (type 4). It also inhibits creatinine secretion, often leading to an increase in creatinine by around 40 points (but not necessarily causing AKI)
1018
Trimethoprim in pregnancy?
Teratogenic risk in first trimester (folate antagonist). Manufacturers advise avoid during pregnancy.
1019
Trypanosomiasis?
Two main form of this protozoal disease are recognised - African trypanosomiasis (sleeping sickness) and American trypanosomiasis (Chagas' disease).
1020
Trypanosomiasis= African trypanosomiasis, or sleeping sickness- features?
Two forms of African trypanosomiasis, or sleeping sickness, are seen - Trypanosoma gambiense in West Africa and Trypanosoma rhodesiense in East Africa. Both types are spread by the tsetse fly. Trypanosoma rhodesiense tends to follow a more acute course. Clinical features include: Trypanosoma chancre - painless subcutaneous nodule at site of infection intermittent fever enlargement of posterior cervical lymph nodes later: central nervous system involvement e.g. somnolence, headaches, mood changes, meningoencephalitis
1021
Trypanosomiasis= African trypanosomiasis, or sleeping sickness- Mx?
early disease: IV pentamidine or suramin later disease or central nervous system involvement: IV melarsoprol
1022
Trypanosomiasis= American trypanosomiasis, or Chagas' disease?
caused by the protozoan Trypanosoma cruzi. The vast majority of patients (95%) are asymptomatic in the acute phase although a chagoma (an erythematous nodule at site of infection) and periorbital oedema are sometimes seen. Chronic Chagas' disease mainly affects the heart and gastrointestinal tract myocarditis may lead to dilated cardiomyopathy (with apical atophy) and arrhythmias gastrointestinal features includes megaoesophagus and megacolon causing dysphagia and constipation
1023
Trypanosomiasis= American trypanosomiasis, or Chagas' disease- Mx?
treatment is most effective in the acute phase using azole or nitroderivatives such as benznidazole or nifurtimox chronic disease management involves treating the complications e.g., heart failure
1024
Vancomycin?
a glycopeptide antibiotic used in the treatment of Gram-positive infections, particularly methicillin-resistant Staphylococcus aureus (MRSA).
1025
Vancomycin= MOA?
inhibits cell wall formation by binding to D-Ala-D-Ala moieties, preventing polymerization of peptidoglycans
1026
Vancomycin= mechanism of resistance?
alteration to the terminal amino acid residues of the NAM/NAG-peptide subunits (normally D-alanyl-D-alanine) to which the antibiotic binds
1027
Vancomycin= adverse effects?
nephrotoxicity ototoxicity thrombophlebitis red man syndrome; occurs on rapid infusion of vancomycin
1028
Yellow fever?
Type of viral haemorrhagic fever (also dengue fever, Lassa fever, Ebola). zoonotic infection: spread by Aedes mosquitos incubation period = 2 - 14 days
1029
Yellow fever= features?
may cause mild flu-like illness lasting less than one week classic description involves sudden onset of high fever, rigors, nausea & vomiting. Bradycardia may develop. A brief remission is followed by jaundice, haematemesis, oliguria if severe jaundice, haematemesis may occur Councilman bodies (inclusion bodies) may be seen in the hepatocytes
1030
Mx of venom allergy?
Broadly speaking, the management of venom allergy in the acute phase is supportive. Anaphylaxis should be managed with intramuscular adrenaline, intravenous steroids and intravenous anti-histamines as required. Oxygen and nebulised bronchodilators may also be required. People who've had a systemic reaction to an insect bite should be referred to an allergy specialist. Venom immunotherapy (VIT) is considered to be one of the most effective immunotherapies in use and may be recommended for patients with a history of a previous reaction which presented with airway and/or haemodynamic compromise and raised levels of venom-specific immunoglobulin E on either skin prick or in vitro testing.
1031
Testing for venom allergy is recommended in who?
any patient with a history of a systemic reaction causing airway compromise or haemodynamic instability. It may also be beneficial in patients with a history of a systemic cutaneous reaction where the allergen is felt to be difficult to avoid e.g. an allergy to bee stings in a beekeeper. Patients with a history of a systemic reaction should be provided with a self-management plan, including guidance on the use of anti-histamines and adrenaline auto-injectors. Patients should also be advised to wear a medical alert device.
1032
Venom allergy: The British Society for Allergy and Clinical Immunology guidance advises that VIT should not be performed in patients without demonstrable venom-specific IgE or in those with a recent history of anaphylaxis or systemic reaction....
Repeat allergy testing should be considered in those with a clear reaction history but no evidence of a venom-specific IgE. A baseline tryptase level should also be performed to exclude indolent mastocytosis (relevant because this may predict subsequent systemic reactions during the course of immunotherapy also should prompt further tests to exclude systemic mastocytosis or monoclonal mast cell activation syndrome). Research suggests that 'VIT is 95-100% and about 80% successful in preventing systemic reactions in wasp and bee sting allergy respectively...(and) has been shown to induce a clinically significant improvement in health-related QOL (quality of life) in patients with anaphylactic reactions as well as generalized non-life-threatening responses to yellow jacket stings...'
1033
Interferons (IFN)?
cytokines released by the body in response to viral infections and neoplasia. They are classified according to cellular origin and the type of receptor they bind to. IFN-alpha and IFN-beta bind to type 1 receptors whilst IFN-gamma binds only to type 2 receptors.
1034
Interferon-alpha?
produced by leucocytes antiviral action useful in hepatitis B & C, Kaposi's sarcoma, metastatic renal cell cancer, hairy cell leukaemia adverse effects include flu-like symptoms and depression bind to type 1 receptors
1035
Interferon-beta?
produced by fibroblasts antiviral action reduces the frequency of exacerbations in patients with relapsing-remitting MS bind to type 1 receptors
1036
Interferon-gamma?
predominately natural killer cells. Also by T helper cells weaker antiviral action, more of a role in immunomodulation particularly macrophage activation may be useful in chronic granulomatous disease and osteopetrosis bind to type 2 receptors
1037
What divides hypersensitivity reactions into 4 types?
Gell and Coombs classification
1038
Gell and Coombs classification of hypersensitivity reactions= Type I?
anaphylactic
1039
Gell and Coombs classification of hypersensitivity reactions= Type I (anaphylactic) mechanism and examples?
Antigen reacts with IgE bound to mast cells * Anaphylaxis * Atopy (e.g. asthma, eczema and hayfever)
1040
Gell and Coombs classification of hypersensitivity reactions= Type II?
Cell bound
1041
Gell and Coombs classification of hypersensitivity reactions= Type II (cell bound) mechanism and examples?
IgG or IgM binds to antigen on cell surface * Autoimmune haemolytic anaemia * ITP * Goodpasture's syndrome * Pernicious anaemia * Acute haemolytic transfusion reactions * Rheumatic fever * Pemphigus vulgaris / bullous pemphigoid
1042
Gell and Coombs classification of hypersensitivity reactions= Type III?
Immune complex
1043
Gell and Coombs classification of hypersensitivity reactions= Type III (immune complex) mechanism and examples?
Free antigen and antibody (IgG, IgA) combine * Serum sickness * Systemic lupus erythematosus * Post-streptococcal glomerulonephritis * Extrinsic allergic alveolitis (especially acute phase)
1044
Gell and Coombs classification of hypersensitivity reactions= Type IV?
Delayed hypersensitivity
1045
Gell and Coombs classification of hypersensitivity reactions= Type IV (delayed hypersensitivity) mechanism and examples?
T-cell mediated * Tuberculosis / tuberculin skin reaction * Graft versus host disease * Allergic contact dermatitis * Scabies * Extrinsic allergic alveolitis (especially chronic phase) * Multiple sclerosis * Guillain-Barre syndrome
1046
Gell and Coombs classification of hypersensitivity reactions= recently a Type V has been added, what is this?
Antibodies that recognise and bind to the cell surface receptors. This either stimulating them or blocking ligand binding * Graves' disease * Myasthenia gravis
1047
What type of hypersensitivity reaction is anaphylaxis?
1
1048
What type of hypersensitivity reaction is asthma?
1
1049
What type of hypersensitivity reaction is pernicious anaemia?
2
1050
What type of hypersensitivity reaction is rheumatic fever?
2
1051
What type of hypersensitivity reaction is SLE?
3
1052
What type of hypersensitivity reaction is post-steptococcal glomerulonephritis?
3
1053
What type of hypersensitivity reaction is allergic contact dermatitis?
4
1054
What type of hypersensitivity reaction is MS?
4
1055
What type of hypersensitivity reaction is graves and myasthenia gravis?
5 (just added)
1056
Way to remember the types of hypersensitivity reactions?
ACID Anaphylactic-Type 1 Cell bound- Type 2 Immune Complex- Type 3 Delayed hypersensitivity- Type 4
1057
How many types of immunoglobulin are there in the body?
5
1058
Name the 5 types of immunoglobulin?
IgG IgA IgM IgD IgE
1059
Immunoglobulins= IgG frequency and shape?
75% monomer
1060
Immunoglobulins= IgA frequency and shape?
15% monomer/dimer
1061
Immunoglobulins= IgM frequency and shape?
10% pentamer
1062
Immunoglobulins= IgD frequency and shape?
1% monomer
1063
Immunoglobulins= IgE frequency and shape?
0.1% monomer
1064
Most abundant immunoglobulin?
IgG but IgA most commonly produced in the body (blood concs lower than IgG)
1065
What is immunoglobulin IgG?
* Enhance phagocytosis of bacteria and viruses * Fixes complement and passes to the fetal circulation * Most abundant isotype in blood serum
1066
What is immunoglobulin IgA?
* IgA is the predominant immunoglobulin found in breast milk. It is also found in the secretions of digestive, respiratory and urogenital tracts and systems * Provides localized protection on mucous membranes * Most commonly produced immunoglobulin in the body (but blood serum concentrations lower than IgG.) * Transported across the interior of the cell via transcytosis
1067
Predominant immunoglobulin found in breast milk?
IgA
1068
What is immunoglobulin IgM?
* First immunoglobulins to be secreted in response to an infection * Fixes complement but does not pass to the fetal circulation * Anti-A, B blood antibodies (note how they cannot pass to the fetal circulation, which could of course result in haemolysis) Pentamer when secreted
1069
What is immunoglobulin IgD?
* Role in immune system largely unknown * Involved in activation of B cells
1070
What is immunoglobulin IgE?
* Mediates type 1 hypersensitivity reactions * Synthesised by plasma cells * Binds to Fc receptors found on the surface of mast cells and basophils * Provides immunity to parasites such as helminths * Least abundant isotype in blood serum
1071
What immunoglobulin enhances phagocytosis of bacteria and viruses?
IgG
1072
What immunoglobulin in found in secretions of digestive, resp and urogenital tracts & provides localised protection on mucous membranes?
IgA
1073
What is the first immunoglobulin to be secreted in response to an infection?
IgM
1074
What immunoglobulin is involved in the activation of B cells?
IgD
1075
What immunoglobulin mediates type 1 hypersensitivity reactions?
IgE
1076
What immunoglobulin is synthesised by plasma cells?
IgE
1077
Neonatal sepsis occurs when?
a serious bacterial or viral infection in the blood affects babies within the first 28 days of life
1078
Neonatal sepsis is characterised into what?
early-onset (EOS, within 72 hours of birth) and late-onset (LOS, between 7-28 days of life) sepsis, with each category tending to have a distinct group of causes and common presentations
1079
Prognosis of neonatal sepsis?
account for 10% of all neonatal mortality and therefore must be promptly identified and managed to prevent significant consequences, as untreated, the mortality can be very high.
1080
Epidemiology of neonatal sepsis?
Male:female incidence 1:1 Incidence of neonatal sepsis: 1-5 per 1000 live births * Term neonates: 1-2 per 1000 live births * Late pre-term infants: 5 per 1000 live births * Birth weight <2.5kg: 0.5 per 1000 live births Black race is an independent risk factor for group B streptococcus-related sepsis
1081
Neonatal infection is present in 8 per 1000 live births (note: this is the incidence of neonatal infection, not yet necessarily progressed to neonatal sepsis), and is the key factor which leads to subsequent....
life-threatening sepsis
1082
Most common cause of neonatal sepsis (2/3rds)?
group B strep (GBS) and E.coli
1083
Main cause of early-onset neonatal sepsis (within 72hrs of birth)?
GBS infection (75%) Infective causes in early-onset sepsis are usually due to transmission of pathogens from the mother to the neonate during delivery
1084
Cause of late-onset neonatal sepsis (7-28 days of life)?
usually occurs via the transmission of pathogens from the environment post-delivery, this is normally from contacts such as the parents or healthcare workers Infective causes are more commonly coagulase-negative staphylococcal species such as Staphylococcus epidermidis, Gram-negative bacteria such as Pseudomonas aeruginosa, Klebsiella and Enterobacter, and fungal species
1085
Less common causes of neonatal sepsis?
Staphylococcus aureus Enterococcus Listeria monocytogenes Viruses including herpes simplex and enterovirus
1086
RFs for neonatal sepsis?
Mother who has had a previous baby with GBS infection, who has current GBS colonisation from prenatal screening, current bacteruria, intrapartum temperature ≥38ºC, membrane rupture ≥18 hours, or current infection throughout pregnancy Premature (<37 weeks): approximately 85% of neonatal sepsis cases are in premature neonates Low birth weight (<2.5kg): approximately 80% are low birth weight Evidence of maternal chorioamnionitis
1087
Presentation of neonatal sepsis?
subacute onset of.... Respiratory distress (85%)= Grunting, Nasal flaring, Use of accessory respiratory muscles, Tachypnoea Tachycardia: common, but non-specific Apnoea (40%) Apparent change in mental status/lethargy Jaundice (35%) Seizures (35%): if cause of sepsis is meningitis Poor/reduced feeding (30%) Abdominal distention (20%) Vomiting (25%) Temperature: not usually a reliable sign as the temperature can vary from being raised, lowered or normal Term infants are more likely to be febrile Pre-term infants are more likely to be hypothermic The clinical presentation can vary from very subtle signs of illness to clear septic shock Frequently, the symptoms will be related to the source of infection (e.g. pneumonia + respiratory symptoms, meningitis + neurological symptoms)
1088
Signs of resp distress in neonatal sepsis (85%)?
Grunting Nasal flaring Use of accessory respiratory muscles Tachypnoea
1089
Temperature in neonatal sepsis?
not usually a reliable sign as the temperature can vary from being raised, lowered or normal Term infants are more likely to be febrile Pre-term infants are more likely to be hypothermic
1090
Ix for neonatal sepsis?
Blood culture: this will usually establish the diagnosis, as the sensitivity for septicaemia is around 90%. Should usually obtain two blood cultures if possible to distinguish from contamination, however one culture is still sufficient depending on hospital protocol Full blood examination: neonatal sepsis is often associated with abnormal neutrophil counts (both neutrophilia and neutropenia), however in neonates, parameters on full blood examination are usually not always useful for diagnosis, rather may help to exclude healthy neonates C-reactive protein: not useful for diagnosis, but sequential assessment will help to guide management and patient progress with treatment. CRP will usually be raised, and a persistently normal level is likely to exclude neonatal sepsis Blood gases: metabolic acidosis is particularly concerning for neonatal sepsis, particularly a base deficit of ≥10 mmol/L Urine microscopy, culture and sensitivity: rarely positive in EOS, more useful in LOS. Will show signs of infection (e.g. raised leukocytes, positive culture, haematuria, proteinuria) if urinary tract infection is the source of sepsis Lumbar puncture: particularly if there is concern of meningitis as the source of sepsis based on clinical features, however many hospitals will require lumbar puncture as part of a septic screen in any baby below the age of 28 days
1091
What signs on blood gas is particularly concerning in neonatal sepsis?
metabolic acidosis esp if a base deficit of ≥10 mmol/L
1092
Mx of neonatal sepsis?
early identification and treatment IV benzylpenicillin with gentamicin as a first-line regimen for suspected or confirmed neonatal sepsis - The exception to this is if microbiological surveillance data reveal local bacterial resistance patterns, in which case an alternative antibiotic should be considered Maintaining adequate oxygenation status Maintaining normal fluid and electrolyte status: severely ill neonates may require volume and/or vasopressor support. Body weight needs to be measured daily for accurate assessment of fluid status Prevention and/or management of hypoglycaemia Prevention and/or management of metabolic acidosis
1093
Duration of Abx in neonatal sepsis?
- CRP should be re-measured 18-24 hours after presentation in babies given antibiotics to monitor ongoing progress and guide duration of therapy - The evidence suggests that antibiotics can be ceased at 48 hours in neonates who have CRP of <10 mg/L and a negative blood culture at presentation and at 48 hours - In all other neonates, the duration of antibiotic treatment will depend on the ongoing investigations and clinical picture, this will involve specialist decision making. Normally, in neonates with culture-proven sepsis, duration will be approximately 10 days
1094
Neonatal sepsis= how to monitor fluid status in very ill neonates who may require volume and/or vasopressor support?
body weight measured daily
1095
Abx 1st line for suspected or confirmed neonatal sepsis?
IV benzylpenicillin + gentamicin unless microbiological surveillance data reveal local bacterial resistance patterns, in which case an alternative antibiotic should be considered
1096